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Summary 
 
Cytokinesis is the process that divides the cytoplasm of a parent cell into two. In animal 
cells, cytokinesis requires the formation of the central spindle and the contractile ring 
structures. The onset of cytokinesis is marked during anaphase with the specification of 
the division site, followed by cleavage furrow formation and ingression, midbody 
formation and abscission. The astral microtubules that originate from the centrosomes 
and the anti-parallel microtubules of the central spindle are proposed to determine the site 
of cleavage furrow formation (Bringmann and Hyman, 2005). The acto-myosin based 
contractile ring assembles at the division site and constricts the cytoplasm which is 
supported by the fusion of membrane vesicles to the ingressing plasma membrane. All 
these processes together result in the formation of two daughter cells.  
The small GTPase RhoA is one of the most upstream regulators of contractile ring 
assembly at the cortex. Rho proteins are activated by GEF’s (guanine nucleotide 
exchange factors) and one GEF that is required for cytokinesis is Ect2 (epithelial cell 
transforming protein2) (Tatsumoto et al., 1999).  
The Drosophila pebble (pbl) gene product is the founding member of the Ect2 
protein family and has been shown to be required for cytokinesis (Lehner, 1992). In 
mammals, Ect2 was originally identified as a transforming protein in an expression 
cloning assay (Miki et al., 1993) and subsequently shown to be essential for cytokinesis. 
In this study, we have explored the temporal and spatial mechanisms that regulate Ect2 
function. In agreement with previous studies, we show that Ect2 is a cell cycle regulated 
protein and is phosphorylated during mitosis. We identify a number of potentially 
interesting endogenous phosphorylation sites in Ect2, including potential Plk1 and Cdk1 
sites. Although we have not been able to determine the function of these phosphorylation 
sites, their strong conservation among different species implies that they accomplish 
evolutionarily conserved roles.The identification of these phosphorylation sites sets the 
stage for future functional analyses. 
In complementary studies, we have shown that the central spindle and cell cortex 
localizations of Ect2 are facilitated by the BRCT and PH domains, respectively. The 
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targeting of Ect2 to the central spindle is mediated by the MKlp1/MgcRacGAP and 
MKlp2/Aurora-B complexes. Of the two complexes, we show that Ect2 interacts and 
colocalizes only with the MKlp1/MgcRacGAP complex in telophase and propose that 
this interaction is mediated by a phosphorylation dependent docking mechanism that 
targets Ect2 to the central spindle. Interestingly, the displacement of Ect2 from the central 
spindle did not prevent cytokinesis, suggesting that localized GEF activity is not 
absolutely essential for cleavage furrow ingression and cytokinesis. 
In the second part of this thesis, we have explored the role of Ect2 during 
cytokinesis and show that, in Ect2 depleted cells, levels of RhoA and Citron kinase are 
diminished at the cleavage site, concomitant with the impairment of cleavage furrow 
formation and ingression. Additionally, overexpression of appropriate amino-terminal 
Ect2 fragments in cells also hinders cytokinesis. In these cells, RhoA and Citron kinase 
localize to the cortex and cleavage furrow ingression occurs, but, the subsequent 
abscission fails. Taken together, these results suggest that proper function of Ect2 is not 
only important for cleavage furrow ingression, but also for cell abscission. Finally, we 
investigate the overexpression phenotypes of different Ect2 truncation mutants. We show 
that abscission failure correlates with the persistence of amino-terminal Ect2 fragments at 
striking ring-like structures surrounding the midbody, indicating that completion of cell 
division requires the displacement of Ect2 from the contractile ring and its re-import into 
the reforming cell nucleus. Collectively, our data indicate that multiple mechanisms 
cooperate to regulate Ect2 in a spatial-temporal manner.  
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1.0 Introduction 
 
1.1 Overview of the cell cycle 
 
The ‘cell theory’ states that all organisms are composed of similar units of organization, 
called cells. This was formally articulated in 1839 by Schleiden and Schwann and has 
ever since remained as the foundation of modern cell biology. The correct interpretation 
for the formation of cells was first phrased by Rudolph Virchow in the form of a 
powerful dictum, ‘Omnis cellula e cellula’, which means that each cell can only arise 
from a pre-existing cell (Virchow, 1854). Cells are generated by means of cell division 
and, whereas in bacteria and yeast a single round of cell division is enough to give rise to 
a new complete organism, in higher eukaryotes more complex rounds of cell division 
occur for various purposes such as replenishing old cells, growth of an organism or 
wound healing. The detailed mechanisms of cell division vary from organism to 
organism, but the most fundamental and conserved aspect of cell division is to pass on 
the genetic information to the newly formed daughter cell. In order to accomplish this, 
the genetic material of the existing cell is first duplicated and then equally segregated 
between the two daughter cells during the process of division so that each cell retains a 
single copy of the genetic material. 
The eukaryotic cell cycle is divided into four phases: G1 (Gap phase1), S 
(Synthesis phase), G2 (Gap phase2) and M (Mitosis and cytokinesis) phase (Fig. 1). DNA 
synthesis occurs in S phase, which lasts about half of the time of the mammalian cell 
cycle. In M phase, a series of events take place beginning with nuclear envelope 
breakdown, chromosome condensation, chromosome alignment, sister chromatid 
segregation and reformation of the new nuclei in the daughter cells. Apart from DNA 
synthesis and chromosome segregation, the cell has to increase its mass and double its 
organelles. This occurs primarily during G1 phase (between M phase and S phase) and 
G2 phase (between S phase and M phase). The length of G1 phase varies depending on 
external conditions and signals from other cells. For example, if the conditions are 
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unfavourable for continued proliferation, cells delay progression through G1 phase and 
may even enter into a resting phase termed G0. However, if the conditions are 
favourable, cells complete G1 phase passing through a point called start in yeast or 
restriction point in mammalian cells after which cells are committed to S phase. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic illustration of different 
phases of the cell cycle. Interphase is 
divided into G1, S and G2 phases. M phase 
is further divided into mitosis (nuclear 
division) and cytokinesis (cytoplasmic 
division). Image adapted from Alberts et al, 
Molecular Biology of the Cell, fourth 
edition, 2002. 
 
 
 
 
1.1.1 An overview of mitosis 
 
M phase is the most remarkable event of the cell cycle. Although it lasts only about 1 
hour in human somatic cells, essential steps of the cell cycle like equal segregation of 
genetic and cytoplasmic material occur during this phase. All important steps of mitosis 
were already described more than 100 years ago by the German anatomist, Walther 
Flemming (Flemming, 1882)(more reading in (Paweletz, 2001)). In brief, mitosis is 
divided into prophase, prometaphase, metaphase, anaphase and telophase (Fig. 2). During 
prophase, the interphase chromatin compresses to form condensed chromosomes. The 
previously duplicated centrosomes, the major microtubule-organizing centres (MTOC) in 
animal cells, increase the nucleation of highly dynamic MTs (microtubules) resulting in 
spindle aster formation (Doxsey, 2001; Meraldi and Nigg, 2002; Paoletti and Bornens, 
1997). During prometaphase, MTs are captured by dense proteinaceous material called 
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kinetochores situated on the centromeres of the mitotic chromosomes. The capture of 
MTs emanating from opposite poles to sister chromatids is essential for the congression 
of chromosomes to an equatorial plane termed the metaphase plate. This results in the 
formation of the characteristic bipolar mitotic spindle. A surveillance mechanism, the 
spindle checkpoint, ensures that chromosome segregation can only occur when all 
chromosomes have attached to MTs in a bipolar manner (Rieder et al., 1995; Rudner and 
Murray, 1996; Wells, 1996). Sister chromatids are held together by a protein complex 
consisting of cohesin proteins (Hagstrom and Meyer, 2003). Sudden loss of cohesin 
between sister chromatids marks the onset of anaphase-A, during which sister chromatids 
are pulled towards the poles by shortening of kinetochore MTs (Hauf et al., 2001; Page 
and Hieter, 1999). Then, the poles move towards the cell cortex during anaphase-B 
assisting further sister chromatid separation. During anaphase, the mitotic spindle is 
transformed into a centrally located structure consisting of non-kinetochore, anti-parallel 
MTs called the central spindle (Burgess and Chang, 2005; Glotzer, 2001). During 
telophase and cytokinesis, chromatin de-condensation begins and the nuclear envelope 
reforms.  
 
 
 
 
 
 
 
 
 
 
   
 Astral MTs 
Central spindle 
 
 
 Figure 2. M phase progression in animal somatic cells. 
Schematic representation of different stages of mitosis and cytokinesis. Mitosis is broadly divided into 
prophase, prometaphase, metaphase, anaphase and telophase. Cytokinesis is intimately linked to 
mitosis. The colours shown here are brown for DNA, light green for centrosomes and dark green for 
MTs. Image adapted from Alberts et al, Molecular Biology of the Cell, fourth edition, 2002.  5 
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1.1.2 An overview of cytokinesis 
 
Cytokinesis is the process of partitioning cellular contents such as chromosomes, 
cytoplasm and organelles into two daughter cells (Fig. 2). Cytokinesis is intimately linked 
to mitosis. Cytokinesis begins at the onset of anaphase-A with the specification of the 
cleavage site. The mitotic spindle plays a key role in determining the site of cleavage 
furrow formation which generally occurs equatorially in animal cells. The cleavage 
furrow contains actin, myosin and other proteins that are organized into a contractile ring-
like structure called the actomyosin ring. Upon ingression, the cleavage furrow constricts 
the components of the central spindle into a focussed structure called the midbody. In the 
final cytokinetic event called abscission, the furrow seals generating two separated cells. 
A more detailed discussion of cytokinesis follows in the next chapter. 
 
 
1.1.3 Regulation of M phase progression 
 
Progression through different mitotic stages is predominantly regulated by two post-
translational mechanisms: protein phosphorylation and proteolysis. These two 
mechanisms are interdependent as the proteolytic machinery is controlled by 
phosphorylation and many mitotic kinases are downregulated by degradation (Nigg, 
2001). 
Out of a handful of known mitotic kinases, Cdk1 (Cyclin dependent kinase1) is 
considered as the master kinase involved in the regulation of mitotic progression 
(Morgan, 1997; Murray, 2004; Nigg, 1995). In general, the Cdks (Cyclin dependent 
kinases) are a family of heterodimeric serine/threonine protein kinases each consisting of 
a catalytic Cdk subunit and an activating cyclin subunit (Hunt, 1991; Nigg, 1995; Pines, 
1993a). The levels of cyclin subunits are extensively controlled by regulated proteolysis 
(Evans et al., 1983). The destruction of mitotic cyclins is important for the onset of 
telophase, as well as for the preparation for the next cell cycle (King et al., 1996). 
Moreover, each Cdk catalytic subunit binds to only a subset of cyclins facilitating the 
controlled and cyclin regulated progression of the cell cycle. For example, Cdk2 interacts 
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with cyclin E at the beginning of S phase to induce the initiation of DNA synthesis, and 
then binds cyclin A throughout S phase (Morgan, 1997). Cdk1 interacts with cyclin A 
and contributes to the preparation for mitosis (Edgar and Lehner, 1996; Nigg, 1995), and 
then with cyclin B to form the Cdk1-cyclin B complex for the initiation of mitosis (Pines, 
1993b).  
Cdks are regulated by several processes. When first synthesized, the catalytic 
Cdk1 subunit has no detectable activity. Furthermore, the Cdk1/cyclin A/B complex is 
only partially active because the Cdk1 subunit is subject to negative regulation by 
phosphorylation on two inhibitory residues in the ATP-binding site (threonine 14 and 
tyrosine 15) due to the activity of the kinases Wee1 and Myt1, respectively (Endicott et 
al., 1994). Inactivation of the Cdk1/cyclin B complex by phosphorylation on tyrosine 15 
is important for the control of initiation of mitosis (Gould and Nurse, 1989). The Cdk1-
cyclin A/B complex is activated by the dephosphorylation of these two residues by the 
dual-specificity phosphatase Cdc25C (Coleman and Dunphy, 1994). Moreover, complete 
activation of the Cdk1 kinase is accomplished by phosphorylation of threonine 161on the 
T-loop of Cdk1 (Nigg, 1996) by the Cdk-activating kinase (CAK) (Harper and Adams, 
2001). This results in additional conformational change of Cdk1 to open the catalytic 
center for substrates (Russo et al., 1996). Once activated, the Cdk1-cyclin A/B complex 
phosphorylates numerous substrates, such as nuclear lamins for nuclear envelope 
breakdown (Nigg, 1995), microtubule-binding proteins for spindle assembly (Andersen, 
1999), Golgi matrix proteins for Golgi fragmentation (Lowe et al., 1998)and condensins 
for chromosome condensation (Kimura et al., 1998). Furthermore, the activity of the 
Cdk1-cyclin A/B complexes is tightly regulated by the anaphase-promoting 
complex/cyclosome (APC/C), a core component of the mitotic ubiquitin-dependent 
proteolytic machinery (Peters, 2002). The timely degradation of cyclin B by APC/C 
results in the inactivation of Cdk1, and consequently Cdk1 substrates are 
dephosphorylated by counteracting phosphatases. Then cells exit mitosis with the 
decondensation of chromosomes and reformation of the nuclear envelope. 
Another mitotic kinase termed polo-like kinase1 (Plk1) is named after the 
Drosophila polo gene. The Plk family of protein kinases is conserved in all eukaryotes 
and bear a catalytic domain at the amino-terminus and a conserved motif, called the polo-
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box domain (PBD), in the carboxyl-terminal region (Nigg, 2001). The PBD has been 
shown to constitute a phosphopeptide binding domain and to interact with a number of 
proteins only after these have been phosphorylated on specific sites (Elia et al., 2003). 
The PBD targets Plk1 to several mitotic structures including spindle poles, kinetochores, 
and to the central spindle structures, the midzone and the midbody (Hanisch et al., 2005; 
Seong et al., 2002). Plk1 is a critical cell cycle regulator and its depletion in human cells 
results in a prometaphase-like arrest (van Vugt et al., 2004). Plk1 is required for 
centrosome maturation, bipolar spindle formation and chromosome congression (Hanisch 
et al., 2005; Lane and Nigg, 1996). Evidence for the requirement of Plk1 in cytokinesis 
comes from studies in Drosophila (Carmena et al., 1998) and yeast (Ohkura et al., 1995; 
Song and Lee, 2001). In Drosophila, polo1 allele mutants are viable although the 
spermatocytes of these mutants have cytokinesis defects. 
Aurora kinases were first identified in Drosophila, in a screen for genes that 
regulate the structure and function of the mitotic spindle (Fig.3). Of these, Aurora-A was 
found to be associated predominantly with the centrosomes from prophase to telophase 
(Berdnik and Knoblich, 2002). It has been shown that the activity of Aurora-A correlates 
with the maturation of mitotic centrosomes. The foremost function of Aurora-A is to 
assist in the maturation of duplicated centrosomes by recruiting proteins such as γ-tubulin 
(Berdnik and Knoblich, 2002), D-TACC (Drosophila-Transforming, Acidic, Coiled Coil 
containing protein) (Giet et al., 2002), SPD-2 (Kemp et al., 2004), centrosomin (Hannak 
et al., 2001; Terada et al., 2003) and chTOG (colonic and hepatic tumour overexpressed 
protein) and, consequently, to participate in spindle assembly and stability.   
Another Aurora family member, Aurora-B, localizes to kinetochores from 
prophase to metaphase, and to the central spindle and midbody in anaphase and telophase 
(Carmena and Earnshaw, 2003), and is therefore called a chromosomal passenger protein 
(Adams et al., 2000; Kaitna et al., 2000) (Fig.3). In mammalian cells, Aurora-B is part of 
a larger complex comprising INCENP, survivin and Borealin (Gassmann et al., 2004; 
Sampath et al., 2004). INCENP is a substrate of Aurora-B and binding of Aurora-B to 
INCENP activates the Aurora-B kinase activity (Bishop and Schumacher, 2002; Honda et 
al., 2003; Yasui et al., 2004). Aurora-B is required for spindle checkpoint signaling as 
depletion of Aurora-B or inhibition of Aurora-B results in the inhibition of spindle-
 8
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checkpoint function (Giet and Glover, 2001). Moreover, the Aurora-B kinase is required 
for central spindle formation and cytokinesis (Giet and Glover, 2001). A number of 
substrates of Aurora-B have been discovered including CENP-A required for 
chromosome condensation (Zeitlin et al., 2001), MCAK (mitotic centromere associated 
kinesin) required for correcting the improper attachment of MTs to kinetochores 
(Andrews et al., 2004; Lan et al., 2004), MgcRacGAP, a GTPase activating protein 
required for cytokinesis (Hirose et al., 2001; Minoshima et al., 2003) and MKlp1 (mitotic 
kinesin-like protein) which is also required for cytokinesis (Guse et al., 2005). These data 
demonstrate that Aurora kinases have multiple roles during mitosis.  
Figure 3. Role of mitotic kinases at different stages of mitosis. Image adapted from Nigg, Nature Reviews, 
Molecular Cell Biology, Volume 2, January, 2001. 
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1.2 Cytokinesis 
 
1.2.1 Cytokinesis in yeasts and plants 
 
Although the basic concepts of cell division are conserved among eukaryotes, the exact 
processes involved in cytokinesis vary in different organisms (Balasubramanian et al., 
2004). This is partially due to the different structural organization of cells from different 
organisms, like animals, plants and yeasts. Yeast genetics have been a powerful tool to 
investigate cell division, and the observations made in yeast and plants will be briefly 
discussed before elaborating animal cytokinesis in more detail.  
In the budding yeast, Saccharomyces cerevisiae, the division plane is determined 
in late G1 and reflects the position of the previous division site (bud scar) (Fig. 4A). 
Whereas haploid cells undergo axial budding in which the bud forms adjacent to the 
previous bud, in diploid cells a bipolar budding pattern can be observed in which the new 
bud forms opposite to the previous bud. These two different ways of division site 
determination are thought to be mediated by axial-specific (Bud3p, Bud4p, Axl1p) and 
bipolar-specific (Bud8p, Bud9p) cortical landmarks (Casamayor and Snyder, 2002; 
Chant, 1999; Lord et al., 2002). These landmark proteins interact with the Rsr1p GTPase 
module which controls polarized growth and organizes the actin cytoskeleton and septin 
ring at the bud neck. Septins are a family of GTP binding proteins that can assemble into 
filamentous structures and form a ring-like structure at the budneck. Septins are 
conserved from yeast to human, but are absent in plants (Gladfelter et al., 2001; Longtine 
and Bi, 2003; Trimble, 1999). In budding yeast, septins are essential for cytokinesis and 
are involved in bud-site selection (Casamayor and Snyder, 2002; Chant, 1999; Harkins et 
al., 2001). Surprisingly, however, the actomyosin ring is not absolutely essential for 
cytokinesis in budding yeast, in clear contrast to animal cells (Sanders and Field, 1994). 
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 (a) 
 
 
 
 
 
 
(b)  
 
 
 
 
(c)  
 
 
 
 
 
 
 
Figure 4. Cytokinesis in yeast and plants. 
(a) In budding yeast, the previous bud site is marked on the mother cell cortex by a bud scar. Near the 
bud scar, a ring containing septins is formed, which marks the site of the new bud. Polarized growth 
causes the new bud to grow outwards from the mother cell cortex. Image adapted from Guertin et al, 
Microbiology and Molecular Biology Reviews, June 2002, p155-178. 
(b) In fission yeast, the position of the nucleus determines the division site. Mid1p is initially in the 
nucleus in interphase. Before division, it exits the nucleus and marks the division site by associating with 
the cortex adjacent to the nucleus. Then, actin polymers are recruited to the division site. Image adapted 
from Guertin et al, Microbiology and Molecular Biology Reviews, June 2002, p155-178. 
(c) In higher plants, a phragmoplast is formed at the shortest nucleus-cortex distance, which then 
positions the medial ring like structure called preprophase band (PPB). This marks the division site in 
plants. Image adapted from Alberts et al, Molecular Biology of the Cell, fourth edition, 2002. 
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Whereas S. cerevisiae divides by budding, the fission yeast Schizosaccharomyces 
pombe divides by septum formation (Fig. 4B). In S. pombe, the division site is 
determined in G2 phase and reflects the position of the interphase nucleus. Cells with 
disrupted MTs have problems in the medial placement of the division plane, however the 
role of MTs in this process might be indirect as their primary function is to place the 
nucleus. Moreover, mutants that are defective in spindle assembly have minor defects in 
contractile ring assembly and its placement (Chang et al., 1996). Recent 
micromanipulation experiments to physically manipulate the nucleus by cell 
centrifugation (Daga and Chang, 2005) showed that the nucleus actively induces 
formation of the contractile ring during metaphase which is much earlier than in animal 
cells. Although it is not exactly clear how the nucleus positions the contractile ring, one 
candidate protein that is thought to appear first at the cleavage site is Mid1p (Bahler et 
al., 1998; Sohrmann et al., 1996). Mid1p is predominantly localized in the nucleus of 
interphase cells, but upon entry into mitosis it relocates to the cytoplasm in a reaction 
dependent on Plo1p (S. pombe polo-like kinase) which is the upstream component of the 
so called septation initiation network (SIN). In addition to Mid1p regulation, plo1p also 
has additional functions for actomyosin ring placement since Mid1p derivatives lacking a 
nuclear localization signal are unable to rescue the ring-positioning defect of plo1-1 
mutants (Paoletti and Chang, 2000). Cytoplasmic Mid1p forms a ring at the cortex 
around the equator of the cell division site. Moreover, Anillin, a mammalian orthologue 
of Mid1p also has properties of a ring organizer, but does not seem to be vital for 
cleavage furrow formation in animal cells (Oegema et al., 2000). Mid1p physically 
interacts with type II myosin heavy chain, Myo2p, and promotes the medial accumulation 
of actomyosin ring components including Myo2p, Rng2p (IQGAP), Cdc15p (PCH) and 
Cdc12 (formin), independently of actin (Balasubramanian et al., 1998; Kitayama et al., 
1997; Motegi et al., 2004; Mulvihill et al., 2000; Rajagopalan et al., 2003). Subsequently, 
actin, Cdc8p (tropomyosin) and Ain1p (α-actinin) are recruited, leading to the formation 
of the contractile ring (Wu et al., 2003). Septins do not seem to be important for 
contractile ring formation in S. pombe and only appear later in anaphase (Glotzer, 2001). 
This contractile ring finally constricts the plasma membrane and at the same time cell 
wall material is produced to form a septum across the division site.  
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One major difference between both types of yeast and animal cells is that the 
nuclear envelope of yeast does not breakdown during mitosis. As a result, the anti-
parallel MTs that are present in animal cells in the form of the central spindle (described 
later) are compartmentalized away from the cortex by the nuclear envelope in yeast. 
Therefore it might not be surprising that, in contrast to animal cells, these anti-parallel 
MTs are not important for cytokinesis in yeasts.  
Cytokinesis in plants is different from yeast and animal cells. Unlike these 
organisms which divide the cytoplasm from “outside in”, the cytoplasm in plant cells is 
partitioned from “inside out” by the formation of a new cell wall, called the cell plate, 
between the daughter cells (Jurgens, 2005; Tabata, 2000) (Fig. 4C). In plant cells, at 
some point in G2, the cortical MTs and the actin filaments rearrange to form a band, 
termed preprophase band that encircles the cell, just below the plasma membrane. The 
preprophase band determines where the new cell plate will join the mother cell wall when 
the cell divides. During telophase and cytokinesis, the phragmoplast is formed by the 
overlap of spindle MTs (Lloyd and Hussey, 2001). Golgi-derived vesicles carrying the 
cell-wall precursors associate with these MTs, accumulate in the equatorial region, and 
fuse to form the early cell plate (Otegui et al., 2001; Segui-Simarro et al., 2004; 
Steinborn et al., 2002). Subsequently, new Golgi-derived vesicles are recruited to this 
region further extending the cell plate outwards and completeing the new cell wall.  
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1.3 Cytokinesis in mammalian cells 
 
1.3.1 Division site determination in mammalian cells 
 
In animal cells, the cell division site is determined during the transition from metaphase 
to anaphase. Early studies using either MT inhibitors or cold treatment to depolymerize 
MTs established that proper positioning of the cleavage furrow requires MTs (Burgess, 
1977). Naturally, asymmetrical placement of the mitotic apparatus leads to cell cleavage 
in the vicinity of the mitotic spindle as observed in Caenorhabditis elegans, amphibian 
zygotes, sea urchin embryos (during formation of micromeres) and oocytes (during 
formation of polar body and polar lobe) (Burgess, 1977; Conrad and Williams, 1974; 
Sawai and Yomota, 1990; Schroeder, 1987). Together with a large number of other 
experiments, it is now well established that the position of the cytokinesis furrow is 
specified by the position of the mitotic spindle in animal cells. This determnation of the 
cell division site by the mitotic spindle provides an elegant way to spatially and 
temporally coordinate cell division with chromosome segregation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  MTs of the mitotic apparatus. 
MTs here are named after their geometrical 
relationships rather than their biochemical 
properties. Image adapted from Burgess et al, 
Trends in Cell Biology, vol.15, No.5, March 2005.
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The anaphase mitotic spindle is comprised of different MTs, but which MTs 
determine the place of cell division still remains unclear. Based on their geometrical 
placement, rather than their biochemical properties, the following nomenclature has been 
proposed for these MTs (Burgess and Chang, 2005) (see Fig. 5); kinetochore MTs 
emanate from centrosomes and attach to the kinetochores at the chromosomes, spindle 
midzone MTs are anti-parallel MTs that are not associated with kinetochores and are 
situated between the segregating chromosomes. Furthermore, there are two types of astral 
MTs, depending on their proximity to the cleavage furrow. Equatorial astral MTs 
emanate from the centrosomes towards the future cleavage furrow whereas polar astral 
MTs emanate from centrosomes towards the polar cell surface and away from the 
equatorial cortex (Fig. 5).  
 
 
1.3.2 Models for the roles of MTs in cleavage furrow formation 
 
A large number of studies have been conducted to reveal which MTs are important for 
cleavage furrow formation. Based on these studies, at least three (partly contradicting) 
models have been suggested (Fig. 6). According to the equatorial stimulation model, 
equatorial astral MTs determine the site of cleavage furrow formation (Fig. 6). This 
model was first proposed by Rappaport and co-workers and is based on easily 
manipulatable echinoderm eggs. For example, blocks (glass beads or oil droplets) were 
introduced to prevent putative MT signals from reaching the cortex. Only the blocks 
between asters and the equatorial region prevented cleavage furrow formation, but the 
blocks between asters and poles had little effect (Rappaport, 1968; Rappaport, 1982). 
Furrows were formed at sites that lack chromosomes, spindle midzone MTs and at 
regions where astral MTs of different poles overlapped. Based on these results it was 
suggested that determination of the cleavage furrow site is dependent on overlapping 
astral MTs and independent of central spindle MTs and chromosomes (Fig. 7a-7d).  
An alternative view is that MTs themselves are sufficient for cleavage furrow 
formation. This is based on micromanipulation experiments in grasshopper spermatocytes 
in which centrosomes and chromosomes were removed (Alsop and Zhang, 2003). In 
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these cells some MTs formed bundles and some partial furrow ingression was observed, 
even though no real cleavage furrowing occurs. This rather artificial situation suggested 
that MTs are important, but did not provide evidence as to which MTs induce cleavage 
furrowing in an unperturbed situation (Fig. 7e-7h).   
More recently, monastrol, an inhibitor of the Eg5 kinesin motor, was used to 
generate monopolar spindles (Canman et al., 2003) (Fig. 7i-7l). Inhibition of the spindle 
checkpoint in these cells resulted in the induction of a cleavage furrow distal to the 
chromosomes where equatorial astral MTs interact with the cell cortex. This experiment 
suggested that the equatorial astral MTs themselves can provide the signal and that it is 
not necessary to have astral MTs coming from opposite poles as suggested by Rappaport 
and co-workers. In addition, the authors showed that the plus ends of these MTs were 
slightly more stable at the future cleavage site, which indicates that factors at these 
microtubule plus ends might contribute to the furrowing process (Canman et al., 2003). 
The exact mechanism, however, remains elusive. 
   
 
 
 
        Equatorial stimulation                                 Polar relaxation                                             Spindle midzone model       
 
Figure 6. Different models for the roles of MTs in cleavage furrow induction. 
Equatorial stimulation model: Here, the overlapping equatorial MTs from opposite poles impart a 
positive signal (red arrows) for cleavage furrow induction at the equatorial cortex. 
Polar relaxation model:  The cortical tension of the polar cortical region is relieved by the polar astral 
MTs (red arrows), resulting in increased tension and cleavage furrow induction at the equatorial cortical 
region, only. 
Spindle midzone model:  Proteins associated with the spindle midzone MTs move towards the cell cortex 
or send signals that induce cleavage furrow formation.   
Image adapted and modified from Burgess et al, Trends in Cell Biology, Vol.15, No.3, March, 2005 
 
 
 
 
 
 
 
 
 16
Introduction                              
 
 
 
 
 
Figure 7. Micromanipulation experiments performed to uncover the structures important for cleavage 
furrow induction. 
Panels a–d show the experiment performed by Rappaport in sand dollar eggs. 
 A glass bead is pressed through the centre of a sand dollar egg to generate a doughnut-shaped cell. (a) 
The first cell cleavage generates a horseshoe-shaped cell. Two spindles are present during the second cell 
division, one in each arm of the horseshoe. (b) During the second cell division, cleavage furrows that bisect 
each spindle are formed. (c, d) In addition to the cleavage furrows bisecting the two spindles, a third 
furrow appears between the two aster poles. Image adapted from Maddox et al, Nature Cell Biology, vol. 5, 
No.9, September 2003. 
Panels e–h summarize the experiments of Alsop and Zhang in grasshopper spermatocytes.  
(e, f) The centrosomes (blue) and chromatin (grey) are removed from a metaphase grasshopper 
spermatocyte using a micromanipulation needle. (g) The spindle collapses, leaving only dynamic MTs in a 
disorganized array. (h) After a delay variable duration, some MTs have self-assembled into a bundle. An F-
actin-enriched furrow (thickened black line) ingresses in proximity to the centre of this bundle. Image 
adapted from Maddox et al, Nature Cell Biology, vol. 5, No.9, September 2003.  
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Panels i–l summarize the experiments of Canman and co-workers in Ptk1 cells. 
 (i) Centrosome separation in a Ptk1 cell is inhibited with monastrol, resulting in a monopolar spindle. (j) 
The spindle checkpoint is overridden by injection of reagents that inhibit checkpoint components. The cell 
then enters into anaphase. (k) In anaphase, a sub-population of stable MTs (solid yellow lines) that 
originate in the vicinity of chromosomes and terminate at the cortex are observed. (l) In telophase, the cell 
furrows (thickened black lines) where the stable MTs make contact with the cortex. Chromosomal 
passenger proteins (red dots) are observed in the region of the furrow. Stable MTs are shown as solid lines, 
whereas more dynamic MTs are indicated with dashed lines. Image adapted from Maddox et al, Nature 
Cell Biology, vol. 5, No.9, September 2003. 
 
 
Another model, the polar relaxation model, suggests an alternative mechanism, 
namely that MTs interacting with the cortex inhibit cleavage furrow formation (Fig. 6). 
This model is based on the observation that equatorial astral MTs in eggs are less dense at 
the cortex of the future cell division site than polar astral MTs at polar regions (Asnes and 
Schroeder, 1979; Dechant and Glotzer, 2003; White and Borisy, 1983; Yoshigaki, 2003). 
This lower MT density at the cell equator is thought to induce a relaxing effect for the 
invagination of the cleavage furrow.  
 Currently, one of the most attractive models is the spindle midzone model, which 
is supported by an increasing amount of genetic evidence, as discussed below (Glotzer, 
2001). According to this model, the anti-parallel central spindle MTs are required for 
cleavage furrow formation (Cao and Wang, 1996; Wheatley and Wang, 1996) (Fig. 6). 
Disruption of the central spindle by either micromanipulation or genetic approaches 
cause varying degrees of cytokinesis defects (Bonaccorsi et al., 1998; Cao and Wang, 
1996; Dechant and Glotzer, 2003). Moreover, as discussed below, a number of central 
spindle localized proteins are required for proper cytokinesis. Nevertheless, there is also 
some evidence that cleavage furrow formation is not entirely dependent on the central 
spindle. It has been shown that in cells depleted of the central spindle protein PRC1, 
central spindle formation is severely affected, but cleavage furrowing still occurs 
(Mollinari et al., 2005). However, it cannot be excluded that some central spindle like 
MTs are sufficient to induce cleavage furrowing in these cells.  
A recent report by Bringmann et al (Nature 2005) suggested that the cytokinesis 
furrow is positioned by two consecutive signals. They examined the relative contributions 
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of astral and spindle midzone MTs to position the cytokinetic furrow in the C.elegans 
zygote. By using an ultraviolet laser, they ablated one aster and could show that the 
cytokinesis furrow is first positioned by a signal determined by microtubule asters, and 
later a second signal is derived from the spindle midzone (Bringmann and Hyman, 2005). 
Thus, the equatorial stimulation and spindle midzone model seems to co-operate in this 
system to form a proper cleavage furrow. In eggs unlike mammalian somatic cells, the 
central spindle is relatively small compared to the whole cell volume and only occupies a 
small region within the egg. Therefore, in an egg, initial cleavage furrow formation might 
depend on astral MTs that contact the cell cortex. Once the initial cleavage furrow 
approaches the neighbourhood of the central spindle, the central spindle dominates 
further cleavage furrow ingression. Whether this also holds true for mammalian somatic 
cells is not yet clear. In mammalian somatic cells, as the central spindle is in close 
proximity of the cell cortex, the initial contribution of astral MTs may not be as dominant 
as in eggs. All together, these results show that different experiments in diverse cell 
types, using various techniques, have revealed alternative answers as which MTs are 
important for cleavage furrow ingression. This is partly owing to the diversity in biology, 
differences in experimental approaches and multiple or redundant mechanisms. 
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1.4 Central spindle and contractile ring formation 
 
1.4.1 The central spindle and its components 
 
Cytokinesis is a complex process and involves numerous proteins (Table.1). One of the 
structures important for cytokinesis is the central spindle which is formed upon the 
metaphase to anaphase transition. At this point, the chromosomes start to seperate on 
shrinking kinetochore MTs, and anti-parallel microtubule bundles are formed between 
the segregating chromosomes. As mentioned above, the central spindle complex is 
composed of anti-parallel MTs to which a variety of proteins associate that regulate its 
structure and function. Among these proteins are the kinesin motor proteins, MKlp1 
(Kuriyama et al., 2002), MKlp2 (Neef et al., 2003) and Kif4 (Lee and Kim, 2004), the 
mitotic protein kinases Plk1 and Aurora-B (Barr et al., 2004; Giet et al., 2005), structural 
proteins like PRC1 (Jiang et al., 1998), a GTPase activating protein termed MgcRacGAP 
(Hirose et al., 2001) and the guanine nucleotide exchange factor (GEF), Ect2 (Tatsumoto 
et al., 1999).  
PRC1 has been shown to form a complex with Kif4, CENP-E and MKlp1 
(Kurasawa et al., 2004). MKlp1 also forms a complex with MgcRacGAP (a complex also 
termed central spindlin) (Mishima et al., 2002) whereas MKlp2 associates with Plk1 and 
Aurora-B (Gruneberg et al., 2004; Neef et al., 2003). Depletion of PRC1 by small 
interfering RNA (siRNA) almost completely abolishes central spindle formation and the 
depletion of the other subcomplex components also strongly affect central spindle 
formation resulting in cytokinesis failure (Mollinari et al., 2005). Only mammalian Plk1 
was not fully investigated in this regard, since depletion or inactivation of this kinase by 
antibody microinjection results in a prometaphase like arrest (Lane and Nigg, 1996; van 
Vugt et al., 2004) and therefore its exact role in later mitotic stages has been difficult to 
study in mammalian cells. However, over expression studies indicate a role for Plk1 in 
cytokinesis (Meraldi et al., 2002; Mundt et al., 1997). Moreover, investigations of Plk1 
homologues in yeast (Ohkura et al., 1995; Song and Lee, 2001)and Drosophila (Carmena 
et al., 1998) have shown that Plk1 indeed plays an important role in cytokinesis. How 
these complexes contribute to central spindle formation remains unclear, but at least in 
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vitro these complexes have strong MT bundling activity, suggesting that these complexes 
can bundle anti-parallel MTs in vivo. Interestingly, the formation and microtubule 
bundling activity of complexes comprising MKlp1 and PRC1 are regulated by reversible 
phosphorylation (Mishima et al., 2004; Mollinari et al., 2002). Mutations of Cdk1 
phosphorylation sites in PRC1 result in premature bundling of spindle MT before the 
onset of anaphase (Mollinari et al., 2002). Similarly, MKlp1 phosphorylation by Cdk1 
prevents the association of MKlp1 with the metaphase spindle and thus inhibits the 
bundling of MTs nucleated at this stage of the cell cycle (Mishima et al., 2004). Only 
upon transition from metaphase to anaphase, when Cdk1 activity drops, these proteins are 
dephosphorylated and therefore able to localize to the central spindle and to function in 
bundling the anti-parallel MTs of the central spindle. Thus, the formation of the central 
spindle is intimately linked to Cdk1 inactivation. How MKlp1 and PRC1 central spindle 
complexes contribute to cytokinesis is not yet clear. On the one hand, the cytokinesis 
defect may simply be a reflection of their essential role in proper central spindle 
formation, on the other hand it is also tempting to assume that these proteins could signal 
to the cell cortex. The latter hypothesis is especially attractive because these central 
spindle complexes contain signal transduction proteins like the kinases Plk1 and Aurora-
B, the GTPase activating protein, MgcRacGAP and the guanine nucleotide exchange 
factor, Ect2.  
 
 
1.4.2 Cleavage furrow determination 
 
At the cortex, the small GTPase RhoA seems to be one of the most upstream components 
required for cleavage furrow positioning, contractile ring formation and contraction 
(Glotzer, 2001). RhoA exists in two different forms; the GDP bound form of RhoA in an 
inactive state and the GTP bound form of RhoA in its active form. Binding of GTP to 
RhoA results in a conformational change of the protein, exposing structural domains 
required for the interaction with downstream target proteins. RhoA-GTP positively 
regulates the actin network and appears to carry out three different functions, namely 
actin polymerization, actomyosin bundle formation and generation of contractility at the 
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cleavage furrow (Glotzer, 2001). Kishi et al, 1993 and Mabuchi et al, 1993 provided the 
first evidence that RhoA is involved in cytokinesis in Xenopus embryos and sand dollar 
eggs, respectively (Kishi et al., 1993; Mabuchi et al., 1993). Moreover, when cells were 
either treated with the RhoA specific inhibitor C3 exoenzyme or subjected to RhoA 
specific siRNA mediated depletion, they became multinucleated (Aktories and Hall, 
1989). 
More recently, Bement et al, used four-dimensional microscopy and a probe 
recognizing active RhoA, consisting of an EGFP-rhotekin fusion protein (Bement et al., 
2005). Rhotekin is a RhoA-GTP target and specifically binds only the active, i.e. GTP-
bound form of RhoA (Kimura et al., 2000). Fertilized sea urchin eggs were microinjected 
with the mRNA encoding this fusion protein and the localization of active RhoA during 
cell cleavage was indirectly visualized by monitoring the EGFP signal. This revealed that 
active RhoA concentrated in a precisely defined zone at the cleavage furrow before 
cytokinesis. To confirm if EGFP-rhotekin labelled specifically active RhoA, fertilized sea 
urchin eggs were also microinjected with C3 exoenzyme, a specific inhibitor of RhoA in 
vertebrates and echinoderms. These cells failed to divide and did not show zones of 
active RhoA. Treatment of sea urchin eggs with cytochalasin dramatically reduced F-
actin and furrows failed to develop, nevertheless the active RhoA zone formed at the 
equator. Thus, RhoA can localize to the site of future cleavage furrow in the absence of 
actin. However, treatment of sea urchin eggs with nocodazole to depolymerize MTs 
before furrow formation prevented both RhoA zone formation and furrowing (Bement et 
al., 2005). Thus, MTs are essential for localizing RhoA and hence for determining the 
site of cleavage furrow formation. In another experiment, embryos were first treated with 
cytochalasin to permit anaphase onset and RhoA zone formation followed by treatment 
with nocodazole. In contrast to embryos treated with cytochalasin alone, which showed 
zones of active RhoA, in eggs treated subsequently with cytochalasin and nocodazole, 
RhoA active zones disappeared 5-10 min after nocodazole exposure. Together, these 
results confirmed the presence of a microtubule-dependent signal for cytokinesis and 
revealed the important sequence of events for cytokinesis. Firstly, furrowing occurs in the 
region that coincides with the zone of active RhoA. Secondly, RhoA zone formation 
precedes furrowing by up to several minutes. Thirdly, active RhoA zone formation occurs 
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not only during cytokinesis in blastomeres, but also in much smaller epithelial cells of 
Echinoderm and Xenopus blastulae and gastrulae. Fourthly, active RhoA zone forms 
despite the disruption of actin cytoskeleton. Finally, RhoA zone formation is controlled 
by MTs (Bement et al., 2005). 
 
 
1.4.3 The contractile ring and formation of the cleavage furrow  
 
The cleavage furrow is often described as an actin rich "purse string" that draws tight to 
complete cytokinesis and to separate daughter cells. Early work established that the 
contractile ring consists of filaments (Schroeder, 1968), which were later identified as 
being composed of actin (Perry et al., 1971; Schroeder, 1978) and myosin II (Fujiwara 
and Pollard, 1976). Treatment of cells with actin depolymerizing drugs delays cells in 
cytokinesis (Bluemink, 1971; Schroeder, 1978) and sliding of the actin filaments was 
found to be critical for cytokinesis since perturbations of myosin II prevented furrow 
ingression (Guo and Kemphues, 1996; Mabuchi and Okuno, 1977; Young et al., 1993). 
Therefore, it has been suggested that the mechanical force required for cleavage furrow 
ingression is provided by the mechanochemical enzyme myosin II. The force producing 
ability of myosin II is regulated by phosphorylation, particularly by the phosphorylation 
of myosin regulatory light chains (MRLC) (Trotter and Adelstein, 1979). It was reported 
that the activating phosphorylation sites serine 18 and 19 in MRLC are 
hypophosphorylated during metaphase but becomes rapidly phosphorylated upon mitotic 
exit (Yamakita et al., 1994). Not surprisingly, therefore, overexpression of non-
phosphorylatable mutants of MRLC also causes cytokinesis defects (Komatsu et al., 
2000). The above data indicate that assembly and function of the contractile ring requires 
phosphorylation of MRLC. 
 The contractile ring protein Anillin has been shown to bind and bundle actin 
filaments. Anillin is a PH (Plekstrin Homology) domain containing protein that localizes 
to the cleavage furrow during cytokinesis. Anillin has been shown to be required for 
cytokinesis as microinjection of anti-Anillin antibodies into cells result in cytokinesis 
defects (Oegema et al., 2000). Localization of Anillin is dependent on the actin ring as 
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cells treated with actin depolymerizing drugs, such as latrunculin-A, were devoid of 
Anillin at the cleavage furrow (Coue et al., 1987). Anillin binds to nonmuscle myosin II 
and this interaction is regulated by myosin light chain phosphorylation (Straight et al., 
2005). Human cells depleted of Anillin fail to properly regulate contraction of myosin II 
late in cytokinesis and also fail cell abscission (Straight et al., 2005). 
The GTPase RhoA is the key regulator of the contractile ring, and active RhoA 
targets many downstream components during cytokinesis, including Rho kinase (ROCK), 
Citron kinase, formin homology proteins and a regulatory subunit of the myosin 
phosphatase. In fibroblasts, activation of RhoA induces the formation of stress fibres 
which are composed of large actin bundles. The structural similarities between the stress 
fibres and the cleavage furrow raise the possibility that similar proteins might be involved 
to induce the formation of these structures (Glotzer, 2001).  
Formins are RhoA targets in budding yeast (Evangelista et al., 1997), fission 
yeast (Chang et al., 1997), Aspergillus (Harris et al., 1997) and animal cells (Castrillon 
and Wasserman, 1994; Swan et al., 1998; Watanabe et al., 1997). These are multidomain 
proteins that govern dynamic remodelling of the cytoskeleton and can also function as 
actin nucleators in the formation of new filaments. Formins exert their effects on the actin 
and microtubule networks during meiosis, mitosis and trafficking (Watanabe and 
Higashida, 2004). Mutations in the Drosophila formin gene diaphanous and the 
nematode formin gene cyk-1 lead to cytokinesis defects (Castrillon and Wasserman, 
1994). Also mammalian mDia1 and mDia2 are essential for cytokinesis, and, moreover, 
localize to the cleavage furrow (Tominaga et al., 2000; Wasserman, 1998; Watanabe et 
al., 1997).  
RhoA also regulates actin dynamics via ROCK and Citron kinase, which were 
reported to associate with RhoA during cytokinesis (Kosako et al., 2000; Madaule et al., 
1998). ROCK concentrates at the cleavage furrow and phosphorylates myosin light chain 
in vitro (Amano et al., 1996; Kosako et al., 2000). ROCK inhibits myosin phosphatase 
thereby inhibiting MRLC dephosphorylation (Amano et al., 1996; Kawano et al., 1999). 
However, an inhibitor of ROCK, Y-27632, blocks neither the initiation nor the 
completion of cytokinesis in HeLa cells, although it slows down cleavage contraction 
(Kosako et al., 2000; Madaule et al., 1998). Also, in Drosophila, a ROCK mutation does 
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not seem to affect cytokinesis, in the examined tissues of wings and eyes (Shandala et al., 
2004; Winter et al., 2001). Mammalian cells have two isoforms of ROCK, ROCK-I (also 
called as Rok β) and ROCK-II (also called Rok α and Rho-kinase). Recent studies in 
mice indicate that knocking out the ROCK-I and ROCK-II genes individually manifests 
prenatal problems but those mice that survive develop in an apparently normal manner to 
adulthood and were not reported to show any cytokinesis defects (Shimizu et al., 2005; 
Thumkeo et al., 2003).  
Citron kinase, another target of active RhoA, also phosphorylates MRLC but does 
not inhibit myosin phosphatase (Yamashiro et al., 2003). Citron kinase was identified in a 
screen for proteins specifically binding to GTP bound RhoA (Madaule et al., 1998) and 
inhibition of RhoA by C3 exoenzyme in HeLa cells abolishes the transfer of Citron 
kinase from the cytoplasm to the cleavage furrow (Eda et al., 2001; Sarkisian et al., 
2002). This suggests that RhoA dependent signalling via Citron kinase is required for 
cytokinesis. In spite of this, it has been reported that Citron kinase knockout mice are 
viable and showed cytokinesis defects only in specialized cell types, notably proliferating 
neuronal and spermatogenic precursors (Cunto et al., 2002; Di Cunto et al., 2000). 
Recently, however, Paolo D’Avino et al showed that the Citron kinase homologue of 
Drosophila, called Sticky, is present in all post embryonic proliferating tissues (D'Avino 
et al., 2004). Moreover, mutations in Sticky lead to defective formation of the contractile 
ring (D'Avino et al., 2004). These apparantly contradicting data sets from mouse 
knockout studies and Drosophila mutants leaves open the question of whether Citron 
kinase is an essential downstream target of RhoA during cytokinesis.  
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Table 1.  Different genes required for cytokinesis and their homologues in different species. Table adapted 
from Balasubramanian et al, Current Biology, Vol.14, September, 2001. 
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1.5 Ect2  
 
1.5.1 Ect2, a Rho family GEF required for cytokinesis 
 
As described above, activation of RhoA in a MT dependent manner at the cell cortex is 
one of the first events that determine cleavage furrow formation and positioning. 
Activation of Rho proteins is mediated by guanine nucleotide exchange factors (GEFs) 
and one GEF that has been discovered to be essential for cytokinesis is Ect2. This GEF, 
which localizes to the central spindle, could therefore be an excellent candidate for 
signalling from the central spindle to the cell cortex.  
The Drosophila pebble (pbl) gene product is the founding member of the Ect2 
protein family (Lehner, 1992; Prokopenko et al., 1999). In Drosophila embryos, the first 
13 mitotic cycles occur in a syncytial cytoplasm without cytokinesis. At the onset of 
anaphase-B in cycle 14, cytokinesis is initiated. Pbl mutant embryos proceed through the 
first 13 syncytial mitoses and cellularize normally during the G2 phase of cell cycle 14. 
However, these embryos fail to undergo cytokinesis during subsequent cell division 
cycles (Lehner, 1992). Analysis of wild type embryos with anti-pbl antibodies in 
Drosophila at the mitotic cycle 14 revealed that pbl was expressed dynamically during 
mitosis (Prokopenko et al., 1999). Pbl protein was first detected in late anaphase of the 
mitotic cycle 14, when it colocalized with the separating sister chromatids. No pbl protein 
was detected during late prophase, metaphase and early anaphase of the mitotic cycle 14 
in Drosophila embryos. The highest level of pbl protein was detected in telophase nuclei 
and this staining persisted during interphase of the following cycle. Moreover, at the end 
of the mitotic cycle 14, pbl accumulated at the equator between dividing cells and in the 
nuclei of the daughter cells. In subsequent divisions, initiation of cytokinesis was marked 
by the appearance of the cleavage furrow and coincided with the accumulation of pbl at 
the cleavage furrow. Therefore, pbl might be required for the initiation of cytokinesis. 
Most interestingly, pbl interacted genetically with Rho1 (a Drosophila orthologue of 
mammalian RhoA), but not with Rac1 and Cdc42. Furthermore, pbl and Rho1 interaction 
was observed in a yeast two hybrid assay. Similar to mutations in pbl, loss of Rho1 or 
expression of a dominant negative form of Rho1 blocked cytokinesis. These results 
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identify pebble as a RhoGEF specifically required for cytokinesis, linked by Rho1 
activity to the reorganization of the actin cytoskeleton at the cleavage furrow 
(Prokopenko et al., 1999). 
Mammalian Ect2, the Drosophila pebble homologue, was originally identified as 
a transforming protein in an expression cloning assay (Miki et al., 1993). The carboxyl-
terminal fragment of Ect2 was able to transform mouse fibroblasts. By the use of 
antibody microinjection experiments and overexpression of an amino-terminal fragment, 
also a role for mammalian Ect2 in cytokinesis has been established (Tatsumoto et al., 
1999). Human Ect2 was shown to catalyze the guanine nucleotide exchange on small 
GTPases like RhoA, Rac1 and Cdc42, at least in vitro (Tatsumoto et al., 1999). 
Moreover, Ect2 expressed from recombinant baculovirus was able to bind with high 
specificity to Rho and Rac proteins, but surprisingly not to Cdc42 (Miki et al., 1993). 
Ect2 is phosphorylated during G2/M phases of the cell cycle and this phosphorylation has 
been suggested to be required for Ect2’s guanine nucleotide exchange activity 
(Tatsumoto et al., 1999). 
 
 
1.5.2 Other functions of Ect2 
 
In addition to the established role in cytokinesis, other functions for Ect2 have also been 
proposed. This includes a role in the regulation of cell polarity. Cell polarity is an 
important biological phenomenon that governs diverse cell functions, including the 
localization of embryonic determinants and the establishment of tissue and organ 
architecture. Although the detailed signalling events are not known, the polarity complex 
Par-6/Par-3 (partition-defective)/atypical protein kinase C and the Rho family GTPases 
play a key role in this signalling pathway (Cox et al., 2001; Drubin and Nelson, 1996). It 
has been shown that Ect2 plays a role in the activation of this polarity complex (Liu et 
al., 2004). Ect2 interacts with Par-6/Par-3 and PKC-ζ. Co-expression of Ect2 and Par-6 
efficiently activates Cdc42 in vivo. Moreover, overexpression of Ect2 stimulates PKC-ζ 
activity, whereas the dominant-negative form of Ect2 inhibits the Par-6 mediated 
stimulation of PKC-ζ activity. Furthermore, Ect2 can be detected at cell-cell contacts as 
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well as in the nucleus in MDCK cells and both the expression and localization of Ect2 are 
regulated by calcium, a critical regulator of cell-cell adhesion. This indicates that Ect2 
regulates the activity of the polarity complex Par-6/Par-3/PKC-ζ (Liu et al., 2004). 
Also, a role for Ect2 in kinetochore microtubule attachment has been suggested. 
In the absence of Ect2, cells are delayed in prometaphase and, moreover, show abnormal 
chromosome segregation and low levels of active GTP bound Cdc42. Furthermore, 
inhibition or depletion of Cdc42 affects microtubule-kinetochore attachments (Oceguera-
Yanez et al., 2005). Cdc42 seems to regulate the formin homology domain protein 
mDia3, which localizes to kinetochores only in the presence of active GTP bound Cdc42 
via interaction with CENP-A (Yasuda et al., 2004). Depletion of mDia3 results in an 
increase in prometaphase cells, in which many chromosomes fail to attach to kinetochore 
MTs. Thus, Ect2 has been proposed to regulate mDia3, via Cdc42, which could be 
important for proper microtubule-kinetochore interactions (Oceguera-Yanez et al., 2005). 
Tatsumoto et al, 2003 identified XEct2 (Xenopus Ect2) and showed that it is 
required for cytokinesis. Like human Ect2, XEct2 is also phosphorylated during mitosis. 
In Xenopus extracts, Ect2 seems to be required for the formation of the metaphase bipolar 
spindle. When compared to control extracts, which showed bipolar spindles, addition of 
anti-XEct2 antibodies resulted in the appearance of abnormal spindles including 
monopolar and multipolar spindles as well as bipolar spindles with misaligned 
chromosomes. Furthermore, a dominant negative form of Cdc42, but not of RhoA and 
Rac1 strongly inhibited spindle assembly in vitro (Tatsumoto et al., 2003). This indicates 
that Ect2 and Cdc42 contribute to the formation of spindles atleast in Xenopus egg 
extracts.  
 
 
1.5.3 Ect2 structure: different domains of Ect2 
 
The carboxyl-terminal domain of Ect2 that results in cellular transformation upon 
overexpression harbours the GEF (Guanine nucleotide Exchange Factor) domain (Fig.8). 
This GEF domain is also termed DH domain, which stands for Dbl homology domain 
(Zheng, 2001). Dbl was the first Rho GEF that was identified as a transforming gene 
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from diffuse B-cell-lymphomas (hence its name) (Srivastava et al., 1986). Most GEFs 
have a DH catalytic domain (69 members in humans), but there are also a few bonafide 
GEFs (e.g. Dock1, Dock2) that have a catalytic domain that is, at least at the primary 
sequence level, unrelated to DH domains (Cote and Vuori, 2002). The DH domain 
consists of about 200 residues and family members comprising this domain show 
catalytic activity to one or more Rho family members. The DH domain is composed of 11 
α-helices that are folded into a flattened, elongated α-helix bundle in which two of the 
three conserved regions, conserved region 1 (CR1) and conserved region 3 (CR3), are 
exposed near the centre of one surface. CR1 and CR3, together with a part of α-6 and the 
DH/PH junction site (Plekstrin homology), constitute the Rho GTPase interacting pocket 
(Liu et al., 1998; Worthylake et al., 2000). In Drosophila, mutations within the catalytic 
DH domain in the most highly conserved region (CR3) inactivate pbl function (e.g. the 
pbl5 allele that carries the V531D mutation) and abolish pbl interaction with Rho1 
(Prokopenko et al., 1999). Mutation of this conserved residue also dramatically reduces 
the catalytic activity in other GEF’s (Liu et al., 1998). 
In most GEFs, the DH domain is associated with a carboxyl-terminally located 
Plekstrin homology (PH) domain, and this is also true for Ect2 (Fig. 8). The PH domain 
which consists of a stretch of 100-120 amino acids was originally identified in Plekstrin 
from platelets and neutrophils (Tyers et al., 1988). It has now been found in many 
proteins and constitutes the 11th most common domain in the human genome.  PH 
domains are known for their ability to bind to phosphoinositides, but also functions in 
protein-protein interactions have been reported (Lemmon, 2004). The PH domain is 
found in a multitude of intracellullar proteins with widespread functions. Many of the PH 
domain containing proteins participate in signalling cascades, but there are also other 
classes of proteins such as cytoskeletal proteins (Spectrin), which carry a PH domain 
(Hyvonen et al., 1995). The PH domain family is very divergent at the sequence level; 
the average pair wise identity is below 20%. Although the PH domain is almost 
invariably present carboxyl-terminal to DH domains, its exact function in these GEFs is 
still not resolved. Different functions have been proposed, including membrane targeting, 
protein-protein interactions and allosteric regulation all of which are likely to be GEF 
specific (Blomberg et al., 1999). 
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Figure 8. Schematic representation of the primary structure of human Ect2. 
Human Ect2 comprises two BRCT (BRCA1 Carboxy-Terminal) repeats (in orange) spanning residues
143-313, a bipartite nuclear localization signal (NLS) between residues 346-374, a Rho GEF domain 
(in blue) spanning residues 425-605 and a PH (Plekstrin Homology) domain (in brown) spanning 
residues 636-763.  
 
Whereas the Ect2 catalytic centre is located in the carboxyl-terminus, a supposed 
egulatory domain is present in its amino-terminus. This domain comprises two tandem 
RCT (BRCA carboxyl-terminal) repeats and is, therefore, termed the BRCT domain 
Fig. 8) (Callebaut and Mornon, 1997; Koonin et al., 1996). This domain was originally 
dentified in BRCA1 (Breast Cancer gene1), a tumour suppressor gene involved in breast 
nd ovarian tumour formation. BRCA1 is inactivated in more than 50% of the hereditary 
reast cancers (Easton et al., 1994). The carboxyl-terminal (BRCT domain containing) 
alf of BRCA1 is important for tumour suppression and this region has been proposed to 
ave evolved through an internal duplication. Sequence analysis using hydrophobic 
luster analysis revealed the presence of 50 copies of the BRCT domain in 23 different 
roteins including BRCA1, 53BP1 (p53 Binding Protein), RAD9, XRCC1 (X Ray Repair 
ross Complementing), RAD4, Ect2, RAP1 (Repressor Activator Protein), terminal 
eoxynucleotidyl transferases (TdT) and three eukaryotic ligases. Most of these proteins 
ave been implicated in DNA repair and are associated with cell cycle checkpoint 
unctions (Bork et al., 1997). Although the BRCT domain is located in the carboxyl-
erminus of BRCA1, it is not limited to the carboxyl-termini. It can also be found in 
ultiple copies or as a single copy, as in RAP1 and TdT, respectively, suggesting that it 
ould constitute an autonomous folding unit of approximately 90-100 amino acids 
Callebaut and Mornon, 1997). In human Ect2, a tandem BRCT repeat is present in the 
mino-terminal half of the protein. 
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Signalling through phosphorylation is a central theme in biology. Like the PBD 
domain (Polo Box binding Domain of Plk1), 14-3-3 proteins and R-Smads (Wu et al., 
2001; Yaffe and Elia, 2001; Yaffe and Smerdon, 2001), the BRCT domains have recently 
been implicated in phosphopeptide binding (Clapperton et al., 2004; Manke et al., 2003; 
Williams et al., 2004; Yu et al., 2003). The identification of BRCT repeats as general 
phosphopeptide binding modules nicely complements the need of DNA damage-induced 
signalling, which relies on specific phosphorylation and recruitment of multiple DNA 
damage-responsive proteins (Caldecott, 2003).  It has been shown that the BRCA1 BRCT 
repeats recognize proteins that have pSer-X-X-Phe residues where X indicates any 
residue (Manke et al., 2003). The signalling specificity of the binding of BRCT domain 
to phosphopeptides is guaranteed by the distinct preferences for amino acids flanking the 
phosphoserine residue. Different BRCT motif-containing proteins were found to prefer 
different phosphopeptides with the strongest selection at the +3 position of the 
phosphopeptide (Manke et al., 2003; Rodriguez et al., 2003). 
 
 
1.5.4 Regulation of Ect2 during mitosis 
 
In eukaryotes, reduction of Cdk1/cyclin B activity is a prerequisite for completion of 
cytokinesis, and this allows the timely coordination of chromosome alignment and 
segregation with cytokinesis (Echard and O'Farrell, 2003). This is nicely exemplified by 
Drosophila cyclin B and B3 mutant embryos in which the cytokinesis furrow appears at 
an earlier stage during mitosis. Moreover, stable cyclin B prevents cytokinesis in these 
cells, and expression of stable cyclin B3 delays cytokinesis. Reduction of pebble (pbl) 
function also delays cytokinesis and incomplete furrows are finally aborted in these cells. 
Genetic interaction studies with pbl and cyclin B3 mutant flies showed that there is a 
synergetic inhibition of cytokinesis by stable cyclin B3 expression and pbl mutations. 
Moreover, cyclin B and cyclin B3 inhibit the contribution of the pebble pathway to 
cytokinesis. From these data it is tempting to suggest that phosphorylation by 
Cdk1/cyclin B or B3 might negatively regulate pebble function (Echard and O'Farrell, 
2003).   
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 In mammalian cells, mitotic Ect2 has a retarded electrophoretic mobility on SDS-
PAGE gels, which is a result of hyperphosphorylation. This hyperphosphorylated Ect2 
form, isolated from mitotically (prometaphase) arrested cells showed activity towards 
Cdc42, RhoA and Rac in in vitro GTP loading assays. Dephosphorylation of mitotic Ect2 
resulted in a strong reduction in its GEF activity. Thus, according to these results, Ect2 
seems to be highly active already during prometaphase and phosphorylation positively 
influences its activity (Tatsumoto et al., 1999). This is somewhat surprising, considering 
that Cdk1/cyclin B inhibits cytokinesis, which in Drosophila is at least partly mediated 
via pebble. Moreover, bulk measurements of an active GTP bound RhoA, using a GST 
tagged GTP-RhoA binding domain of rhotekin, showed that maximal levels of GTP 
bound RhoA were present 90 min after release from a nocodazole block (Kimura et al., 
2000). This most likely reflects the time when cells undergo cytokinesis. Therefore, the in 
vivo regulation of Ect2 might be more complex and probably also requires timely 
targeting to its sites of action.  
The targeting of Ect2 to the central spindle is mediated via its amino-terminal 
BRCT-containing domain. In Drosophila, a two hybrid interaction between pebble and 
RacGAP50C (the Drosophila orthologue of human MgcRacGAP) was observed (Somers 
and Saint, 2003). This interaction was mapped to the first BRCT repeat of pebble and the 
amino-terminal coiled coil domain of RacGAP50C. Like in C. elegans, Drosophila 
RacGAP50C interacts with the kinesin Pavarotti (the Drosophila orthologue of MKlp1) 
forming the central spindlin complex (Mishima et al., 2002; Somers and Saint, 2003). 
Also, in Drosophila, it was proposed that the MT bound RacGAP50C-Pavarotti complex 
travel on cortical MTs to the cell equator and associates with pebble thereby activating its 
GEF activity to position the contractile ring (Somers and Saint, 2003).  
The amino-terminal domain of Ect2 is not only important for its proper 
localization, but has also been suggested to regulate the function of Ect2.  It was shown 
that Ect2 normally exists in an inactive conformation, whereby the amino-terminus of 
Ect2 interacts in an intramolecular fashion with the carboxyl-terminus of Ect2 (Saito et 
al., 2004). Overexpression of amino-terminal Ect2 containing the BRCT domains 
apparently resulted in reduced RhoA-GTP levels during the time of cytokinesis, 
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suggesting that the amino-terminus of Ect2 might negatively regulate GEF activity (Kim 
et al., 2004; Kimura et al., 2000). 
                           
 
1.6 Goal of my research 
 
Previous studies of Ect2 have revealed that Ect2 localizes to the central spindle and is 
required for cytokinesis (Tatsumoto et al., 1999). However, the exact mechanisms that 
regulate central spindle targeting of Ect2 and its role during cytokinesis have remained 
elusive. Furthermore, the role of the different Ect2 domains (BRCT, GEF and PH 
domains) is still unknown. Although Ect2 is phosphorylated in mitosis (Tatsumoto et al., 
1999), the role of phosphorylation of Ect2 and its function during cytokinesis still 
remained unknown. Therefore, I set out to explore the mechanism for targeting of Ect2 to 
the central spindle and to identify the molecular interactions with other central spindle 
components in this process. I also aimed at identifying the residues phosphorylated on 
Ect2 in mitosis and discovering the upstream kinase(s) responsible for the various 
phosphorylations.  
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2.0 Results  
 
2.1 Mitotic phosphorylation of human Ect2 
 
2.1.1 Production of polyclonal Ect2 antibodies 
 
In order to explore the function of human Ect2, polyclonal antibodies were raised in 
rabbits against an amino-terminal fragment of Ect2 (residues 1-388) (Fig. 9A). This 
fragment was expressed as a polyhistidine-tagged fusion protein in E.coli and purified 
using Ni-NTA agarose beads. This resulted in a relatively pure Ect2 protein fragment as 
revealed by Coomassie Blue staining of a SDS-PAGE gel (Fig. 9B). After preparative gel 
isolation of this protein fragment it was used for immunization of rabbits. Two rabbits 
were boosted several times and the immune sera were tested by Western blot analysis 
performed on cell extracts from exponentially growing U2OS cells. Whereas with serum 
of rabbit 762 a band could be detected migrating at around 100 kDa, the expected size of 
Ect2, no specific signal was observed with serum of rabbit 763 (Fig. 9C). Nevertheless, 
after immunopurification, using the Ect2 fusion protein immobilized on nitrocellulose, 
purified antibodies from sera of both rabbits 762 and 763 detected a similar band at 
around 100 kDa on Western blots (Fig. 9C). The absence of reactivity with the serum of 
rabbit 763 is therefore most likely a result of a low titre in this serum, which is in 
agreement with the observation that only low amounts of specific Ect2 antibodies could 
be isolated from this serum. No specific signals were observed with the pre-immune sera, 
attesting to the specificity of these antibodies. Moreover, the specificity of the antibody 
762 (763 not tested) was further confirmed by immunoprecipitations and by siRNA 
depletion of Ect2, as described later. Therefore, for all subsequent experiments affinity 
purified specific Ect2 antibodies from serum of rabbit 762 were used.  
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Figure 9. Production of rabbit polyclonal anti-Ect2 antibodies. 
(A) Schematic representation of the amino-terminal Ect2 1-388 protein fragment used for raising 
polyclonal antibodies in rabbits. 
(B) Coomassie Blue stained gel containing samples from different purification steps of His6-Ect2 1-388 
protein expressed in E.coli strain JM109. The lanes represent: U, uninduced bacteria; I, bacteria induced 
with IPTG; E1 and E2, Ni-NTA eluted His6-Ect2 1-388 fusion protein.  
(C) About 20 µg of U2OS whole cell lysates were separated by SDS-PAGE and transferred onto 
nitrocellulose membranes. These membranes were probed with: lane1, pre-immune serum (1:2000 
dilution); lane2, immune serum (1:2000 dilution); lane3, affinity purified Ect2 antibodies (1 µg/ml) from 
the serum of rabbit 762 (left) and rabbit 763 (right), respectively. 36
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2.1.2 Ect2 is phosphorylated during early mitosis 
 
To analyze cell cycle dependent changes in Ect2, HeLa S3 cells were synchronized using 
a drug arrest-release protocol. HeLa S3 cells were first synchronized at the G1/S phase 
boundary using aphidicolin, a drug that inhibits DNA-polymerases (Heintz et al., 1983). 
After 14 hours incubation, cells were released from the aphidicolin block by washing out 
the drug and were subsequently blocked in M-phase using low doses of nocodazole, a 
drug that depolymerizess MTs, resulting in the activation of the spindle checkpoint (De 
Brabander et al., 1986). Mitotic cells were collected by shake off and subsequently 
released into nocodazole free medium. Cell samples for immunofluorescence microscopy 
inspection, FACS and Western blot analysis were collected every 20 min. FACS analysis 
of the propidium iodide stained cell samples confirmed proper synchronization of the 
cells and showed that cells entered interphase about 100 min after release from the 
nocodazole block (Fig. 10A). This was further confirmed by counting of DAPI stained 
cells, using immunofluorescence microscopy (Fig. 10B). Moreover, the latter analysis 
revealed that cells entered anaphase between 60 and 80 min after the nocodazole release 
(Fig. 10B). Western blot analysis showed that Ect2 protein levels were relatively constant 
throughout the cell cycle. Ect2 showed, however, a retarded electrophoretic mobility 
during early stages of mitosis (0-60 min), as compared to Ect2 from asynchronously 
growing cells. This change in electrophoretic mobility of Ect2 has been described before 
and has been attributed to mitotic phosphorylation (Tatsumoto et al., 1999). This retarded 
electrophoretic mobility paralleled the presence of cyclin B during this stage of mitosis 
and moreover shows that Ect2 became dephosphorylated upon meta- to anaphase 
transition. This indicates that Cdk1 could be responsible for the observed Ect2 
phosphorylation. The mitotic kinase Plk1 has also been shown to be cell cycle regulated, 
but its levels clearly fluctuated less strongly than cyclin B levels and no direct correlation 
between Plk1 protein levels and Ect2 phosphorylation could be observed.  
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Figure 10. Changes in Ect2 electrophoretic 
mobility during mitotic progression. 
Mitotic HeLa S3 cells were released from a 
nocodazole block and samples were taken at the 
indicated time intervals (min). As a control, cells 
from asynchronously growing cultures (Asn) were 
used. (A)  Ethanol fixed cell samples were stained 
with propidium iodide and analyzed by FACS. (B) 
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and T (telophase). Numbers indicate percentages 
(%) and at least 200 cells were counted for each 
time point. (C) Cell extracts were separated by 
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(2nd panel), anti-Cyclin B (3rd panel) and anti-α-
tubulin antibodies (bottom panel). 
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2.1.3 Identification of multiple phosphorylation sites in mitotic Ect2 
 
Our cell cycle analysis confirmed mitosis dependent changes in the Ect2 phosphorylation 
state. Since many mitotic proteins are regulated by post-translational modifications, 
notably reversible phosphorylation, it is tempting to believe that Ect2 functions could be 
regulated by phosphorylation. In fact, it has been suggested that Ect2 GEF activity might 
be regulated by reversible phosphorylation (Tatsumoto et al., 1999). To identify putative 
regulatory phosphorylation sites, Ect2 was immunoprecipitated from HeLa S3 cells using 
our purified rabbit polyclonal Ect2 antibody (762). HeLa S3 cells were grown in spinner 
culture flasks and synchronized using a sequential aphidicolin/nocodazole block release 
protocol, as described above. Cells were released for about 60 min from the nocodazole 
block before harvesting. Since spinner culture cells need a longer recovery time than 
attached cells, most cells were still in a prometaphase state at this time point (as checked 
by microscopy). In parallel, cells were arrested with aphidicolin and released for 60 min 
into S phase. Highly concentrated cell extracts were prepared from these mitotic and S 
phase HeLa S3 cells for immunoprecipitation using purified polyclonal anti-Ect2 
antibodies bound to affiprep protein A beads (Biorad) and as a control, pre-immune IgG 
antibody beads were used. The immunoprecipitates were separated on a 4-12% NuPAGE 
gradient gel (Invitrogen) and upon Coomassie Blue staining revealed a specific protein in 
the Ect2 immunoprecipitates, migrating at approximately 100 kDa (Fig. 11A). This 
protein showed a retarded electrophoretic mobility in immunoprecipitates from mitotic 
cells as compared to immunoprecipitates from interphase cells (Fig. 11A). The gel bands 
were excised in a dust free environment and tryptic digestion was performed. Using 
matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass 
spectrometry (MS) the protein in these bands was identified to be Ect2. No Ect2 was 
detected in corresponding gel slices from control pre-immune IgG immunoprecipitates. 
 For identification of phosphorylation sites within these tryptic digests 
(Shevchenko et al., 1996), phosphorylated peptides were first identified by MALDI-TOF 
mass spectrometry (Brucker Daltonik, Bremen, Germany) and subsequently confirmed 
by post source decay (PSD) (Hoffmann et al., 1999). 
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 (A) Anti-Ect2 and pre-immune immunoprecipitates from S- and M-phase HeLa S3 cell extracts were 
separated by SDS-PAGE gel and stained with Coomassie Blue. Ect2, as identified by MS analysis is 
indicated. IgG HC and IgG LC, indicate antibody heavy chains and light chains, respectively. 
 (B) Fragmentation of the phosphorylated peptides 14TSLADSSIFDSK25 and 334SVSMLSLNTPNSNR347 by 
nanospray ionization Q-TOF (quadrupole-time of flight) mass spectrometry in positive ion mode. Arrows 
marked in red indicate phosphorylated fragments and arrows in black indicate unphosphorylated 
fragments.  
(C) Schematic representation of the identified mitosis specific phosphorylation sites in Ect2 and their 
respective localization within Ect2.       
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With the latter method, peptides showing losses of 98 mass units (phosphoric acid) and 
80 mass units (phosphate group) were considered as phosphopeptides. The exact 
localization of the phosphorylated residues within the peptides was determined by MS-
MS based sequencing using a quadrupole time-of-flight (QTOF) mass spectrometer. The 
phosporylation pattern of tryptic peptides of Ect2 protein from mitosis specific samples 
was compared to that of interphase specific samples. In this way we could map six 
phosphorylation sites in six different Ect2 peptides that were specifically present in 
mitotic Ect2 (Fig. 11C, Table 2). All the phosphorylation sites mentioned here were from 
mitosis specific samples. As an example, the fragments of two phosphorylated peptides, 
14TSLADSpSIFDSK25 and 334SVpSMLSLNTPNSNR347, are schematically depicted in Fig. 11B. 
Bioinformatic analysis of the evolutionary conservation of these sites showed that five 
out of these sites were conserved among human (Homo sapiens), mouse (Mus musculus), 
frog (Xenopus leavis), fish (Takifugu rubripes) and fruitfly (Drosophila melanogaster) 
(Table 2, Fig. 12A). This suggests that these five phosphorylation sites could constitute 
important regulatory sites. Three of the identified conserved sites matched Cdk1 and 
MAPK consensus phosphorylation sites (pS/pT P), suggesting that Cdk1 or MAPK might 
be responsible for creating these phosphosites. 
 
  
 
 
Table 2. Summary of the phosphorylation sites identified in mitotic endogenous Ect2, in recombinant Ect2 
phosphorylated by Plk1 in vitro and in recombinant Ect2 purified from okadaic acid (OA) treated Sf9 insect
cells. Two other Ect2 phosphorylation sites, S411 and S417, have been reported to be phosphorylated in 
interphase cells (Beausoleil et al, 2004). T815 was mentioned to be phosphorylated in vitro by Cdk2/Cyclin 
A kinase (Stefan Geley, personal communication). The phosphorylated residues are indicated in red.  
 
 
 
 
 
S.No Residue Peptide In vivo Plk1  
in vitro 
OA in Sf9 
cells 
Others 
1 S20 TSLADSpSIFDSK  √   √ √  
2 S40 ENLLIGSTpSYVEEEMPQIETR  √   √   
3 T328 ANpTPELK  √    
4 S336 SVpSMLSLNTPNSNR    √   
5 S366 ETDVpSPFPPR  √   √  
6 S685 pSPHGQTRPPASLK  √   √  
7 S811 AFpSFSK  √   √ √  
8 S411, S417 SpSTPVPpSK     Nuclear 
9 T815 AFSFSKpTPK    Cdk2/cyclin A 
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1-70                         S20(in vivo/Plk1)    S40(in vivo/Plk1) 
Hs       MAENSVLTSTTGRTSLADSSIFDSKVTEISKENLLIGST-SYVEEEMPQIETRVILVQEAGKQEELIKAL 
Mm       MADDSVLPSPSEITSLADSSVFDSKVAEMSKENLCLAST-SNVDEEMPQVEARVIMVQDAGKQEELLKAL 
Xl MGDNSMLAQIAGKSLLADSSVFDSKITETSKDNLFAGS--ADIDEEMPQIETRVVLVEDAGRNEELIKAL 
Tr    MADSSILTLGTARSLLVDSSVCDSRIAETTKDHLFLGMACEDGEDMLPKVETRVVLVGEVGRNGALLKAL 
Dm   ----------MEMETIEEQSKCEMSITTLP---------------------TRICLVGGVGQDADTLQAA 
 
310-378                     T328(in vivo) S336(Plk1)              S366(in vivo) 
Hs        IQMDARAGETMYLYEKANTPELKKSVSMLSLNTPNSNRKRRRLKETLAQLSRETDVSPFPP-RKRPSAEH 
Mm        IQMDARAGETMYLYEKANTPELKKSVSLLSLSTPNSNRKRRRLKETLAQLSRETDLSPFPP-RKRPSAEH 
Xl        IQMDARAGETMYLFEKNESPALKKSVSLLTLNTPSSNRKKRRLKDTLAQFTRETDLTPFPP-RKRPSAEH 
Tr        IQMDARAGESMYLYEKNDSPAMKKAVSLLSLTTPNSNRKRRRLKDTLAQLTKETEISPFPPPRKRPSAEH 
Dm        IQN-GYANEMDYLFGDYLDSITNTPNTDRRDSLPISFNKRKRKRFSQRIQLEGTPLGSGKR-RSSVSDAG 
 
658-727                              S685(in vivo) 
Hs        GEQVTLFLFNDCLEIARKRHKVIGTFRSPHGQTRPPASLKHIHLMPLSQIKKVLDIRETEDCHNAFALLV 
Mm        GEQVTLFLFNDCLEIARKRHKVIGTFRSPHDRTRPPASLKHIHLMPLSQIKKVLDIRETEDCHNAFALLV 
Xl        GEQVTLFLFNDCLEIARKRHKVIGAFKTLHGHTRPPACLKHICLMLLSQIKKVLNVKDTEECHNAFALVV 
Tr        GENVTLFLFNDCLEIARKRHKVINTFKSPMGQTRPPPSLKHIALMPLSQIRRVLDLQDTEGDMRAF---- 
Dm        GDSLVLYLFSDSIELCKRRSKGFNTAKSPS--T--AKTHKHLKLISLNTIRLVIDISDSPRAFGLLLR— 
 
797-865                 S811(in vivo/Plk1) 
Hs        RAIKKTSKKVTRAFSFSKTPKRALRRALMTSHGSVEGRSP-SSNDKHVMSRLSSTSSLAGIPSPSLVSLP 
Mm        RAIKKTSKKVTRAFSFSKTPKRALRMALSSSH-SSEGRSP-PSSGKLAVSRLSSTSSLAGIPSPSLVSLP 
Xl        RAIKKTSKKVTRAFSFTKTPKRALQRALMVQN--ADGRSPGPSNEGFASCRMPSTSSLAAVPSPSLVNLS 
Tr        RAIKKTSKKVR----FSS---------------------------------------------------- 
Dm        KLAAKTRLKVGRAFSFNKTPNKLKRAVSTMMTSPFGSTNSLTPASQLAQMRLASCTNINEVDDEDCASMR 
                           (T815- Cdk2/cyclin A) 
 
 
 
 
 
 
Figure 12. Multiple sequence alignment of Ect2 and its homologues in other species. 
(A) Clustal-W sequence alignment of Ect2 and its homologues in different species. Only parts of the 
sequences representing the phosphorylation sites are shown. The phosphorylated peptides identified by 
MALDI-TOF mass spectrometry are depicted in green colour and the phosphorylated residues are 
depicted in red colour. The abbreviations indicate: Hs (Homo sapiens), Mm (Mus musculus), Xl 
(Xenopus laevis), Tr (Takifugu rubripes) and Dm (Drosophila melanogaster).   
 
 
2.1.4 Plk1 can phosphorylate Ect2 in vitro   
 
To investigate which kinase(s) could be responsible for the phosphorylation of Ect2 
during mitosis, in vitro kinase assays were performed. For this, a GST-tagged 
recombinant Ect2 protein was produced in Sf9 insect cells using a recombinant 
baculovirus expression system (Pharmingen). As shown in Fig. 13A, a considerable 
amount of soluble GST-Ect2 could be produced in Sf9 insect cells and isolated with 
glutathione sepharose beads (Fig. 13A). Since a PreScission protease site was engineered 
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between the GST-tag and the Ect2 protein, we could remove the GST-tag by incubation 
of GST-Ect2 protein with PreScission protease (Amersham), resulting in the isolation of 
GST-tag free recombinant Ect2 protein (Fig. 13A).  
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Figure 13. Purification of recombinant human Ect2 from Sf9 insect cells. 
(A) Different cell fractions and GST-Ect2 isolation steps of Sf9 insect cells infected with a GST-Ect2 
recombinant baculovirus were separated on a SDS-PAGE gel and stained with Coomassie Blue. 
For in vitro kinase assays recombinant human GST tagged Plk1 WT (wild type) 
and Plk1 KD (catalytically impaired, K82R) were produced in Sf9 insect cells, according 
to standard isolation procedures present in the laboratory (Casenghi et al., 2003). A GST-
Aurora-B WT/INCENP complex and Aurora-B KD (K106R)/INCENP complex 
produced in Sf9 insect cells were a kind gift from Dr. Reiko Honda (Honda et al., 2003) 
and recombinant Cdk1/cyclin B, also purified from Sf9 insect cells, was kindly provided 
by Dr. Rüdiger Neef. In vitro kinase assays with radioactive [γ32-P]-ATP were performed 
for 20 min at 30oC with recombinant Ect2 as a substrate in the presence of the different 
kinases mentioned above. As a negative control, Ect2 was also incubated in the kinase 
buffer without the addition of exogenous kinase. Proteins in the different samples were 
then separated by SDS-PAGE and phosphorylation of Ect2 was determined by 
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autoradiography of the Coomassie Blue stained gels.  As shown in Fig. 14A and 14B, a 
substantial amount of radioactive phosphate was already incorporated into Ect2 in the 
absence of exogenously added kinases. This suggests that although the isolated Ect2 
protein looked relatively pure (Fig. 13A), contaminating kinase(s) were present in the 
Ect2 isolate resulting in a significant background phosphorylation. Additional wash steps 
(with higher salt concentrations) during the purification of recombinant Ect2 did not 
significantly improve this background problem. Nevertheless, incubation of Ect2 with 
Plk1 resulted in a strong increase in Ect2 phosphorylation, and, moreover, this resulted in 
a retarded mobility of Ect2 on a SDS-PAGE gel.    
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Figure 14. In vitro phosphorylation of Ect2 by mitotic kinases. 
(A) Recombinant Ect2 protein was incubated with the different, indicated, mitotic kinases in the presence of 
[γ32-P]-ATP for 20 min.  Proteins were subsequently separated by SDS-PAGE and the Coomassie Blue stained 
gel was then subjected to autoradiography. 
(B) The Coomassie Blue stained gel corresponding to the autoradiography in A is shown. Note the retarded 
mobility of Ect2 phosphorylated by Plk1 (lane 2).  
(C) Different exogenous substrates were incubated with the indicated mitotic kinases in the presence of [γ32-
P]-ATP.  Phosphorylation of these proteins was determined by autoradiography as in (B).  441-Ect2+Cdk1/cyclin B 
2-Ect2+Plk1 WT 
3-Ect2+Plk1 KD 
4-Ect2+Aurora-B WT/INCENP 
5-Ect2+Aurora-B KD/INCENP 
6-Ect2 alone 
7-Cdk1/cyclin B+Histone 1 
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9-Plk1 KD+Casein 
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11-Aurora-B KD/INCENP+Histone 3 
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Some increase in Ect2 phosphorylation was also observed in the presence of the 
catalytically impaired Plk1 (K82R) mutant, which is probably a result of low residual 
kinase activity of this mutant kinase. Surprisingly, no obvious increase in Ect2 
phosphorylation was observed upon incubation with Cdk1/cylin B or Aurora-B/INCENP. 
This was not a result of the absence of kinase activity, because these kinases readily 
phosphorylated other exogenous substrates (Fig. 14C). Because of the high background 
activity with Ect2, it cannot be ruled out that low amounts of phosphate are incorporated 
into Ect2 by these kinases in vitro.  In particular, as some of the consensus Cdk1/cyclin B 
sites on Ect2 were phosphorylated in vivo, we assume that Ect2 might be phosphorylated 
by Cdk1/cyclin B at least in vivo. An alternate possibility to be tested for reducing the 
background activity of Ect2 is to treat the recombinant Ect2 with protein phosphatases 
prior to performing in vitro kinase assays. 
Since Ect2 was phosphorylated by Plk1 in vitro, resulting in a retarded 
electrophoretic mobility of Ect2, we wondered if Plk1 could be responsible for the 
phosphorylation of some of the identified endogenous Ect2 phosphorylation sites. To 
investigate this, non-radioactive kinase assays were performed with recombinant Ect2 in 
the presence or absence of exogenous Plk1. After separation on a SDS-PAGE gel, the 
Ect2 protein bands were excised and processed for mass spectrometry analysis as 
described in the previous section. In total, four Plk1 specific phosphorylation sites were 
identified in recombinant Ect2 (Table 2, Fig. 12). Of these, three did correspond to 
endogenous Ect2 phosphorylation sites, strongly arguing that Plk1 might be responsible 
for the phosphorylation of these sites in vivo. Interestingly, one of the identified sites S20 
is a putative PBD (Polo-Box Domain) docking site. The PBD is located in the carboxyl-
terminal half of Plk1 and has recently been shown to bind to phosphorylated peptides 
containing the consensus sequence X-S-pS/pT-P/X. To investigate if phosphorylation of 
these sites was responsible for the marked upshift of Ect2 in mitosis, we depleted Plk1 
from HeLa S3 cells by siRNA. Depleted cells were then arrested in interphase 
(aphidicolin) and in mitosis (nocodazole), respectively. As a control, cells were treated 
with siRNA duplex against the luciferase gene (GL2) (Elbashir et al., 2001). Cell lysates 
were subsequently separated by SDS-PAGE and transferred onto nitrocellulose 
membranes. As shown in Fig. 15A, Western blot analysis revealed that Ect2 was clearly 
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upshifted in mitotic control (GL2) cells, but also in Plk1 siRNA treated cells. The 
effective depletion of Plk1 in these cells was confirmed by Western blot analysis (Fig. 
15A). Therefore, Plk1 seems not to be the only kinase that is responsible for the upshift 
of Ect2 in vivo.  Alternatively, it cannot be excluded that low residual levels of Plk1 
might be sufficient for effective Ect2 phosphorylation. 
 
 Figure 15. Retarded Ect2 electrophoretic mobility is 
also observed in mitotic Plk1 depleted cells. GL2 
and Plk1 siRNA oligo duplexes were transfected 
into HeLa S3 cells. These cells were subsequently 
arrested in interphase (I-phase) with aphidicolin 
and in mitosis (M-phase) with nocodazole. Protein 
extracts of these cells were separated by SDS-PAGE 
and transferred onto nitrocellulose membranes. The 
Western blots were probed with the indicated 
antibodies. 
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.1.5 No obvious interaction between Ect2 and Plk1 kinase 
s described above, the PBD of Plk1 has recently been shown to bind to phosphorylated 
eptides containing the consensus site X-S-pS/pT-P/X (Barr et al., 2004; Elia et al., 
003). One of the identified Ect2 sites (S20) matches this consensus site and hence Plk1 
ight bind directly to Ect2. Indeed Anja Hanisch in our laboratory could show that 
ndogenous Ect2 from human cells binds to the wild type PBD of Plk1 but not to a 
hosphopeptide binding mutant of the PBD. We therefore tested if Ect2 could co-
recipitate endogenous Plk1 from mitotic cell lysates. As shown in Fig. 16A, we could 
eadily precipitate Ect2 from mitotic cells, but Plk1 was not present in these cell lysates. 
oreover, the over expressed flag-tagged amino-terminal domain of Ect2 (1-333) could 
ot be identified in immunoprecipitates of the myc-Plk1 precipitated using anti-myc 
E10 antibodies from mitotic HeLa S3 cells (Fig. 16B). Thus, although we cannot 
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exclude the possibility that our antibodies interfere with the Plk1-Ect2 interaction, so far 
there is no clear evidence that this S20 site is a functional Plk1 docking site. Furthermore, 
as shown below, no obvious phenotype could be detected with the S20 mutants.  
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Figure 16.  No in vivo interaction was observed between Ect2 and Plk1 kinase. 
(A) HeLa S3 cells were synchronized either with thymidine-aphidicolin or with aphidicolin-nocodazole 
block release protocols to enrich cells in interphase (I) and mitosis (M), respectively. Endogenous Ect2 
was immunoprecipitated from these cell extracts. These immunoprecipitates (IP) were separated by 
SDS-PAGE and transferred onto nitrocellulose membranes. The blots were probed with anti-Ect2 and 
anti-Plk1 antibodies. 
(B) HeLa S3 cells were transfected with myc-Plk1 and flag-Ect2 (1-333) constructs for 36 hours and 
myc-Plk1 was immunoprecipitated using anti-myc beads. The immunoprecipitates (IP) were separated 
by SDS-PAGE and transferred onto nitrocellulose membranes and probed with anti-myc and anti-flag 
antibodies.                     
                                         
.1.6 Analysis of Ect2 phosphorylation site mutants 
o explore the physiological significance of the identified Ect2 phosphorylation sites, site 
irected mutagenesis was performed. The identified phosphorylated serine and threonine 
esidues were singly mutated to alanine residues, thus mimicking an unphosphorylated 
tate, and into aspartic acid residues, which can sometimes mimic a phosphorylated state. 
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In addition, all alanine mutations (except the non-conserved S40A) were also combined 
into one construct and the same was done with the aspartic acid mutations.  
We first analyzed the overexpression phenotype of wild type and mutant myc-
tagged Ect2 constructs. Again these constructs were transiently expressed in HeLa S3 
cells and 48 hours after transfection, cells were analyzed by immunofluorescence 
microscopy. Since Ect2 is required for cytokinesis we particularly investigated the 
presence of binucleated cells, an indication of cytokinesis failure. Expression of wild type 
Ect2 resulted in a clear increase in the number of binucleated cells, as compared to 
control myc-Tlk1 (Tousled Like Kinase) transfected or untransfected cells (Fig. 17) 
(Sillje et al., 1999). Thus, high levels of Ect2 interfered with proper cytokinesis. We next 
analyzed the percentages of binucleated cells expressing mutant Ect2 proteins. As shown 
in Fig. 17A, expression of some of the alanine mutants (especially S20) resulted in a 
higher percentage of binucleated cells, as compared to the wild type. However, 
expression of the Ect2 mutant form with all six residues mutated into alanine residues 
showed an almost similar increase in binucleated cells as wild type Ect2.  
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 48Figure 17. Increase in the number of 
binucleated cells with overexpressed myc-
tagged wild type and mutant Ect2 proteins. 
The indicated myc-tagged proteins were 
overexpressed in HeLa S3 cells for 48 hours. 
Cells were then fixed and stained with anti-
myc (9E10) antibody to identify the 
transfected cells. Cells were counterstained 
with DAPI for the determination of the 
percentage of binucleated cells. This 
experiment was done in duplicates and 
always the difference of values between the 
two experiments was not more than 10%.   
(A) Analysis of cells expressing the alanine 
mutant Ect2 proteins. As a control, myc-Tlk1 
was used.  
(B) Analysis of cells expressing the aspartic 
acid mutantEct2 proteins. 
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The low numbers of Ect2 transfected cells could possibly be the reason for the 
strong variation in the number of binucleated cells which we obtained with the different 
mutants, and these numbers must hence be interpreted with caution. Cells expressing the 
mutant Ect2 forms in which the phosphorylated residues were mutated to aspartates, all 
showed percentages of binucleated cells as was observed with wild type Ect2 (Fig. 17B). 
Under the conditions tested here, we could not obtain a clear indication whether the 
mutant Ect2 proteins showed an effect on cytokinesis, which was different from that of 
the overexpressed wild type Ect2 protein. 
To analyze if the localization of these mutant Ect2 proteins to the central spindle 
was altered, the myc-tagged wild type and mutated full length constructs were transfected 
into HeLa S3 cells and their localization was analyzed by indirect immunofluorescence, 
using anti-myc (9E10) antibodies. As shown in Fig. 18A, wild type myc-tagged Ect2 
localized to the central spindle in anaphase and to the midbody in telophase cells, in 
agreement with previous reports (Tatsumoto et al., 1999) and data shown below (see 
chapter 2.2). Similarly, all mutant Ect2 proteins tested localized to these spindle 
structures, suggesting that central spindle and midbody localization of Ect2 is not 
regulated by reversible phosphorylation of these specific residues. An example of one 
Ect2 mutant (S20A) localizing to the central spindle is shown in Fig. 18A.  
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 49        Figure 18. Localization of myc-
tagged Ect2 wild type and myc-
Ect2S20A to the central spindle. 
(A) The indicated myc-Ect2 proteins 
were transiently overexpressed in 
HeLa S3 cells for 36 hours and fixed 
and permeabilized with 
paraformaldehyde/Triton X-100. 
These cells were stained with anti-
myc (9E10) antibodies (red), anti-α-
tubulin antibodies (green) and DNA 
was labelled with DAPI (blue). 
Scale bar 10 µm. 
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Ect2 is a GTP exchange factor and hence we next tested Ect2 GEF activity. Except for 
one publication (Tatsumoto et al., 1999), showing Ect2 GEF activity towards RhoA, 
Rac1 and Cdc42 small GTPases, no other studies on Ect2 GEF activity have been 
reported. As this is not an assay commonly used in our laboratory, we asked Dr. Anja 
Schmidt from Prof. Allan Hall’s laboratory to help us with these assays. Since 
immunoprecipitations from cells only resulted in the purification of low amounts of Ect2 
we decided to use recombinant Ect2 purified from Sf9 insect cells. To obtain 
phosphorylated Ect2 from Sf9 insect cells we treated these cells with Okadaic acid (OA), 
a PP1A and PP2 (Protein Phosphatase) phosphatase inhibitor (Cohen et al., 1990), which 
has been shown to result in a mitosis-like phosphorylation of many proteins. For 
example, OA is generally used to produce phosphorylated active recombinant Plk1 kinase 
(Jackman et al., 2003). Using the recombinant GST-Ect2 encoding baculoviruses 
described above we generated recombinant Ect2 from untreated and OA treated Sf9 
insect cells and removed the GST- tag using PreScission protease. As shown in Fig. 19A, 
OA treatment resulted in an upshift of recombinant Ect2 on a SDS-PAGE gel, similar to 
what has been observed in mitotic cell extracts. Moreover, MS/MS analysis of this 
protein revealed that at least four of the five identified conserved endogenous Ect2 
phosphorylation sites (S20, S366, S685 and S811) were specifically phosphorylated in 
this recombinant protein isolated from OA treated Sf9 insect cells. Thus, the 
phosphorylation pattern of this recombinant Ect2 is similar to the phosphorylation pattern 
of endogenous mitotic Ect2. Since only RhoA has been implicated to be essential for 
cytokinesis, we tested the GEF activity of these recombinant Ect2 proteins with RhoA as 
the substrate (performed by Dr. Anja Schmidt). Equal amounts of recombinant Ect2 
protein treated with and without OA were used for GEF assays. For measuring the 
exchange activity, Ect2 together with [γ32-S]-GTP was added to the pre-loaded GDP-
RhoA. Samples were then collected every five min and the reactions were terminated by 
addition of ice-cold termination buffer, followed by filtration through nitrocellulose 
filters. Filters were washed once with the termination buffer and radioactivity was 
measured using a liquid scintillation counter. Initial experiments with 50 pmol Ect2 in the 
reaction assays did hardly show any GEF activity. Only when the amount of Ect2 was 
increased to 150 pmol some GEF activity could be measured, but this was clearly much 
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less as compared to a positive SopE GEF control (Fig. 19B). SopE is a GEF from 
Salmonella typhimurium that is often used as a positive control in GEF assays (Rudolph 
et al., 1999). Unfortunately, no significant differences in activity between 
hypophosphorylated recombinant Ect2 [no OA treatment] and phosphorylated-Ect2 (OA 
treated) were observed in this assay. Since this assay required high amounts of Ect2, it 
was not possible to analyze the mutant proteins isolated from transiently transfected cells. 
This would require additional efforts, including the generation of recombinant 
baculoviruses. Since the obtained results were not very promising we have not further 
followed up this line of investigation.  
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Figure 19. In vitro GEF assay of recombinant Ect2 proteins on RhoA. 
(A) GST-Ect2 protein bound to glutathione sepharose beads was purified from Sf9 insect cells, which were 
either treated with OA or left untreated. Note the retarded mobility shift of phosphorylated GST-Ect2 
purified from OA (okadaic acid) treated Sf9 insect cells compared to GST-Ect2 purified from untreated 
cells. 
(B) Based on the gel shown in A, the concentrations of GST cleaved recombinant Ect2 proteins isolated 
from non-treated (Ect2) and OA treated (P-Ect2) Sf9 insect cells were normalized and equal amounts were 
used for in vitro GEF assays with RhoA in the presence of [35S]-GTPγS. As a positive control, recombinant 
SopE GEF was used. Samples were taken every five min, filtered and measured by liquid scintillation. 
Results are plotted in a graph. 
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2.1.7 Conclusion: 
  
In this part of the study, we demonstrated that Ect2 becomes hyperphosphorylated during 
early mitosis and is dephosphorylated upon metaphase to anaphase transition. Using mass 
spectrometry we could identify conserved mitosis specific phosphorylation sites in 
endogenous Ect2 as well as in recombinant Ect2 phosphorylated by Plk1 kinase in in 
vitro kinase assays. Upon site directed mutagenesis of these phosphorylation sites, no 
clear functions could be attributed to individual sites. In particular, we could not 
determine any significant difference in activity between hypophosphorylated and 
phosphorylated Ect2 in in vitro GEF assays. This result is contradictory to the report 
made by Tatsumoto et al (Tatsumoto et al., 1999) who claimed that Ect2 becomes active 
only upon phosphorylation. Future studies will be required to resolve the function of 
these phosphorylation sites and will probably require improved protocols to analyze the 
GEF activity of these mutant proteins. 
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2.2 Regulation of Ect2 localization 
 
2.2.1 Ect2 localizes predominantly to the central spindle and cell cortex 
 
To examine the exact localization of Ect2 in HeLa S3 cells, indirect immunofluorescence 
microscopy was performed with anti-Ect2 antibodies. These antibodies predominantly 
stained the central spindle and midbody in mitotic cells (Fig. 20A, upper two rows) in 
accordance with a previous report (Tatsumoto et al., 1999). In addition, however, we 
could observe cortical staining of Ect2 throughout mitosis. In interphase cells Ect2 
localized predominantly to the nucleus, but also a weak cortical staining could be 
observed especially at cell-cell contacts (data not shown). No such staining was observed 
with pre-immune IgG attesting to the specificity of the used anti Ect2-antibodies (data not 
shown).    
To further confirm that this staining was specific for Ect2 protein, we depleted 
Ect2 in HeLa S3 cells by siRNA duplex specifically targeting Ect2 and indirect 
immunofluorescence microscopy was performed. In Ect2 siRNA transfected cells (48 
hours), the central spindle, midbody and cell cortex staining was strongly reduced and 
also nuclear staining was clearly diminished in interphase cells (Fig. 20A bottom two 
rows). To confirm efficient depletion of Ect2, cell extracts were prepared from control 
(GL2) and Ect2 siRNA treated HeLa S3 cells after 24 and 48 hours of transfection. These 
cell extracts were separated by SDS-PAGE and after Western blotting, the membranes 
were probed with anti-Ect2 antibodies. As compared to the control (GL2), Ect2 levels 
were clearly diminished in Ect2 siRNA treated cells (Fig. 20B upper panel). As a loading 
control, α-tubulin was detected with anti-α-tubulin antibodies (Fig. 20B lower panel). 
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(A) HeLa S3 cells were treated with GL2 or Ect2 siRNA duplexes for 48 hours and were subsequently 
fixed and permeabilized with paraformaldehyde/Triton X-100. These cells were stained with anti-Ect2 
antibodies in red (left),anti-α-tubulin antibodies in green (middle) and DNA was labelled with DAPI in 
blue. Merged images are shown at the right. Scale bar 10 µm.  
(B) HeLa S3 cells were transfected with GL2 or Ect2 siRNA duplexes and after 24 hours and 48 hours of 
transfection, Hepes lysis buffer extracts were made. Proteins were separated by SDS-PAGE and 
transferred onto nitrocellulose membranes. These membranes were probed with anti-Ect2 antibodies 
(upper panel) and, as a loading control, with anti-α-tubulin antibodies (lower panel). 2.2.2 The amino-terminal BRCT domain
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cell cortex. Amino-terminal Ect2 fragments containing the full BRCT domain (two 
BRCT repeats, residues 1-420 and 1-333) also localized to the central spindle, but were 
absent from the cell cortex (Fig. 21B). However, another amino-terminal construct 
encoding myc-Ect2 1-288, which has a truncated second BRCT repeat, did not localize to 
the central spindle in anaphase cells (Fig. 21B, lower panel). This strongly suggests that 
an intact BRCT domain, consisting of two BRCT repeats, is required for targeting Ect2 to 
the central spindle.  
Whereas the amino-terminal half of Ect2 was sufficient for central spindle 
targeting, the carboxyl-terminal half of Ect2 strongly associated with the cell cortex, but 
was absent from the central spindle (Fig. 21C). The carboxyl-terminus of Ect2 consists of 
a DH domain (Dbl Homology) which is a Rho GEF domain, followed by a PH domain 
(Plekstrin Homology). Further truncation analysis revealed that the PH domain was 
essential for targeting Ect2 to the cell cortex (Fig. 21C). Considering that PH domains 
constitute lipid-binding motifs (Blomberg et al., 1999), it is attractive to postulate that the 
cortex association of Ect2 reflects a direct interaction with the plasma membrane. The PH 
domain has been shown to be essential for the cell transforming activity of Ect2 in 
NIH/3T3 cells by an yet unknown mechanism (Miki et al., 1993; Solski et al., 2004), 
suggesting that the cortex-associated pool of Ect2 is critical for its oncogenic potential. 
 
 
2.2.3 Ect2 is targeted to the central spindle via the MKlp1/MgcRacGAP 
and Aurora-B/MKlp2 complexes 
 
The central spindle is composed of non-kinetochore, anti-parallel MTs and many proteins 
required for cytokinesis are localized to this structure. Therefore we next asked which 
central spindle proteins were required for targeting Ect2 to the central spindle. 
Specifically, we depleted the kinesins MKlp1 and MKlp2, the mitotic kinase Aurora-B 
and the GTPase activating protein MgcRacGAP from HeLa S3 cells, using previously 
validated siRNA duplexes. In agreement with previous reports (Kitamura et al., 2001; 
Matuliene and Kuriyama, 2002; Neef et al., 2003; Terada et al., 1998), depletion of all 
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these proteins resulted in a significant increase in binucleated cells, indicative of 
cytokinesis defects (data not shown).  
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igure 22. Ect2 requires the MKlp1/MgcRacGAP and Aurora-B/MKlp2 complexes to localize to the 
entral spindle. 
A) HeLa S3 cells were transfected with siRNA duplexes against MKlp1, MgcRacGAP, Aurora-B and 
Klp2 genes for 36 hours and were subsequently fixed and permeabilized with 
araformaldehyde/Triton X-100. These cells were stained with anti-Ect2 antibodies in red (left), anti-α-
bulin antibodies in green (middle) and DNA was labelled with DAPI in blue. Merged images are 
hown at the right. Scale bar 10 µm.  
B) HeLa S3 cells were transfected with an Ect2 siRNA duplex for 36 hours and were subsequently 
xed and permeabilized with paraformaldehyde/Triton X-100. These cells were stained with anti-
Klp1, anti-MgcRacGAP (Cyk4), anti-Aurora-B and anti-MKlp2 antibodies in red (left), anti-α-tubulin 
ntibodies in green (middle) and DNA was labelled with DAPI in blue. Merged images are shown at the 
ight. Scale bar 10 µm. 
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(C) HeLa S3 cells were transfected with siRNA duplexes against GL2, MKlp1, MgcRacGAP, MKlp2, 
Aurora-B and Ect2 genes for 36 hours. Cell extracts were made in Hepes lysis buffer and after SDS-PAGE, 
the separated proteins were blotted onto nitrocellulose membranes and probed with anti-Ect2 antibodies 
(upper panel) and anti-α-tubulin antibodies (lower panel) as loading control.  
 
In MKlp2 and Aurora-B depleted cells, the central spindle was often strongly deformed, 
missing many of the anti-parallel MTs in this region. Also in MKlp1 and MgcRacGAP 
depleted cells central spindle formation was affected, but to a lesser extent than in 
Aurora-B and MKlp2 depleted cells. At present it is not clear if this reflects a stronger 
dependency of central spindle formation on MKlp2 and Aurora-B or if this reflects the 
efficiency of the depletion. These data are consistent with the view that all the above 
proteins contribute to central spindle formation (Fig. 22A). Importantly, depletion of each 
of these four proteins abolished the interaction of Ect2 with residual central spindle and 
midbody structures, but did not affect its localization to the cell cortex (Fig. 22A and data 
not shown). Since the absence of Ect2 from central spindle and midbody could not be 
explained by diminished Ect2 levels (Fig. 22B), we conclude that MKlp1, MKlp2, 
Aurora-B and MgcRacGAP were all required for proper localization of Ect2 to these 
structures. In Ect2 depleted cells, on the other hand, MKlp1, MKlp2, Aurora-B and 
MgcRacGAP localization to the central spindle was not affected. These results strongly 
suggest that Ect2 acts downstream of MKlp1, MKlp2, Aurora-B and MgcRacGAP and 
merely uses the central spindle to position itself.  
We could not directly compare the respective localization of these endogenous 
proteins at the central spindle as most antibodies were generated in rabbits. Hence, we 
could only determine co-localization at the central spindle of all these proteins with Plk1 
which was detected with a mouse monoclonal antibody. Although MKlp1, MKlp2, 
Aurora-B, MgcRacGAP, Plk1 and Ect2 all co-localize at the central spindle during early 
anaphase (Fig. 23A), close examination of late stage dividing cells revealed distinct 
localization patterns for some of these proteins. In late anaphase and telophase cells, 
MKlp2 co-localized with Aurora-B and Plk1 in two bands adjacent to the midbody 
structure (Fig. 23B), consistent with the notion that MKlp2 interacts with these two 
kinases (Gruneberg et al., 2004; Neef et al., 2003). In contrast, both MKlp1 and 
MgcRacGAP localized more closely to the midbody structure (Fig. 23B), in line with 
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their ability to form a stable complex, called central spindlin (Mishima et al., 2002; 
Mishima et al., 2004). When Ect2 localization was analyzed carefully, it clearly matched 
the localization of the MKlp1/MgcRacGAP complex near the midbody (Fig. 23B), 
suggesting that this complex could be involved in targeting Ect2 to the central spindle 
and midbody. 
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Plk1                                        merge+DNA        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 23. Ect2 co-localizes with MKlp1 and MgcRacGAP 
in telophase. 
(A) HeLa S3 cells were fixed and permeabilized with 
paraformaldehyde/Triton X-100 and stained with anti-Plk1 
antibodies in red (left) and anti-Aurora-B, anti-MKlp2, 
anti-Ect2, anti-MKlp1 and anti-MgcRacGAP antibodies in 
green (middle). DNA was labelled with DAPI in blue. 
Merged images are shown at the right. Scale bar 10 µm. 
(B) HeLa S3 cells were fixed and processed as in A and 
stained with the above mentioned antibodies. Midbody 
structure localization at telophase is shown. Scale bar 3.3 
µm.  
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2.2.4 Ect2 interacts with the MKlp1/MgcRacGAP complex via the amino-
terminal BRCT domain 
  
Since Ect2 localization to the central spindle is dependent on the MKlp1 and 
MgcRacGAP proteins and Ect2 co-localizes with these proteins at the midbody, we next 
asked whether these proteins exist in a complex. To determine whether Ect2 interacts 
with the MKlp1/MgcRacGAP complex, co-immunoprecipitation experiments were 
performed. HeLa S3 cells were synchronized by an aphidicolin/nocodazole block release 
protocol and harvested when most cells were present in anaphase or telophase. 
Endogenous Ect2 was then immunoprecipitated using anti-Ect2 antibodies or pre-
immune antibodies for control (Fig. 24A). The resulting immune complexes were probed 
after Western blotting for the presence of various central spindle components. The 
mitotic kinesin MKlp1 (Kuriyama et al., 2002; Matuliene and Kuriyama, 2002) and the 
GTPase activating protein MgcRacGAP (Hirose et al., 2001) could readily be detected in 
Ect2 immunoprecipitates, whereas the mitotic kinase Aurora-B (Terada et al., 1998) and 
the mitotic kinesin MKlp2 (Hill et al., 2000; Neef et al., 2003) were absent, and none of 
these proteins were observed in control immunoprecipitates (Fig. 24A). These data 
indicate that Ect2 interacts specifically with the MKlp1/MgcRacGAP complex. These 
results are in agreement with the dependency of Ect2 on MKlp1 and MgcRacGAP 
proteins for its central spindle and midbody localization (Fig. 22A). In addition, these 
results suggest that MKlp2 and Aurora-B might have an indirect regulatory function in 
targeting Ect2 to the central spindle. 
Since Ect2 localization is mediated via the amino-terminal BRCT domain (Fig. 
21B), we next investigated whether this domain could directly interact with the 
MKlp1/MgcRacGAP complex. To investigate this possibility, different amino-terminal 
myc-tagged fragments were transiently expressed in HeLa S3 cells and 
immunoprecipitated using anti-myc (9E10) antibodies after synchronization, as described 
above. As shown (Fig. 24B), the amino-terminal fragments comprising residues 1-420 
and 1-333 were able to co-precipitate MKlp1 and MgcRacGAP. A smaller fragment with 
a truncated BRCT domain (residues 1-288) on the other hand was unable to co-
precipitate MKlp1 and MgcRacGAP and the same was true for an unrelated control 
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protein, hWW45 (Fig. 24B and 25C) (Chan et al., 2005; Valverde, 2000). In agreement 
with Ect2’s requirement to localize to the central spindle (Fig. 21A and 21B), the 
minimal domain identified here that could still bind to the MKlp1/MgcRacGAP complex 
comprised again the complete BRCT domain. These results show that targeting of Ect2 to 
the central spindle is mediated via the interaction of its BRCT domain with the 
MKlp1/MgcRacGAP complex. 
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Figure 24. The MKlp1/MgcRacGAP complex co-immunoprecipitates with Ect2. 
(A) Hepes lysis buffer extracts were made of HeLa S3 cells synchronized in anaphase and telophase 
stages by an aphidicolin-nocodazole block and release protocol. Immunoprecipitation experiments were 
performed on these extracts using anti-Ect2 antibodies and IgG pre-immune antibodies as a control. 
These immunoprecipitates were separated on SDS-PAGE, transferred onto nitrocellulose membranes and 
probed with anti-Ect2, anti-MKlp1, anti-MgcRacGAP, anti-Aurora-B and anti-MKlp2 antibodies.  
(B) HeLa S3 cells were simultaneously synchronized and transfected with myc-Ect2 1-420, myc-Ect2 1-
333, myc-Ect2 1-288 and myc-hWW45 as a control. Immunoprecipitation experiments were done as 
described above with anti-myc antibodies. Blots were then probed with anti-myc, anti-MKlp1 and anti-
MgcRacGAP antibodies.  
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2.2.5 The interaction between the BRCT domain of Ect2 and the 
MKlp1/MgcRacGAP might be phosphorylation dependent 
 
Recently, it was shown that the BRCT domain of BRCA1 constitutes a phosphopeptide-
binding domain (Clapperton et al., 2004; Manke et al., 2003; Williams et al., 2004; Yu et 
al., 2003). The crystal structure of the BRCA1 BRCT domain in complex with the 
BACH1 (BTB and CNC homology 1) phosphopeptide has been determined (Fig. 25A). 
This structure revealed that two amino acid side chains of S1655 and K1702 in the BRCT 
domain directly interact with the phosphate group of the phosphopeptide and another 
direct interaction was made with an amide bond of glycine residue G1656. Given that the 
two side-chain interactions critical for phosphoprotein binding in BRCA1 are present and 
highly conserved in Ect2 (T153, K195), we considered the possibility that the interaction 
of Ect2 with the MKlp1/MgcRacGAP complex could require a phosphorylated docking 
site. Also, the Clustal-W sequence alignment of the first Ect2 BRCT repeat with BRCT 
repeats of BRCA1, BARD1, XRCC1, RFC1 and PTIP revealed that although the primary 
sequence of BRCT repeats is not well conserved, the critical residues that have been 
implicated in phosphopeptide binding are conserved in all the BRCT repeats analyzed 
(Fig. 25B). Therefore, we mutated the two highly conserved residues (T153, K195) in the 
Ect2 1-333 BRCT domain to alanine residues (Fig. 25B) (Clapperton et al., 2004; 
Williams et al., 2004). This myc-tagged mutant fragment (1-333, T153A/K195A) was 
transiently overexpressed in HeLa S3 cells and immunoprecipitated after synchronization 
in ana- and telophase of the cell cycle. As shown in Fig. 25C, the wild type 1-333 
fragment readily co-precipitated MKlp1 and MgcRacGAP, but only low levels were 
bound to the mutant BRCT (T153A/K195A) domain. Immunofluorescence microscopy 
analysis revealed that the BRCT T153A/K195A mutant fragment was only present at low 
levels at the central spindle, in accordance with its weak interaction with the 
MKlp1/MgcRacGAP complex (Fig. 25D). Together, these data strongly suggest that the 
localization of Ect2 to the central spindle could be mediated via the BRCT dependent 
binding to the MKlp1/MgcRacGAP complex and probably involves a phosphorylation-
site specific docking mechanism. 
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 Figure 25. The MKlp1/MgcRacGAP complex interacts with the BRCT domain of Ect2 possibly in a 
phosphorylation dependent manner. 
(A) Schematic representation of BACH1 phosphopeptide (blue) contacts with the tandem BRCT domains 
of BRCA1. The residues marked in red coloured boxes within the BRCT domain are highly conserved 
throughout the whole family of BRCT domains (see arrows in Fig. 25B). Dashed lines, hydrogen bonds; 
pink crescent, van der waals interactions; green circles, water molecules.Image adapted and modified 
from Clapperton et al, Nature Structural and Molecular Biology 11, 512-518 (2004). 
(B) Clustal-W sequence alignment of the first Ect2 BRCT repeat with BRCA1 (Breast Cancer Carboxyl 
terminal), BARD1 (BRCA1 associated ring domain1), XRCC1 (X-ray repair complementing defective 
repair in chinese hamster cells 1), RFC1 (replication factor C1) and PTIP (pax transactivation domain-
interacting protein). The BRCT domain number indicates the BRCT repeat used for alignment out of the 
total number of BRCT repeats present in each protein. Arrows indicate the highly conserved residues in 
this alignment.  63DC
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(C) HeLa S3 cells were simultaneously synchronized and transfected with myc-Ect2 1-333, myc-Ect2 1-
333 T153A/K195A and myc-hWW45 (as a control), respectively. Anti-myc antibodies coupled to protein 
G sepharose beads were used to immunoprecipitate these proteins from cell extracts of cells 
synchronized in anaphase and telophase of the cell cycle. The immunoprecipitates were separated by 
SDS-PAGE, blotted and probed with anti-myc, anti-MKlp1 and anti-MgcRacGAP antibodies.  
(D) U2OS cells were transfected with myc-Ect2 1-333 and myc-Ect2 1-333 T153A/ K195A plasmids for 
36 hours and were subsequently fixed and permeabilized with paraformaldehyde/Triton X-100. These 
cells were stained with anti-myc in red (left) and anti-α-tubulin antibodies in green (middle). DNA was 
labelled with DAPI in blue. Merged images are shown at the right. Scale bar 10 µm. 
 
 
 
 
 
 
 
 
 
2.2.6 Ect2 central spindle localization is not essential for cytokinesis  
 
As shown above, the intact BRCT domain is necessary and sufficient for central spindle 
localization of Ect2. We next wondered if overexpression of this domain could displace 
endogenous Ect2 from the central spindle. To examine this, an antibody that detects a 
carboxyl-terminal epitope in Ect2 recognizing only endogenous Ect2 protein was used. 
Examination of cells overexpressing the amino-terminal fragments (1-333 and 1-420) 
showed that endogenous Ect2 was indeed displaced from the central spindle by these 
fragments (Fig. 26A). Expression of a shorter amino-terminal fragment (1-288) with a 
truncated BRCT domain (1-288) that does not localize to the central spindle did not 
interfere with endogenous Ect2 localization. This indicates that the BRCT domain is able 
to displace endogenous Ect2 from the central spindle, most likely as a result of 
competition with endogenous Ect2 for binding to the MKlp1/MgcRacGAP complex.  
Despite displacement of endogenous Ect2 from the central spindle by the large 
amino-terminal Ect2 fragment (1-420), these cells did not show obvious cytokinesis 
defects (Fig. 26, right panel) as revealed by their mononuclear appearance (data not 
shown). This suggests that Ect2 central spindle localization is not absolutely required for 
cytokinesis and that the cortical pool of Ect2 might be sufficient to carry out cytokinesis 
in these cells. Surprisingly, though, cells expressing the smaller BRCT containing Ect2 
fragment (1-333) became binucleated after 48 hours of expression, indicative of a 
cytokinesis failure in these cells (Fig. 26, right panel). Since both BRCT domain-
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containing fragments displaced endogenous Ect2 equally well (Fig. 26), the cytokinesis 
defect upon overexpression of the 1-333 fragment is unlikely to be a result of Ect2 central 
spindle displacement.  
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Figure 26. Exogenously expressed myc tagged Ect2 fragments at the central spindle displaces 
endogenous Ect2.  
(A) HeLa S3 cells were grown on cover slips and transiently transfected with myc-Ect2 1-420, 
myc-Ect2 1-333 and myc-Ect2 1-288 constructs for 36 hours and were simultaneously fixed and 
permeabilized with formaldehyde/Triton X-100. These cells were stained with anti-Ect2 
antibodies recognizing a carboxyl-terminally located Ect2 epitope in red (left) and anti-myc 
9E10 antibodies in green (middle). DNA was labelled with DAPI in blue. Merged images are 
shown at the right. Scale bar 10 µm. 
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2.2.7 Conclusion: 
 
In this part of the study, we examined the localization of endogenous Ect2 in human cells 
and, moreover, identified the domains and interacting proteins that control the subcellular 
localization of Ect2. We show that Ect2 localizes both to the central spindle and the cell 
cortex during mitosis. The central spindle localization is dependent on the amino-
terminally located BRCT domain, whereas the cell cortex localization is mediated by the 
carboxyl-terminal PH domain. Although the central spindle targeting of Ect2 requires 
both the MKlp1/MgcRacGAP and MKlp2/Aurora-B complexes, only the former complex 
directly interacts with Ect2. We also show that targeting of Ect2 to the central spindle 
requires the interaction of its BRCT domain to the MKlp1/MgcRacGAP complex and is 
probably mediated by a phosphorylation dependent docking mechanism. Finally, we 
show that Ect2 central spindle localization is not absolutely essential for cytokinesis, 
indicating that localized GEF activity is not critical for cytokinesis. Taken together, these 
data show that although the targeting of Ect2 to the central spindle is mediated by protein 
complexes through phosphorylation dependent docking mechanism, other unknown 
mechanisms operate in the cell to faithfully complete cytokinesis in the absence of 
localized Ect2 at the central spindle.  
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2.3 Requirement of Ect2 in cytokinesis 
 
2.3.1 Ect2 controls both early and late cytokinesis events  
 
Cytokinesis involves several steps including cleavage furrow specification, contractile 
ring formation, cleavage furrow ingression and abscission. To explore the role of human 
Ect2 in this process we investigated the cytokinesis defects in Ect2 depleted cells, as well 
as in cells expressing the BRCT domain containing amino-terminal Ect2 fragment (1-
333) in more detail.  For the latter, a stable tetracycline inducible HeLa S3 cell line was 
generated. Addition of tetracycline to this cell line for 24 hours resulted in a strong 
induction of this myc-tagged Ect2 fragment as determined by Western blotting (Fig. 
27A).  About 50 % of the cells became binucleated within this 24 hours induction period, 
confirming that this fragment strongly interfered with cytokinesis. 
To analyze and compare the cytokinesis defects in Ect2 depleted and amino-
terminal Ect2 (1-333) overexpressing cells, spindle formation in these cells was analyzed. 
In cells expressing the amino-terminal Ect2 fragment (1-333), normal central spindle 
formation, midbody formation and cleavage furrow ingression were observed (Fig. 27B, 
upper panel). Despite this, these cells finally failed cytokinesis at a late stage during 
cytokinesis and became binucleated. In Ect2 depleted cells, bipolar spindle formation and 
initial central spindle formation looked apparently normal (Fig. 27B, middle panel). This 
is in clear contrast to what was observed after depletion of other central spindle proteins 
and suggests that Ect2 is not required for central spindle formation per se.  Nevertheless, 
in most late anaphase cells, spindles were aberrant in that they were very voluminous and 
MTs were present all over the equatorial cortical region. The cause of this is most likely 
the absence of cleavage furrow ingression. As a result of this ingression defect, 
midbodies were practically absent in Ect2 depleted telophase cells and instead an 
abnormal spindle-like structure was present between the two reforming nuclei. Finally, 
the interphase microtubule structure was reformed in these cells without having 
undergone any form of cytokinesis. Thus, in contrast to cells expressing the BRCT-
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containing fragment, cells depleted of Ect2 were not even able to form a proper cleavage 
furrow to start ingression.  
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To confirm the distinct phenotypes of cells overexpressing the amino-terminal 
Ect2 fragment and cells depleted of Ect2, live-cell imaging was performed. In cells 
expressing the amino-terminal fragment, cleavage furrow formation and ingression was 
observed (Fig. 27C, upper panel). However, this was accompanied by extensive 
membrane blebbing during metaphase to anaphase transition in more than 50% of the 
cells. The cause of this blebbing is not clear, but we like to note that blebs are caused by 
rupture of the plasma membrane from the cytoskeleton, suggesting that these cells have 
problems with cytoskeleton rearrangements during this phase of mitosis (Charras et al., 
2005). The time spent in mitosis was highly variable and it seemed that cells often had 
difficulties to position the cleavage furrow properly. Only at a very late stage during 
cytokinesis the cleavage furrow regressed, finally resulting in one cell with two nuclei. 
We often observed that one cell had already flattened on the culture dish surface, whereas 
the other cell was still rounded up, suggesting that the cytoplasmic contents of these cells 
were practically separated. However, these cells finally regressed and fused to form one 
cell, suggesting that these cells exhibited a late cytokinesis defect and that abscission 
failed. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Requirement of Ect2 during cytokinesis. 
(A) Western blots analysis of lysates from myc-Ect2 1-333 expressing stable cell line before and after 
induction with tetracycline for 24 hours are shown. Blots were probed with anti-myc and anti-α-tubulin 
antibodies (as a loading control). 
(B) HeLa S3 cells were treated for 24 hours with GL2 (control) and Ect2 siRNA duplexes and the inducible 
myc-Ect2 1-333 stable cell line was induced for 24 hours with tetracycline. After fixation and 
permeabilization with paraformaldehyde/Triton X-100, the myc-Ect2 1-333 expressing cells were stained 
with anti-myc 9E10 antibodies (red), α-tubulin antibodies (green) and with DAPI (blue) and the siRNA 
treated cells were stained with anti-Ect2 antibodies (red), anti-α-tubulin antibodies (green) and DNA was 
labelled with DAPI (blue). Images are projection of deconvolved images of a series of Z stacks. Scale bar 10 
µm. 
(C) Live-cell imaging of myc-Ect2 1-333 expressing cells (upper panel), Ect2 depleted HeLa S3 cells 
(middle 2 panels) and cells treated with GL2 control oligos (lower panel). Images were made every two min 
and only representative frames are shown. In the myc-Ect2 1-333 expressing cell line time ‘0’ is the last 
time frame for the cell on the right side, in which the cell still showed an interphase appearance. In Ect2 
depleted cells and control cells (cells treated with GL2 oligos), time ‘0’ is the last time frame for both cells 
that still showed an interphase appearance. Scale bar 10 µm.  69
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In contrast, in most of the Ect2 depleted cells no obvious cleavage furrow formation or 
ingression could be observed and cells exited mitosis without showing any signs of 
cytokinesis (Fig. 27C, 2nd panel). These cells spent about 100 min in mitosis, which is 
similar to control cells (Fig. 27C, lower panel). Only a small number of Ect2 depleted 
cells showed signs of furrow formation and ingression, but then failed cytokinesis at later 
stages of cytokinesis. This late stage cytokinesis defect was more prominent, when cells 
were treated with less efficient siRNA duplex (Fig. 27C, 3rd panel). 
Together, these results show that Ect2 is required for cleavage furrowing, but that 
overexpression of the amino-terminal Ect2 fragment affected predominantly cell-
abscission. 
 
 
2.3.2 RhoA and Citron kinase are not targeted to the cleavage furrow in 
Ect2 depleted cells 
  
One of the early critical steps during cytokinesis is the activation of RhoA (Bement et al., 
2005). This GTPase then controls several proteins that regulate the dynamics of the actin 
cytoskeleton, leading to contractile ring formation and contraction (Glotzer, 2001). A 
recent study in Drosophila showed that both Rho1 (RhoA) and one of the downstream 
targets, Sticky (Citron kinase), required pebble (Ect2) for proper localization to the 
contractile ring (Shandala et al., 2004). In Drosophila, both Rho1 and Sticky are required 
for cytokinesis, but in mammalian cells the role of Citron kinase in cytokinesis has 
remained controversial (Cunto et al., 2002; Di Cunto et al., 2000). To examine this issue, 
we used siRNA to deplete Citron kinase and monitored HeLa S3 cells for the formation 
of binucleated cells, implying cytokinesis defects. As shown in Fig. 28A, in cells 
depleted of Citron kinase a strong increase in binucleated cells was observed and the 
effective depletion of Citron kinase was confirmed by Western blot analysis (Fig. 28B). 
Thus, Citron kinase is clearly essential for cytokinesis in HeLa S3 cells.  
We next analyzed the localization of RhoA and Citron kinase during cytokinesis 
in human cells. In undisturbed cells, both proteins localized to the contractile ring during 
cytokinesis (Fig. 28C, 28D, upper panels), confirming previous results (Eda et al., 2001; 
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Mabuchi et al., 1993; Madaule et al., 1998). The localization was more difficult to 
analyze in Ect2 depleted cells, as most of these cells do not form a cleavage furrow at all. 
However, in those Ect2 depleted cells that showed some cleavage furrow formation both 
RhoA and Citron kinase was strongly diminished at this site (Fig. 28C and 28D, middle 
panels), confirming and extending recent observations (Yuce et al., 2005). Therefore, 
these data indicate that Ect2 regulates RhoA, as well as its target Citron kinase, also in 
human cells. 
In contrast to the situation in Ect2 depleted cells, RhoA and Citron kinase could 
readily be detected at the cleavage furrow in cells expressing the amino-terminal Ect2 
fragment (Fig. 28C and 28D, bottom panels). This result falls in line with the observation 
that these cells showed cleavage furrow formation and ingression (Fig. 27C). Taken 
together, our data indicate that the inability to target RhoA and Citron kinase to the 
cleavage furrow may constitute the main reason for the cytokinesis defects observed in 
Ect2 depleted cells. On the other hand, since RhoA and Citron kinase were properly 
targeted to the cleavage furrow in cells expressing the amino-terminal Ect2 fragment, it 
follows that cytokinesis failure in these latter cells must result through another 
mechanism. 
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 Figure 28. Ect2 targets RhoA and Citron kinase to the cleavage furrow. 
(A) HeLa S3 cells were treated with siRNA duplexes against GL2 and Citron kinase for 48 hours and
subsequently fixed and permeabilized with paraformaldehyde/Triton X-100. These cells were stained
with anti-α-tubulin antibodies (green).  DNA was labelled with DAPI (blue). Scale bar 10 µm.  
B) Same as in A, but now Hepes lysis buffer extracts were made and the proteins were separated by
SDS-PAGE, blotted and probed with anti-Citron kinase antibodies and anti-α-tubulin antibodies (as
loading control).  
C) HeLa S3 cells were treated for 36 hours with control (GL2) and Ect2 siRNA duplexes and the myc-
Ect2 1-333 expressing stable cell line was induced for 36 hours with tetracycline. After fixation and
permeabilization with 10% TCA/Triton X-100, siRNA treated cells (upper and middle panels) were
stained with anti-Ect2 (left) in red, anti-RhoA (middle) antibodies in green and DNA was labelled with
DAPI in blue. Merged images are shown on the right. The stable cell line (lower panel) was stained
with anti-myc 9E10 (left) in green, anti-RhoA (middle) antibodies in red and DNA was labelled with
DAPI in blue. Merged images are shown on the right. Scale bar 10 µm.  
D) HeLa S3 cells were treated for 36 hours with control (GL2) and Ect2 siRNA duplexes and the myc-
Ect2 1-333 expressing stable cell line was induced for 36 hours with tetracycline. After simultaneous
fixation and permeabilization with paraformaldehyde/Triton X-100, siRNA treated cells (upper and
middle panels) were stained with anti-Ect2 (left) in red, anti-Citron kinase (middle) antibodies in green
and DNA was labelled with DAPI in blue. Merged images are shown on the right. The stable cell line
(lower panel) was stained with anti-myc 9E10 (left) in green, anti-Citron kinase (middle) antibodies in
red and DNA was labelled with DAPI in blue. Merged images are shown on the right. Scale bar 10 µm.                                      
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2.3.3 Nuclear targeting of the amino-terminal Ect2 (1-333) fragment can 
prevent cytokinesis defects 
 
The above results clearly revealed why in Ect2 depleted cells cleavage furrow ingression 
is impaired, but do not explain why overexpression of the Ect2 1-333 fragment interfered 
with cell abscission. Whereas overexpression of full length Ect2 and the larger Ect2 
amino-terminal fragment (1-420), hardly interfered with cytokinesis and localized to the 
nucleus during interphase, this smaller fragment localized to the cytoplasm (Fig. 30, data 
not shown). This is in agreement with the presence of two potential nuclear localization 
signals (NLS) or alternatively one bipartite NLS between residues 346-374. Based on this 
observation it is tempting to speculate that nuclear translocation of Ect2 during telophase 
could be essential for cell abscission.  
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We therefore analyzed additional myc-tagged Ect2 truncation fragments and observed 
that myc-tagged Ect2 fragments 1-360 and 1-370, which localized both to the cytoplasm 
and the nucleus during interphase, resulted in a clear increase in binucleated cells, 
whereas the amino-terminal fragment 1-388, which localizes predominantly to the 
nucleus resulted only in a small increase in the number of binucleated cells (Fig. 29). 
Thus, only those fragments that do not have an intact NLS and hence localize 
predominantly to the cytoplasm affect proper cytokinesis. To further examine the 
requirement of nuclear translocation, we generated a construct that could express the Ect2 
1-333 fragment with three SV40 NLS sequences tagged to its amino-terminus. Analysis 
of cells transiently expressing this NLS-Ect2 (1-333) fragment revealed that this fragment 
now localized predominantly to the nucleus in interphase cells, although some weak 
cytoplasmic staining could sometimes be observed (Fig. 30). Interestingly, this fragment 
was much less potent in generating binucleated cells (30 % as compared to 80 % with the 
fragment lacking the NLS). These results show that nuclear translocation of this Ect2 
fragment during late telophase can prevent cytokinesis failure. 
To further investigate the requirement of nuclear translocation, the NLS´s in full 
length Ect2 and in the 1-388 fragment were removed by mutating lysine residues in the 
NLS sequences to aspargine residues and arginine residues to glutamine residues 
(348KRR350 to 348NQQ350 and 371RKR373 to 371QNQ373) (Robbins et al., 1991). 
Overexpression of these mutated Ect2 proteins in HeLa S3 cells showed that both 
mutants localized to the cytosol in interphase cells (data not shown). Overexpression of 
the NLS mutant version of myc-Ect2 did, however, not result in an increase in 
binucleated cells as compared to cells overexpressing wild type Ect2 (measured values 
being 12% and 17%, respectively). However, although the NLS mutated 1-388 fragment 
did localize to the cytoplasm, its overexpression only marginally increased the formation 
of binucleated cells when compared to its nuclear counterpart (25% to 9%, respectively). 
Thus, although the NLS motifs contribute to determine the extent of cytokinesis failure 
produced by various Ect2 fragments, additional sequences flanking the central Ect2 NLS 
region also appear to be important. 
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 .3.4 The amino-terminal BRCT-containing fragment (1-333) mislocalizes 
s a stripe perpendicular to the midbody during cytokinesis. 
Figure 30. Effects of cytoplasmic and nuclear localization of the Ect2 fragments 1-333 and 1-388 on 
proper cytokinesis. 
(A) HeLa S3 cells were transfected with myc-Ect2 1-333 and 3x-NLS-myc-Ect2 1-333 constructs for 36 
hours and subsequently were fixed and permeabilized with paraformaldehyde/Triton X-100. These cells 
were stained with anti-myc antibodies in red, anti-α-tubulin antibodies in green and DNA was stained 
with DAPI in blue. Merged images are shown at the right. Scale bar 10 µm. 
(B) HeLa S3 cells were transfected with myc-Ect2 1-333 and 3x-NLS-myc-Ect2 1-333 constructs for 48 
hours and subsequently were fixed and permeabilized with paraformaldehyde/Triton X-100. These cells 
were stained as described above and the transfected cells were analyzed for the presence of either a 
single nucleus or binucleation. The mean value of the percentage binucleated cells from two independent 
experiments is represented in the form of a histogram.  1-333     
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2.3.4 The amino-terminal BRCT-containing fragment (1-333) is 
mislocalized as a ring-like structure perpendicular to the midbody during 
cytokinesis 
 
Careful analysis of the localization of the Ect2 1-333 fragment showed that this fragment 
mislocalized as a ring-like structure perpendicular to the midbody in most telophase cells 
around the time of nuclear envelope reformation (Fig. 31A, lower panel). Co-staining 
with FITC-phalloidin, which stains the actin cytoskeleton, showed that this fragment 
partly co-localized with the contractile ring during cytokinesis (Fig. 31B). Surprisingly, 
when we analyzed MKlp1 and MgcRacGAP localization in these cells, we observed that 
those proteins also co-localized with this Ect2 fragment (Fig. 31C). MKlp1 and 
MgcRacGAP contain NLS sequences, like Ect2, and upon completion of cytokinesis, 
these proteins are translocated into the nucleus. In the presence of this amino-terminal 
Ect2 (1-333) fragment, however, MKlp1 and MgcRacGAP were partly retained at the 
midbody/contractile ring structure. This mislocalization was not observed when we 
overexpressed the larger fragments (1-420 and 1-388) and the Ect2 (1-333) fragment that 
contains the SV40 NLS sequences (Fig. 31A and data not shown). All these latter 
fragments were translocated to the nucleus during telophase and interfered only slightly 
with cytokinesis. Surprisingly, the Ect2 1-388 fragment containing the NLS mutations 
did not show this abnormal accumulation at the midbody/contractile ring (Fig. 31A), 
although it remained in the cytoplasm during telophase and, as mentioned above, it 
interfered with cytokinesis only slightly. Thus, a clear correlation exists between the 
abnormal midbody/central spindle localization of the Ect2 fragments and cytokinesis 
failure. Both nuclear translocation and sequences located between residue 333 and 388 
can prevent this abnormal localization. Although the exact nature of this mislocalization 
is still unclear, these results indicate important regulatory functions of the region between 
the BRCT domain and the GEF domain, including the targeting of Ect2 to the nucleus.  
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 A 
Figure 31. Ect2 1-333 is mislocalized as a 
ring at the cell cortex near the midbody 
during cytokinesis. 
(A) Myc-Ect2 1-420, myc-Ect2 1-333, and 
NLS-myc-Ect2 1-333 and myc-Ect2 1-388-
NLS-mutant were transiently 
overexpressed in HeLa S3 cells and grown 
for 48 hours before fixation and 
permeabilization with 
paraformaldehyde/Triton X-100 as 
described above. Cells were stained with 
anti-myc in red, anti-α-tubulin in green 
and DNA was labelled with DAPI in blue. 
Merged images are shown at the right. 
Scale bar 10 µm. 
(B) Myc-Ect2 1-333 stable cell line was 
induced for 36 hours and stained with 
FITC-phalloidin in green, anti-myc 
antibodies in red and DNA was stained 
with DAPI in blue. Merged images are 
shown at the right with scale bar 10 µm. 
 (C) Myc-Ect2 1-333 stable cell line was 
induced for 36 hours and stained with anti-
MKlp1 and anti-MgcRacGAP antibodies in 
red, anti-α-tubulin antibodies in green and 
DNA was labelled with DAPI in blue. 
Merged images are shown at the right. 
Scale bar 10 µm. 
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2.3.5 Conclusion: 
 
Although Ect2 has been shown to be required for cytokinesis, the exact mechanisms by 
which Ect2 controls cell division were not known. Here we show that depletion of Ect2 
impaired cleavage furrow formation and ingression. Concomitantly, two proteins 
required for cytokinesis, RhoA and Citron kinase, fail to accumulate at the cell cortex. 
Also, overexpression of appropriate amino-terminal Ect2 fragments blocked cytokinesis, 
but in these cells, RhoA and Citron kinase localized to the cell cortex concomitant with 
the ingression of the cleavage furrow. However, cell abscission finally failed in these 
cells. This abscission failure could be correlated with the persistence of the amino-
terminal Ect2 fragments at striking ring-like structures surrounding the midbody, 
indicating that completion of cell division requires the displacement of Ect2 from the 
contractile ring and its re-import into the reforming cell nucleus. These data show that 
interference with Ect2 function blocks cytokinesis by both impairing cleavage furrow 
formation and cell abscission. They also provide evidence that Ect2 is required 
throughout cytokinesis accompanied with multiple regulation mechanisms.  
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3.0 Discussion 
 
Cytokinesis is the process that completes the programme of cell division resulting in two 
daughter cells. This process is fundamental to life and has recently attracted a lot of 
attention, primarily because it is essential for genome maintenance, and thus its proper 
functioning is essential for human health. Despite this, relatively little is know about it, 
partly due to its complexity. Moreover, because of the low conservation of the regulatory 
processes that control cytokinesis, extrapolation from genetically tractable organisms, 
like yeasts, is often not possible. Nevertheless, in the past years a number of proteins 
have been identified that are required for proper cytokinesis in animal cells. These 
include components required for central spindle formation, assembly of the contractile 
ring, cleavage furrow ingression and addition of new membranes during the invagination 
of plasma membrane (Balasubramanian et al., 2004; Guertin et al., 2002). Here we have 
investigated the human guanine nucleotide exchange factor (GEF) Ect2, an orthologue of 
the Drosophila pebble gene, which is essential for cytokinesis. In particular, we have 
explored the potential regulatory role of Ect2 phosphorylation by mitotic kinases, its 
targeting to the central spindle and its functions during cytokinesis. 
 
 
3.1 Mitotic phosphorylation of Ect2 
 
Reversible protein phosphorylation by protein kinases is one of the main regulatory 
posttranslational mechanisms controlling mitotic progression (Nigg, 2001). 
Phosphorylation not only directs the allosteric regulation of enzyme activity, but is also 
important for controlling protein-protein interactions and regulating the subcellular 
localization of proteins. In agreement with a previous report (Tatsumoto et al., 1999), we 
could show here that Ect2 is hyperphosphorylated during mitosis indicating that Ect2 
may possibly be regulated by reversible phosphorylation. Although it has been suggested 
that phosphorylation of Ect2 is required for its maximal GEF activity (Tatsumoto et al., 
1999), this observation seemed to be somewhat controversial. In Drosophila, cyclin B 
and cyclin B3 interfered with cytokinesis in a pebble dependent manner suggesting that 
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pebble’s function is inhibited, rather than activated, by Cdk1 activity (Echard and 
O'Farrell, 2003). We observed that in human cells, Ect2 phosphorylation paralleled the 
presence of cyclin B and recent results have shown that Ect2 is rapidly dephosphorylated 
in cells upon addition of the Cdk1 inhibitor BMI-1026 (Niiya et al., 2005), suggesting 
that human Ect2 is a direct substrate of Cdk1. Since Ect2 activity is required for cleavage 
furrow formation during anaphase and telophase, a period of low Cdk1 activity, it is more 
likely that Ect2 dephosphorylation, rather than phosphorylation, could be important for 
its activation. Our attempts to investigate the effects of Ect2 GTP exchange activity on 
RhoA in vitro did not reveal a difference between phosphorylated and dephosphorylated 
recombinant Ect2 suggesting that phosphorylation might not directly regulate Ect2 
activity. These experiments were performed with recombinant Ect2 purified from Sf9 
insect cells. Although Ect2 from OA treated Sf9 insect cells showed a phosphorylation 
pattern similar to endogenous recombinant Ect2 (as determined by MS), the 
phosphorylation pattern might not be identical. Therefore, these results do not rigorously 
exclude a contribution of Ect2 phosphorylation in regulating its GEF activity. 
Alternatively, (de)phosphorylation might not directly regulate Ect2 GEF activity, but 
rather its localization or interaction with upstream and downstream binding partners as 
described below.  
To further explore the function of Ect2 phosphorylation during mitosis, we used 
mass spectrometry to identify mitosis specific phosphorylation sites in endogenous Ect2. 
In total, we could identify six sites that were specifically phosphorylated during mitosis. 
Of these, five sites are highly conserved throughout evolution, suggesting that these could 
have important regulatory functions. Three of the identified phosphorylation sites were 
followed by a proline residue, indicating that these sites were phosphorylated by proline 
directed kinases, e.g. Cdks or MAPKs. Although we could not directly demonstrate that 
Ect2 is a Cdk1 substrate in vitro, Niiya and co-workers showed that inhibition of Cdk1 
resulted in the dephoshorylation of Ect2, indicating that Ect2 is a Cdk1 substrate in vivo 
(Niiya et al., 2005). Moreover, recently an important Cdk1 phosphorylation site has been 
identified in Ect2 as described further below (Hara et al., 2005; Yuce et al., 2005). Three 
of the identified sites that were phosphorylated in vivo could also be phosphorylated by 
Plk1 in vitro suggesting that these are Plk1 sites. Indeed, one of them (S20) is located 
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within the Plk1 consensus phosphorylation sequence (D/E-X-pS/pT). Thus, both Plk1 and 
Cdk1 might be prime regulators of Ect2. Unfortunately, however, our mutational analysis 
did not clearly reveal important roles for these phosphorylation sites in regulating Ect2 
function. Although some elevated increase in multinucleated cells was observed upon 
expression of the individual alanine mutants, especially S20A, the mutant form in which 
all these mutations were combined did not result in any increase in multinucleate cells 
when overexpressed. This is rather surprising, but might indicate that too many mutations 
have an adverse effect on the protein (e.g. folding problems). All Ect2 mutants still 
localized properly, indicating that the observed effect could not be attributed to improper 
targeting and suggesting that these phosphorylation sites are not required for localizing 
Ect2 to its sites of action. Since endogenous Ect2 was still present in all these cells, we 
cannot exclude the possibility that the absence of more severe phenotypes (and proper 
localization) could be a result of the presence of the endogenous protein. Ideally, these 
experiments should be performed in an Ect2 depleted cell line. However, despite the fact 
that siRNA rescue experiments are becoming more common, we were not able to perform 
such experiments with human Ect2. The main reason for this is the low transfection 
efficiencies of Ect2 encoding constructs, a problem that has also been reported by others 
(Hara et al., 2005). Thus, although we have identified a number of potentially interesting 
Plk1 and Cdk1 phosphorylation sites in Ect2, we have so far not been able to discover the 
functions of these phosphorylation sites. While one could suggest that these 
phosphorylation sites might not be important for Ect2 regulation, their strong 
conservation among different species implies that they fulfill evolutionarily conserved 
functions. Improvements of siRNA rescue experiments will hopefully reveal the function 
of these intriguing phosphorylation sites in the near future.  
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3.2 Ect2 targeting and oncogenic potential  
  
Ect2 has been shown to localize to the central spindle and the midbody during mitosis 
and we could confirm these observations (Tatsumoto et al., 1999). In addition, however, 
we observed cortical staining of Ect2 throughout mitosis. This suggests that two different 
pools of Ect2 exist, one targeted to spindle structures and the other one to the cortex. To 
further investigate the targeting of Ect2 to these structures, a number of truncation 
constructs were generated. Analysis of the localization of these truncated proteins in 
HeLa S3 cells revealed that the central spindle targeting domain was located in the 
amino-terminal half, whereas the cortical targeting was mediated by the carboxyl-
terminal domain. In particular, the central spindle localization required an intact BRCT 
domain whereas the cortical localization was dependent on the PH (pleckstrin homology) 
domain. Considering that PH domains constitute lipid-binding motifs (Blomberg et al., 
1999), it is likely that the cortex association of Ect2 reflects a direct interaction with the 
plasma membrane. The PH domain has been shown to be essential for the cell 
transforming activity of the carboxyl-terminal (GEF containing) Ect2 domain (Miki et 
al., 1993; Saito et al., 2004; Solski et al., 2004). Recent results in C. elegans indicate that 
the human Ect2 homologue in C. elegans positively regulates the Ras signalling pathway 
during vulval development in a Rho1 dependent manner (Canevascini et al., 2005). This 
raises the possibility that the transforming activity of the mammalian Ect2 could be due 
to hyperactivation of the RAS/MAPK pathway. The fact that only the carboxyl-terminal 
Ect2 fragment containing the PH domain has this potential, and not the full length 
protein, is most likely due to the reason that this fragment localizes to the cytoplasm (and 
membranes) and therefore can interact with RhoA during interphase, in contrast to full 
length Ect2 which is present in the nucleus. Accordingly, it has been shown that full 
length Ect2 lacking an NLS also has transforming potential, albeit to a lesser extent than 
the carboxyl-terminal domain (Saito et al., 2004). The requirement of the PH domain for 
the transforming activity indicates that membrane targeting of Ect2 is important for this 
activity.   
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3.3 A model for Ect2 targeting to the central spindle 
 
To explore the mechanism(s) responsible for targeting of Ect2 to the central spindle, we 
depleted the central spindle components MKlp1, MgcRacGAP, MKlp2 and Aurora-B, 
respectively. Even though MKlp1, MgcRacGAP, MKlp2 and Aurora-B complexes 
contribute to the central spindle formation, some central spindle structures were still 
present in these depleted cells, allowing us to analyze the localization of Ect2. This 
revealed that both the MKlp1/MgcRacGAP and MKlp2/Aurora-B complexes were 
required for targeting Ect2 to the central spindle. However, although both complexes 
were required for Ect2 targeting, only the MKlp1/MgcRacGAP complex showed a direct 
interaction with Ect2 in biochemical experiments. Moreover, only the 
MKlp1/MgcRacGAP complex co-localized with Ect2 at the midbody in telophase cells. 
The MKlp2/Aurora-B complex might therefore have a more indirect role in targeting 
Ect2 to the central spindle, as discussed below. The interaction of Ect2 with the 
MKlp1/MgcRacGAP complex was mediated via the Ect2 BRCT domain. The BRCT 
domains of BRCA1 have recently been shown to bind to their target proteins in a 
phosphorylation dependent manner (Clapperton et al., 2004; Manke et al., 2003) and the 
critical residues required for binding the phosphate moiety are highly conserved. The 
Ect2 BRCT domain has been shown to preferentially bind to phosphopeptides (Yu et al., 
2003) and this encouraged us to mutate the two critical phosphopeptide binding residues 
(T153A, K195A) in the Ect2 BRCT domain. Interestingly, this mutant Ect2 (1-333) 
fragment was much less efficient in co-precipitating the MKlp1/MgcRacGAP complex 
from mitotic cell lysates and only showed weak central spindle localization and was 
predominantly spread throughout the cytoplasm as compared to the wild type fragment. 
These results strongly suggest that the binding of Ect2 to the MKlp1/MgcRacGAP 
complex requires a phosphorylated docking motif within this complex. Unfortunately, so 
far, no consensus docking site for Ect2 BRCT domains has been identified and hence, the 
exact mechanism of docking of Ect2 to the MKlp1/MgcRacGAP complex is still 
unknown. However, it is interesting that the Aurora-B kinase has been shown to 
phosphorylate MgcRacGAP and, moreover, the MKlp2/Aurora-B complex is required for 
targeting Ect2 to the central spindle. It is therefore tempting to speculate that Aurora-B 
 83
Discussion 
might generate a docking site on MgcRacGAP (Fig. 32). Alternatively, Plk1, another 
mitotic kinase targeted to the central spindle via MKlp2, could be another interesting 
candidate kinase that could create a potential docking site.  
Recently, Yuce et al identified a phosphorylation site, T342, in mitotic Ect2 that 
prevents the interaction of Ect2 with MgcRacGAP in metaphase (Yuce et al., 2005). Hara 
et al independently identified the same site (although they erroneously termed it T341) by 
analyzing recombinant Ect2 protein, which was simultaneously phosphorylated in vitro 
by Cdk1 and Plk1 (Hara et al., 2005). A proline residue follows this site, indicating that it 
is a consensus Cdk1 phosphorylation site. We have not been able to identify this 
interesting site in endogenous mitotic Ect2, which might either reflect a low 
phosphorylation stochiometry in vivo, and/or the use of different MS protocols and 
possibly poor ionization or flight behaviour of this particular peptide. According to Yuce 
et al, this site becomes dephosphorylated upon metaphase to anaphase transition allowing 
interaction of Ect2 with MgcRacGAP only during ana- and telophase of the cell cycle. 
Taken together, we therefore like to propose that both Ect2 dephosphorylation (from 
metaphase to anaphase transition) and the simultaneous generation of a BRCT docking 
site on MgcRacGAP by Aurora-B (or Plk1) could be important for targeting Ect2 to the 
central spindle (Fig. 32). This dual mechanism would provide a tight regulation of the 
spatial and temporal localization of Ect2 to spindle structures. 
 
 
 
 
 
 
 
 
 
 
 
 Figure 32. Proposed model for the targeting of Ect2 to the central spindle. For details see text. 
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3.4 Ect2 targets RhoA to the cleavage furrow independently of its central 
spindle localization 
 
Several theories have been put forward for signals that determine cleavage plane 
specification (Burgess and Chang, 2005). In mammalian somatic cells, the central spindle 
and/or astral MTs are believed to be required for this specification. Spindle MTs are 
necessary for activation of RhoA and its specific targeting to the plane of future cell 
division (Bement et al., 2005). In turn, RhoA regulates the actin cytoskeleton and hence 
is required for the formation and contraction of the actomyosin based contractile ring. 
How exactly the MTs signal to RhoA has long been a mystery. The identification of Ect2 
GEF proteins in different higher eukaryotes and their essential function during 
cytokinesis provided a possible link between central spindle MTs and RhoA activation.  
Here, we could show that Ect2 is essential for RhoA targeting to the cleavage 
furrow. It has recently been shown that RhoA at the cleavage furrow is in its active state 
(GTP bound), indicating that Ect2 targets RhoA to the cleavage furrow by exchanging 
GDP for GTP on RhoA (Bement et al., 2005; Glotzer, 2005). In the absence of Ect2 
(using siRNA mediated gene silencing), RhoA was not targeted to the cortex and no 
cleavage furrow formation and ingression occurred. This resulted in the exit of mitosis, 
without any form of cytokinesis, resulting in the formation of binucleated cells. Some 
cells depleted of Ect2 still showed some signs of cleavage furrow ingression and this 
percentage increased when a siRNA duplex was used that depleted Ect2 less efficiently. 
This indicates that Ect2 is not only required for cleavage site determination, but also for 
ingression. This is in agreement with the role of RhoA in both processes.  
The striking localization of Ect2 suggested that a precisely localized population of 
Ect2 would activate RhoA locally, thereby ensuring cleavage furrow formation at a 
position determined by the central spindle. Surprisingly, however, we found that we 
could displace endogenous Ect2 from the central spindle without abolishing cytokinesis. 
This was achieved by overexpression of particular Ect2 amino-terminal fragments, which 
compete with endogenous Ect2 for binding sites on the MKlp1/MgcRacGAP complex. 
Similarly, RhoA was still targeted to the site of cleavage furrow formation in cells 
depleted of MKlp1, which also results in mislocalization of Ect2 (Yuce et al., 2005), and 
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cleavage furrow ingression still occurred in cells depleted of PRC1, which essentially 
lack central spindle structures (Mollinari et al., 2005). Although it is difficult to 
rigorously exclude that very low amounts of Ect2 might have persisted at the central 
spindle (or remnants thereof) under all these conditions, these results indicate that 
physiological levels of localized Ect2 activity are not strictly required for cytokinesis. 
These results suggest that it is not solely the localized Ect2 GEF activity that targets 
RhoA specifically to the cleavage furrow but that additional landmarks might be present 
at the cleavage furrow to which RhoA is recruited. If so, this would mean that RhoA is 
not the most upstream component at the cortex that specifies the place of cleavage furrow 
formation, but that other “earlier” factors must be involved. The placement of this 
potential landmark is, however, microtubule dependent (astral microtubules?), since in 
the absence of MTs, RhoA is not targeted to the cleavage furrow. 
Mitotic cells treated with actin depolymerizing drugs cannot undergo cytokinesis, 
because the actomyosin ring is absent and these cells delay mitotic exit. Remarkably, 
cells depleted of Ect2 cannot undergo cytokinesis either, but do not show any obvious 
mitotic delay. However, cells overexpressing the amino-terminal Ect2 (1-333) domain 
that interfered with cytokinesis did show great variations in the duration of cytokinesis. 
Although not tested, this could indicate that the presence of Ect2 is involved in delaying 
cytokinesis under unfavourable conditions. If true, this might suggest a role for Ect2 in 
some kind of cytokinesis checkpoint.   
One of the established downstream targets of RhoA is Citron kinase (Naim et al., 
2004; Shandala et al., 2004) and, in agreement, we observed that Citron kinase is targeted 
to the cleavage furrow in an Ect2 (and hence RhoA-GTP) dependent manner. The role of 
Citron kinase in cytokinesis in mammalian cells is, however, still controversial (Di Cunto 
et al., 2000; Eda et al., 2001; Madaule et al., 1998). We therefore analyzed HeLa S3 cells 
depleted of Citron kinase (using siRNA oligoduplexes) and discovered that this kinase is 
essential for cytokinesis in these cells. Since mice lacking Citron kinase display relatively 
mild phenotypes (Di Cunto et al., 2000), this either suggests that mouse cells are less 
dependent on Citron kinase or that other homologous kinases, including ROCK kinases, 
could complement this function in mice.  
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3.5 Interference with Ect2 function blocks cytokinesis by impairing both 
cleavage furrow formation and abscission 
 
It has been suggested that the cytokinesis defect in cells overexpressing the amino-
terminal Ect2 domain (1-333) could be a result of low Rho-GTP levels, because this 
domain interacts with the carboxyl-terminal half of endogenous Ect2 that harbours the 
catalytic GEF domain (Kimura et al., 2000). Our detailed analysis of the cytokinesis 
defects caused by the 1-333 fragment showed, however, that RhoA and Citron kinase 
were still targeted to the cleavage furrow. Since it is the active form of RhoA that 
localizes to the cleavage furrow, this shows that still enough active RhoA was formed in 
these cells and, in agreement, cleavage furrow formation and ingression still occured in 
these cells. Moreover, we observed extensive membrane blebbing in these cells, 
suggestive of highly dynamic cortical cytoskeletal rearrangements. Rho regulates various 
cortical activities through actin remodelling and it has been shown that depletion of 
RhoA could suppress membrane blebbing. This implies that cells overexpressing the 
amino-terminal Ect2 domain (1-333) produce sufficient amounts of mislocalized RhoA-
GTP. The membrane blebbing in these cells could therefore be caused by mislocalized 
Rho-GTP resulting from displaced Ect2. These results strongly argue against the 
hypothesis that the amino-terminal fragment induces cytokinesis failures by its effect on 
Ect2 GEF activity (Kimura et al., 2000). 
Not only the 1-333 fragment interfered with cytokinesis, but also larger fragments 
(Ect2 1-360, Ect2 1-370) resulted in cytokinesis defects (80%, 65% and 58% 
multinucleated cells, respectively), albeit to a lesser extent than the Ect2 1-333 fragment 
(80%). These larger fragments contained the T342 phosphorylation site excluding the 
possibility that it is the absence of this regulatory site that determines the potential to 
interfere with cytokinesis. Further investigations showed that all Ect2 amino-terminal 
fragments that interfered with cytokinesis lacked a proper NLS sequence and remained in 
the cytosol throughout the cell cycle. Therefore, the sustained presence of these 
fragments at the central spindle and the contractile ring during telophase could be an 
explanation why these particular fragments interfered with cell abscission. In agreement, 
addition of SV40 NLS sequences to the fragment (Ect2 1-333) that interfered maximally 
 87
Discussion 
with cytokinesis, strongly reduced the potential of this fragment to interfere with 
cytokinesis, indicating that nuclear relocalization during telophase can prevent cell 
abscission failure. However, when we mutated the NLS in full length Ect2 and expressed 
this cytoplasmic protein, it did not interfere with cytokinesis. One reason for this could be 
the low expression of full length Ect2 even when expressed from a CMV promoter. 
However, even expression of an amino-terminal fragment, Ect2 1-388, with a mutated 
NLS resulted in only a marginal increase in the number of multinucleated cells compared 
to the wild type Ect2 1-388 fragment (approximately 25% multinucleated cells compared 
to 9% multinucleate cells). Therefore, it is not only the nuclear targeting that prevents 
larger Ect2 amino-terminal fragments to interfere with cytokinesis. Instead, sequences 
around NLS might play an essential role in preventing cytokinesis. The NLS mutant 1-
388 fragment showed a normal midbody localization during telophase, in clear contrast to 
those fragments that interfered with abscission, which all showed a midbody associated 
speckled ring-like localization at the contractile ring.  
In Drosophila, pebble has been shown to localize predominantly at the site of the 
contractile ring and so far has not been reported to be present at the central spindle. 
Nevertheless, also Drosophila pebble interacts with the Drosophila homologues of 
human MgcRacGAP and MKlp1 (Somers and Saint, 2003). In Drosophila, a model has 
therefore been proposed in which the cortically localized pebble interacts with the central 
spindle associated MgcRacGAP/MKlp1 complex, and thereby forms a connection 
between the cortical ring and the central spindle (Somers and Saint, 2003). In human 
cells, a ring like Ect2 structure has not been observed, but our observation that 
overexpressed amino-terminal fragments show a ring like structure at the site of the 
contractile ring suggests that a similar structure could also be formed in human cells. 
Moreover, MgcRacGAP and MKlp1 are targeted to this structure, similar to as what has 
been shown in Drosophila.  As such a structure can only be observed in human cells 
upon overexpression of certain amino-terminal fragments, it suggest that either very low 
levels of Ect2 localize to this site or that under normal conditions this association is very 
transient in human cells. The cytokinesis defect observed with cells expressing the 
amino-terminal domain is therefore likely a result of sustained presence of this structure 
at the contractile ring. The reason why this is only observed with certain amino-terminal 
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fragments that lack NLS sequences suggest that the formation of this structure is 
negatively regulated by sequences around this NLS motif.   
Our study strengthens the conclusion that Ect2 is a key component of the 
molecular machinery that brings about cytokinesis. We have identified both interaction 
partners and regulatory domains within Ect2 and demonstrate that the precise temporal 
and spatial regulation of this GEF is critical for cleavage furrow formation and ingression 
as well as abscission. Continued studies of the regulation and function of Ect2 will 
undoubtedly contribute to a better understanding of the regulatory circuits that control 
cytokinesis.   
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4.0 Materials and Methods 
 
4.1 Materials 
 
Chemicals were obtained from Sigma-Aldrich or Merck unless otherwise specified. Cell 
culture media and sera were obtained from Invitrogen and media for growing bacteria 
were purchased from DIFCO Laboratories or Merck. DNA primers were synthesized by 
Thermo-Hybaid and synthetic siRNA duplexes by Dharmacon research, Inc. Restriction 
enzymes were obtained from New England Biolabs, Inc., reagents for purification of 
DNA from QIAGEN, the minigel system from Bio-rad, Hoefer Semiphor blotting system 
from Pharmacia-Biotech and NUPAGE gradient gels from Invitrogen. 
 
 
4.2 Plasmid constructions and site directed mutagenesis 
 
All cloning procedures were performed according to standard techniques as described in 
Molecular Cloning, A Laboratory Manual, 2nd editition, Sambrook, J.,Fritsch, E.F., 
Maniatis, T., Cold Spring Harbor Laboratory Press 1989 and Current Protocols in 
Molecular Biology, Wiley, 1999. Restriction enzyme reactions were carried out as 
specified by the suppliers (NEB). Ligation reactions were done using T4 DNA Ligase 
(NEB) or using a Rapid Ligation Kit (Roche) as described by the manufacturer’s 
instructions. Extraction of DNA from agarose gels and preparation of plasmid DNA was 
performed using kits from QIAGEN according to the manufacturer’s instructions. For 
PCR reactions, the Pfu DNA polymerase PCR System was used as recommended by the 
manufacturer (Promega) and reactions were carried out in a Perkin Elmer GeneAmp PCR 
System 9600. All PCR products were checked by sequencing at Medigenomix or Max-
Planck In-house DNA sequencing facility. All DNA modifying enzymes including 
Klenow polymerase fragment, T4 PNK kinase and calf-intestinal phosphatase were used 
from NEB according to manufacturer’s instructions. 
Full-length human Ect2 cDNA was amplified from a HeLa S3 cDNA library 
(Clonetech Laboratories, Inc.) with primers M1451 (5’ GCT GAT TTA GAA GAA TAC 
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AAA TCA TGG CGT 3’) and M1452 (5’ TAA GAT TTT GGT AAC GCT TCA TAT 
CAA ATG 3’) using Pfu DNA polymerase. The amplified PCR product was purified and 
used as a template for primers M1386 (5’ CCG GAT CCA TCA TGG CTG AAA ATA 
GTG TAT TAA C 3’) and M1387 (5’ CCC TCG AGT CAT ATC AAA TGA GTT GTA 
GAT CTA C 3’) comprising BamHI and XhoI restriction enzymes and cloned into a 
pBSKS(+) vector. The sequence of the cDNA was confirmed by sequencing. This cDNA 
was subcloned into a pcDNA3.1/3x-myc-C vector in frame with sequences that encode 
three amino-terminal myc-tags. In addition, a series of constructs was made with different 
amino-terminal tags including EGFP (pEGFP-T7/C1), GST (pGEX-6P-3), His6 (pQE-30), 
FLAG (pcDNA3.1/Flag-C) and HA (pcDNA3.1/HA-C) vectors. For details, see the 
plasmid list (supplementary table 1). In order to create recombinant baculovirus for 
expression of GST-tagged Ect2 in Sf9 insect cells, the Ect2 cDNA was subcloned into the 
pVL13GST93 vector.  
Deletion constructs Ect2 1-420, Ect2 1-333, Ect2 320-883, Ect2 414-630 and Ect2 
753-883 were made by PCR amplification using the full-length ECT2 cDNA as a 
template and specific primers containing BamHI (5’ end) and XhoI (3’ end) sites. These 
cDNA fragments were then ligated into the pcDNA3.1/3x-myc-C vector. These 
constructs were verified by sequencing. Truncation construct Ect2 1-388 was made by 
restriction digestion of the pcDNA3.1/3x-myc-Ect2 with BamHI and EcoRV restriction 
enzymes and the excised Ect2 cDNA fragment was cloned into the pcDNA3.1/3x-myc-C 
vector. In addition, this cDNA fragment was cloned into the bacterial expression vector 
pQE-30 for the production of recombinant His6-tagged protein for generating antibodies 
in rabbits. Truncation construct Ect2 1-288 was made by restriction digestion of the 
pcDNA3.1/3x-myc-Ect2 with KpnI and BglII and the excised Ect2 cDNA fragment was 
cloned into the pcDNA3.1/3x-myc-C vector. For generating a 3x-myc-NLS-Ect2 1-333 
construct, the triple SV40T NLS sequence was excised from pEYFP-Nuc (Clonetech, a 
gift from Dr. Frauke Melchior) by BglII/BamHI digestion and the excised fragment was 
cloned into the BamHI site of the pcDNA3.1/3x-myc-Ect2 1-333 construct. The 
orientation of the fragment was confirmed by sequencing. For the 3x-myc-Ect2 1-333 
stable cell line generation, the pcDNA3.1/3x-myc-Ect2 1-333 vector was digested with 
the AflII restriction enzyme and filled in the 5’ overhangs with Klenow fragment 
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followed by subsequent XhoI restriction digestion. This excised Ect2 cDNA fragment 
was then cloned into the pcDNA4/TO puromycin vector. 
Site directed mutagenesis was performed by PCR using complementary 
oligonucleotides according to Stratagene’s quick change site directed mutagenesis 
method.  For a list of all point mutations see the plasmid list (supplementary table 1). All 
mutations were confirmed by DNA sequencing.  
An EST clone encoding the hWW45 cDNA was obtained from the Image 
consortium (IMAGp99J155583Q3, Genbank ID ai679398). This cDNA was amplified by 
PCR with primers M1770 (5’ CCG GAT CCA GGA TGC TGT CCC GAC AGA AAC 
C3’) and M1771 (5’ CCT CTA GAC TCG AGT CAA AAA TTT TTT CCA TGT TGT 
TGG GC 3’). The insert was excised using BamHI and XbaI restriction enzymes and 
cloned into a pBS-SK vector. The cDNA sequence was verified by sequencing and 
subcloned into pcDNA3.1/3x-myc-C vector using the restriction sites BamHI and XhoI. 
Wild type and mutant (K82R) Plk1 plasmids have been described before (Meraldi et al., 
2002; Smits et al., 2000).  
 
 
4.3 Antibodies 
 
For generating rabbit polyclonal antibodies against human Ect2, an amino-terminal Ect2 
protein fragment (residues 1-388) fused to a polyhistidine tag was used. Escherichia coli 
strain JM109 carrying this plasmid was grown overnight at 37oC in LB medium with 
Ampicillin and diluted (20 times) next day into 500 ml of pre-warmed LB medium with 
Ampicillin and grown for three hours at 37oC until the OD600 of the culture reached 
approximately 0.5-0.8.  At this density, the expression of the His6-Ect2 fusion protein 
was induced with 1 mM IPTG for 3-4 hours. Cells were harvested, resuspended in lysis 
buffer (150 mM NaCl, 10 mM imidazole, 0.05 % NP40, 1 mM PMSF, 0.1 mM EDTA, 5 
mM β-Mercaptoethanol, 20 mM NaH2PO4/Na2HPO4 (pH 7.8) and 0.5 mg/ml lysozyme) 
and disrupted using a sonicator at 4°C (Bandelin SONOPLUS homogenisatoren HD2070, 
HD2200). The lysate was then cleared (centrifuged at 10000 rpm for 10 min) and 
incubated with one ml of 50% Ni-NTA agarose beads (Qiagen) on a rotating wheel for 
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one hour at 4°C. Thereafter, the Ni-NTA beads were washed three times with 10 mM 
imidazole wash buffer (10 mM imidazole, 500 mM NaCl, 0.05 % NP40, 20 mM 
NaH2PO4/Na2HPO4 (pH 7.8) and 5 mM β-Mercaptoethanol) followed by two washes 
with 10 mM imidazole wash buffer containing 5 mM ATP and two washes with 20 mM 
imidazole wash buffer. The His6-Ect2 fusion protein was then eluted with three bead-
volumes of 250 mM imidazole elution buffer (250 mM imidazole, 500 mM NaCl, 0.05 % 
NP40, 20 mM NaH2PO4/Na2HPO4 (pH 7.8) and 5 mM β-Mercaptoethanol). The isolated 
fusion protein was further purified by a preparative SDS-PAGE gel. For this, the protein 
in the gel was stained with an ice cold solution of 0.25 M KCl and 1 mM β-
mercaptoethanol. The milky white band containing the fusion protein was then cut out of 
the gel and placed in the dialysis bag. The protein was eluted from the gel by 
electrophoresis at 100V for three hours in 0.5x SDS buffer in the cold room.  
This purified fusion protein fragment was then used for immunization of New 
Zealand white rabbits (Elevage Scientifique des Dombes, Chatillon sur Chalarone, 
France). In brief, about 250 µg of the His6-Ect2 1-388 protein was first injected 
subcutaneously with Freund’s complete adjuvant and three subsequent injections with 
200 µg of protein were done intramuscularly. Specific Ect2 antibodies were purified from 
the serum, using the same antigen as used for immunization, immobilized on a 0.45 µm 
nitrocellulose membrane (Schleicher & Schuell). The serum was incubated for two hours 
with the immobilized antigen and unbound antibodies were washed away with PBST 
(PBS + 0.05% Tween-20). The specifically bound antibodies were then eluted with six 
volumes of 100 mM Glycine pH 2.8 and the pH of each eluate was immediately adjusted 
to pH 8.0 by addition of 1/10 volume of 1 M Tris-HCl pH 8.0. The first three eluates 
containing the highest antibody concentrations were pooled and dialyzed overnight 
against PBST. Finally, the antibodies were concentrated (using Amicon filters) to 1 µg/µl 
and frozen as small aliquots at -80°C. 
       A rabbit polyclonal antibody against human MgcRacGAP was made using a 
carboxyl-terminal peptide (CSKSKSATNLGRQG N) of human MgcRacGAP coupled to 
keyhole limpet haemocyanin (Sigma Genosys). For affinity purification, about 167 mg of 
thiopropyl sepharose powder was added to 500 µl of double distilled water. The slurry 
was washed twice with water and then with binding buffer (100 mM Tris-HCl pH 7.5, 
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500 mM NaCl, 1 mM EDTA and 5 mM β-Mercaptoethanol). About one mg of peptide 
was added to this slurry in 750 µl of total volume and incubated for over night at 4°C on 
a rotating wheel. The supernatant was removed and the sepharose beads were washed 
once with the binding buffer and blocked with 200 mM Ethanolamine pH 8.0 in one ml 
total volume for two hours at 4°C. To isolate peptide specific antibodies, about one ml of 
serum was incubated for three hours with the peptide bound thiopropyl sepharose beads 
on a rotating wheel at 4°C. After five washes with 10 mM Tris-HCl pH 7.5, 100 mM 
NaCl, 0.1% NP40, the bound antibody was eluted with seven times 300 µl of 100 mM 
Glycine pH 2.8 and the pH of the eluates was subsequently adjusted to pH 8.0 by addition 
of 1/10 volume of 1 M Tris-HCl pH 8.0. All the eluates were pooled and dialyzed 
overnight against PBS and concentrated to 1 µg/µl.  
Affinity purified rabbit polyclonal antibodies against human MKlp1 and MKlp2 
were gifts from Stefan Huemmer and Thomas Mayer (Max Planck Institute of 
Biochemistry, Martinsried, Germany).  
 
 
4.4 Binding of antibodies to beads 
 
Polyclonal antibodies were bound to Affiprep protein A beads (Biorad), by adding 15 µg 
of antibodies to 30 µl beads and incubated for one hour at 4°C on a rotating wheel. For 
coupling monoclonal antibodies, including anti-myc 9E10, a similar procedure was 
followed, except that immunopure immobilized protein G (Pierce) resin was used, instead 
of Affiprep beads. To covalently cross-link antibodies to the used matrix, the beads were 
washed twice with 500 µl Na Borate (pH 9.0) and then incubated in the same buffer 
containing 20 mM dimethyl pimelimidate. After incubation for 30 min at room 
temperature on rotating wheel, the beads were washed once with blocking buffer (0.5 ml 
of 0.2 M Ethanolamine, pH 8.0) followed by two hours incubation in this buffer on a 
rotating wheel at room temperature. Finally, the beads were washed with PBS. 
To isolate IgGs from pre-immune sera to be used in control experiments, about 
100 µl of serum was added to 150 µl of Affiprep protein A beads (Biorad) and incubated 
on a rotating wheel for 30-60 min at 4°C. The beads were subsequently washed three 
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times with ice-cold PBS followed by elution with eight times 150 µl of 100 mM Glycine 
pH 2.8. The pH of the eluates was adjusted to 8.0 by mixing with 1/10 volume of 1 M 
Tris-HCl pH 8.0. Finally, the fractions (1-3) with the highest antibody concentrations 
were pooled and dialyzed against PBS and concentrated to 1 µg/µl. 
 
 
4.5 Generation of recombinant baculo viruses 
 
Baculogold DNA (0.25 µg) was mixed with 2.5 µl of transfer vector (BaculoGold Kit, 
Pharmingen) and incubated for five min followed by the addition of 500 µl buffer-B. In 
the mean time, the Sf9 insect cell medium of a 3 cm plate seeded with Sf9 insect cells 
was replaced with 500 µl buffer-A and the DNA mixture in buffer-B was then slowly 
added (drop by drop) to these cells. After four hours incubation at 27°C, the cells were 
washed once with 2.5 ml of insect cell medium and incubated for 2-3 days at 27°C in the 
same medium. The medium supernatant was then collected and spun for five min at 1000 
rpm and 100 µl of this cleared supernatant (Passage 0, P0) was then used to infect Sf9 
cells in a 10 cm dish. After 3-4 days, the medium culture supernatant (P1) was collected 
and used for a next amplification round. Finally, the P3 supernatant culture medium had a 
sufficient virus titer for the production of recombinant protein.  
 
 
4.6 Production of GST-Ect2 protein from sf9 insect cells 
 
About 250 µl (depending on the titre) of P3 amplified recombinant Ect2 baculovirus were 
used for transfecting Sf9 insect cells in a 15 cm dish. After 36-48 hours of transfection, 
these cells were collected by centrifugation for five min at 1000 rpm. These cells were 
washed once with PBS containing 1 mM PMSF and lysed in 500 µl lysis buffer (10 mM 
HEPES pH 7.7, 20 mM β-Mercaptoethanol, 5 mM EGTA, 150 mM NaCl, 1% NP40, 1 
mM PMSF, 5 mM NaF, 10 µg/ml each of Leupeptin, Chymostatin, Aprotinin and 0.1 
mM Na-Vandate). Extracts were passed five times through a G27 needle and incubated 
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for 15 min on ice. The lysate was cleared by centrifugation at 4°C for 15 min at 
maximum speed in table top centrifuge and about 100 µl of glutathione sepharose beads 
were then added to the extract and incubated for one hour at 4°C on a rotating wheel. The 
beads were subsequently washed twice with lysis buffer containing 300 mM NaCl and 
incubated overnight at 4°C with PreScission protease (Amersham) in cleavage buffer (50 
mM Tris HCl pH 7.0, 150 mM NaCl, 1 mM EDTA, 1 mM DTT and 0.01% NP40). Next 
day, the supernatant containing the soluble Ect2 protein without a tag was collected and 
concentrated if required. 
 
 
4.7 siRNA experiments 
 
For siRNA, the following target sequences were used: 
Ect2:                      5’AAG AGU GGU UCU GGG GAA GCA 3’,  
                              5’AAA UAC UGC UGU GAA UCU AUU 3’, 
                              5’CAA UUU AUG CAG AGA UUA AUU 3’, 
                              5’CAU UUG AUA UGA AGC GUU AUU 3’, 
MgcRacGAP:       5’AAG UGG CAG AGG ACU GAC CAU 3’;  
MKlp1:                 5’AAG CAG UCU UCC AGG UCA UCU 3’;  
MKlp2:                 5’AAC CAC CUA UGU AAU CUC AUG 3’; 
Aurora-B:             5’AAG GUG AUG GAG AAU AGC AGU 3’  
Citron kinase:      5’CAG GAT ATA CCG TAA CAC GAA 3’ 
                             5’ ATG GAA GGC ACT ATT TCT CAA 3’ 
SiRNA duplexes were transfected with oligofectamine (Life Technologies) according to 
manufacturer’s instructions. As a control, the GL-2 duplex targeting the luciferase gene 
was used (Elbashir et al., 2001).   
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4.8 Cell culture and generation of stable cell lines 
 
HeLa S3 cells were grown at 37°C under 5 % CO2 in Dulbecco’s modified Eagle’s 
medium (DMEM) (GIBCO) supplemented with 10 % heat-inactivated fetal calf serum 
(GIBCO-BRL) and penicillin-streptomycin (100 IU/ml and 100 µg/ml, respectively).  Sf9 
insect cells were grown at 27°C in TC-100 medium (GIBCO-BRL) supplemented with 
10% heat inactivated serum (GIBCO-BRL) and penicillin-streptomycin (100 IU/ml and 
100 µg/ml, respectively). Transfections of mammalian cells were performed using 
Fugene 6 reagent (Roche) according to manufacturer’s instructions.  
For the generation of tetracycline-inducible stable cell lines, about 10 µg of 
plasmid (pcDNA4T/O puromycin) encoding the myc-tagged Ect2 1-333 protein fragment 
was transfected using Fugene 6 (Roche) into HeLa S3 cells (15 cm dish) that stably 
expressed a CMV controlled tetracycline repressor gene together with a blasticidine 
resistance marker (pcDNA6/TR, Invitrogen). The transfected cell lines were grown in 
medium containing 5 µg/ml blasticidin and 36 hours after transfection 1.5 µg/ml 
puromycin was added to select the stably transfected clones. After three days, when small 
cell colonies were seen, the concentration of puromycin was reduced to 1 µg/ml. About 
two days later, 48 clones were picked and screened for the inducible expression of myc-
Ect2 1-333 protein by addition of 1 µg/ml tetracycline. After 24 hours, cells were fixed 
with paraformaldehyde and analyzed by immunofluorescence microscopy after staining 
the cells with anti-myc 9E10 antibodies. The stable inducible cell lines were selected only 
if the expression of myc-Ect2 1-333 was seen upon induction with tetracycline.  
 
 
4.9 Cell extracts, immunoprecipitations and western blot analysis 
 
To enrich cells in prometaphase and metaphase stages of the cell cycle, an aphidicolin-
nocodazole block/release protocol was used. In brief, HeLa S3 cells were first treated 
with 1.6 µg/ml aphidicolin for 17 hours, washed three times with PBS to release from the 
block and fresh medium was added without drugs for another six hours. Cells were then 
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treated with 50 ng/ml nocodazole for eight hours to arrest cells in a prometaphase like 
state. Mitotic cells were then collected by a “mitotic shake off”, washed three times with 
PBS and released in fresh medium for about 90 min (spinner culture). The mitotic cell 
cycle stage of these cells was monitored by indirect immunofluorescence microscopy of 
cell aliquots stained with 4´, 6-diamidino-2-phenylindole (DAPI). To enrich HeLa S3 
cells in metaphase of the cell cycle that transiently express recombinant proteins, cells 
were transfected with the respective plasmid constructs and simultaneously treated with 
aphidicolin. Further synchronization procedures were then similar to the one described 
above.  
For making cell extracts, cells were washed with ice cold PBS containing 1 mM 
phenylmethylsulfonyl fluoride (PMSF) and resuspended in ice cold HEPES lysis buffer 
(50 mM Hepes pH7.4, 150 mM NaCl, 0.5% Triton X-100) containing 30 µg/ml RNase A, 
30 µg/ml DNase, 1 µM Okadaic acid, 2 µg/ml Latrunculin-B and protease and 
phosphatase inhibitors (Silljé et al., 1999). After 15 min incubation on ice, extracts were 
cleared at 13000 rpm for 15 min at 4°C. Protein concentrations were determined using 
the Dc protein assay (Bio-Rad). For immunoprecipitations, about 10 µg of polyclonal 
antibodies coupled to Affi-prep protein A beads (Bio-Rad) were used. For 
immunoprecipitation of myc-tagged recombinant proteins, anti-myc 9E10 antibodies 
bound to Immunopure immobilized protein G resin (Pierce) was used. Lysates were 
incubated for four hours with the respective antibody bound resins and subsequently 
washed three times with lysis buffer. For immunoblotting, equal protein amounts were 
separated by SDS-PAGE, followed by transfer onto nitrocellulose membranes 
(Schleicher & Schuell). Membranes were incubated for one hour in blocking buffer (5% 
low-fat dry milk in PBST (PBS + 0.1% Tween-20). All antibody incubations were carried 
out in blocking buffer at 4°C for overnight.  Membranes were probed with the following 
antibodies in PBST containing 5 % milk: affinity-purified rabbit anti-Ect2 (1 µg/ml), 
chicken anti-MgcRacGAP antibodies (R&D systems, 1 µg/ml), affinity purified rabbit 
MKlp1 (0.5 µg/ml), rabbit MKlp2 serum (1:1000), monoclonal anti-myc 9E10 (1:10 
culture supernatant), monoclonal anti-Plk1 (1:20, PL2), monoclonal anti-α-tubulin 
(Sigma-Aldrich, 1:3000). Signals were detected by ECL SuperSignal (Pierce Chemical 
Co.).   
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4.10 Immunoprecipitation of endogenous Ect2 from HeLa S3 spinner 
culture cells 
 
Five flasks of HeLa S3 cells (each 175 cm2) grown to 90% confluence were trypsinized 
and and inoculated in one litre spinner culture flasks containing 500 ml DMEM + 500 ml 
RPMI1640 medium and 10% FCS and 1% penicillin-streptomycin. These cells were 
grown for 3-4 days and the medium was then removed by decanting, leaving the cell 
clumps at the bottom. These cells were washed once with PBS, trypsinized briefly (10 ml 
of trypsin was added and incubated at 37°C) to disperse the cell clumps and resuspended 
in the same medium containing either 1 mM thymidine or 75 ng/ml nocodazole to enrich 
cells in interphase and mitosis, respectively. Subsequently cells were cultured for another 
20 hours in this medium, washed three times with cold PBS and released in fresh medium 
without drugs. Cells were then harvested, washed with PBS containing 1mM PMSF and 
resuspended in 10 mM Triethanolamine pH 7.2 buffer containing 150 mM NaCl for 10 
min. These cells were centrifuged at 1000 rpm for three min and washed with 10 ml HB 
buffer (100 mM Sucrose, 25 mM HEPES pH 3.4, 2 mM EGTA, 2 mM MgCl2, 1 mM 
DTT, 1 mM PMSF, 20 mM NaF, 0.3 mM Na-Vanadate, 1 µM Okadaic acid and 1 µg/ml 
of Leupeptin, Pepstatin and Aprotinin). Finally, cells were homogenised in HB buffer 
using a douncer with pestle B. Staining cells with trypan blue monitored the efficiency of 
homogenization. The extracts were cleared by centrifugation at 10000 rpm for 10 min in 
a SS34 rotor (Beckman), followed by ultra centrifugation at 90000 rpm in a three ml 
polycarbonate TLA 100.3 Beckman tube for 15 min at 4°C in a TLA 100.3 rotor 
(Beckman). The supernatant was collected avoiding the pellet and floating lipid layer, 
and transferred into a new tube. About 0.1% NP40 was added to these lysates and 
immunoprecipitations were done by the addition of 100-300 µl of anti-Ect2 antibody 
beads or pre-immune IgGs beads. After overnight incubations at 4°C on a rotating wheel, 
these beads were washed three times with HB buffer containing 0.1% NP40 and 150 mM 
NaCl but without sucrose, leupeptin, pepstatin and aprotinin. Finally the beads were 
resuspended in 100 µl SDS-PAGE sample buffer and one-third of the immunoprecipitates 
were separated on a NUPAGE 4-12% gradient gel (Invitrogen). 
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4.11 Cell cycle profile and flow cytometry analysis 
 
Mitotic HeLa S3 cells obtained from eight triple flasks (525 cm2 each) using the 
aphidicolin/nocodazole block release protocol as described above, were released in fresh 
medium without drugs. Cells were then collected at 20 min time intervals for 140 min. 
For FACS analysis, HeLa S3 cells were fixed in 70% ethanol followed by incubation for 
30 min in PBS containing 10 µg/ml RNase A (Sigma-Aldrich) and 5 µg/ml propidium 
iodide (Sigma-Aldrich). Analysis of the stained cells was performed with a FACScan 
according to the manufacturer’s instructions and Cell Quest Software (Becton Dickinson) 
was used to analyze the data. 
 
 
4.12 Immunofluorescence microscopy 
 
Cells grown on HCl treated coverslips were fixed with 3% paraformaldehyde/2% sucrose 
for 10 min at room temperature and subsequently permeabilized with ice cold 0.5% 
Triton X-100 for five min.  For visualizing RhoA, cells were fixed with 10% TCA (Tri 
Chloro Acetic Acid) at room temperature for 15 min and permeabilized with 0.5% Triton 
X-100 for five min. To visualize Ect2 with polyclonal antibodies recognizing the 
carboxyl-terminus of Ect2 (Santa Cruz), cells were fixed and permeabilized 
simultaneously with 20 mM PIPES pH 6.8, 4% formaldehyde, 0.2% Triton X-100, 10 
mM EGTA, 1 mM MgCl2 for 10 min at room temperature. Afterwards, cells were 
incubated for 30 min at room temperature in blocking solution (PBS, 1% BSA). All 
antibody incubations were carried out for one hour at room temperature in a humidified 
chamber, followed by three washes with PBS. Primary antibodies used were rabbit 
polyclonal anti-Ect2 (762) (1 µg/ml), rabbit polyclonal anti-Ect2 raised against carboxyl-
terminal epitopes (Santacruz, 1:200), rabbit polyclonal anti-MgcRacGAP (1 µg/ml), 
chicken polyclonal anti-MgcRacGAP (R&D systems, 1 µg/ml), rabbit polyclonal anti-
MKlp1 (Santacruz, 1:200), mouse AIM-1 monoclonal anti-Aurora B (Becton Dickinson, 
1:200), mouse monoclonal anti-RhoA (Santa Cruz Biotechnology, 1:200), mouse 
monoclonal anti-Citron kinase (BD Transduction laboratories 1:200), mouse monoclonal 
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anti-Plk1 (PL2) culture supernatant 1:20, sheep polyclonal anti-MKlp2 (1:1000). Primary 
antibodies were detected with Alexa-Fluor-488- and Alexa-Fluor-555-conjugated goat 
anti-mouse or anti-rabbit IgGs (1:1000, Molecular Probes). DNA was stained with DAPI 
(2 µg/ml). Following three washes with PBS, coverslips were mounted onto slides using 
mounting medium with 80% glycerol and 3% DABCO (in PBS). Immunofluorescence 
microscopy was performed using a Zeiss Axioplan II microscope with Apochromat 40x 
and 63x oil immersion objectives, respectively. Photographs were taken using a 
Micromax CCD camera (model CCD-1300-Y, Princeton Instruments) and Metaview 
software (Visitron Systems GmbH, Puchheim, Germany). For high-resolution images, a 
Deltavision microscope on a Nikon Eclipse TE200 base (Applied Precision) equipped 
with S Fluor 40x/1.3 and Plan Apo 60x/1.4 oil immersion objectives and a photometrics 
Cool Snap HQ camera was used for collecting 0.15 µm distanced optical sections in the 
Z-axis. Images at single focal planes were processed with a deconvolution algorithm and 
then projected into a single picture using the Softworx software (Applied Precision). 
Images were cropped in Adobe Photoshop 6.0, and then sized and placed in figures using 
Adobe Illustrator 10 (Adobe Systems Inc.). 
 
 
4.13 In vitro kinase assays 
 
In vitro kinase reactions were carried out for 30 min at 30°C in buffers supplemented 
with 10 µM ATP and 2 µCi of [γ32-P]-ATP (Amersham Corp.) For Plk1 kinase assays, 
recombinant Plk1 WT and Plk1 KD (K82R) proteins produced in insect cells were used 
and kinase activities were assayed in 20 mM Hepes (pH 7.7), 10 mM MgCl2, 1 mM 
EGTA, 5 mM NaF and 1 mM DTT with 1 µg/ml each of Leupeptin, Pepstatin and 
Chymostatin. Recombinant Cdk1/cyclin B complex was also produced in insect cells and 
kindly provided by Dr.Rudiger Neef. For measuring Cdk1/cyclin B activity, the kinase 
activities were assayed in buffer containing 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 
mM DTT, 50 mM β-glycerophosphate and 10 mM NaF. GST-Aurora-B kinase WT and 
KD (K106R) in complex with His6-INCENP were kind gifts from Dr. Reiko Honda. The 
Aurora-B kinase activities were assayed in a buffer containing 50 mM Tris-HCl, pH 7.4, 
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10 mM MgCl2, 1 mM EGTA, 1 mM DTT, 5 mM NaF, 5 mM β-glycerophosphate and 5 
mM Na-Vanadate. Substrates used in these kinase assays were recombinant Ect2 (0.2 
mg/ml for all kinase assay reactions), 0.5 mg/ml casein (for Plk1), 0.4 mg/ml histone H1 
(for Cdk1/cyclin B) and 0.5 mg/ml histone H3 (for Aurora-B). Kinase reactions were 
terminated by addition of SDS-PAGE sample buffer and heating for five min at 95°C. 
After separation of the proteins by SDS-PAGE, 32P incorporation was visualized by 
autoradiography. 
 
 
4.14 Live-cell imaging 
 
For live-cell imaging, HeLa S3 cells were grown in 35 mm dishes and treated with 
aphidicolin (1.6 µg/ml) for 16 hours to arrest cells at the G1/S phase boundary. Cells 
were then washed three times with PBS, released in fresh (drug free) medium and eight 
hours later the medium was changed into CO2 independent medium without L-Glutamine 
(GIBCO). The cell culture dish was then placed on a heated (37°C) sample stage and 
live-cell imaging was performed with a Zeiss Axiovert-2 microscope with Plan Neofluar 
40x objective. Images were captured with 10 milliseconds exposure time at two minute 
intervals for 16 hours using metaview imaging software. For live-cell imaging of the 
myc-Ect2 1-333 stable inducible cell line, tetracycline (1 µg/ml) was added upon release 
from the aphidicolin block. For live-cell imaging of siRNA treated HeLa S3 cells, cells 
were simultaneously arrested with aphidicolin and transfected with siRNA oligoduplexes 
and upon release from the aphidicolin block after 16 hours, cells were again transfected 
with siRNA duplexes.   
 
 
4.15 Mass spectrometry 
 
Coomassie stained protein bands were excised from SDS-PAGE gels in a dust free 
environment and in-gel digested (Shevchenko et al., 1996) with trypsin (Promega, 
sequencing grade). Matrix-assisted laser desorption/ionization (MALDI) time-of-flight 
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(TOF) mass spectrometry (Brucker Daltonik, Bremen, Germany) was used to identify the 
phosphorylated peptides. As a matrix, 2,5 dihydroxybenzoic acid (Bruker Daltonik) or α-
cyano-4-hydroxycinnamic acid (Bruker Daltonik) were used. Subsequently, the 
phosphorylation sites were confirmed by post source decay (PSD) (Hoffmann et al., 
1999). Peptides showing the typical losses of 98 mass units (Phosphoric acid) and 80 
mass units (phosphate group) were considered as phosphopeptides. The exact localization 
of the phosphorylated residues within the peptides was determined by MS-MS based 
sequencing using a quadrupole time-of-flight (QTOF) mass spectrometer. 
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List of Abbreviations 
 
AA                                   amino acid 
ATP                                 adenosine 5´-triphosphate 
BRCT                              carboxyl-terminal domain of breast cancer susceptibility protein 
BSA                                 bovine serum albumin 
CDK                                cyclin-dependent kinase 
cDNA                               complementary deoxyribonucleic acid  
CHAPS                            3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate 
Cm                                    centi-metre 
CMV                                cytomegalo virus 
CO2                                                  carbon dioxide 
DAPI                                4´,6-diamidino-2-phenylindole 
DNA                                deoxyribonucleic acid 
DTT                                 dithiothreitol 
ECL                                 enhanced chemiluminescence 
EDTA                              ethylene dinitrilo tetraacetic acid 
ELISA                             enzyme linked immunosorbent assay 
FACS                               fluorescence activated cell sorter 
FCS                                  fetal calf serum 
GDP                                 guanosine 5’-diphosphate 
GEF                                 guanine nucleotide exchange factor 
GFP                                 green fluorescent protein 
GTP                                 guanosine 5’-triphosphate 
HCl                                  hydrochloric acid 
HEPES                             N-2-Hydroxyethylpiperazine-N`-2-ethane sulfonic acid 
IgG                                   immunoglobulin G 
IP                                      immunoprecipitation                                    
IPTG                                isopropyl-beta-D-thiogalactopyranoside 
IU                                     international unit 
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KD                                  catalytically impaired 
kDa                                 kilo-daltons 
LB                                  luria-broth 
M                                   molar                       
mAb                               monoclonal antibody 
µCi                                 micro-curie 
µl                                    micro-litre 
µg                                   micro-gram 
MA                                 mitotic apparatus 
MgCl2                            magnesium chloride 
Min                                 minutes 
Ml                                   milli-litre 
Mm                                 milli-metre 
mM                                 milli-molar 
MT                                  microtubules 
MS                                  mass spectrometry 
MW                                 molecular weight marker 
NaF                                 sodium fluoride 
NaCl                                sodium chloride 
ng                                    nano-gram 
NLS                                 nuclear localization signal 
OA                                   okadaic acid 
OD                                   optical density 
PBS                                  phosphate-buffered saline 
PCR                                  polymerase chain reaction 
PH                                    plekstrin homology 
PIPES:                              1,4-Piperazinediethanesulfonic acid 
PMSF                               phenylmethylsulfonyl fluoride 
RNA                                 ribonucleic acid 
rpm                                   revolutions per minute 
RT                                    room temperature 
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SDS-PAGE                      sodium-dodecylsulfate polyacrylamid gelelectrophoresis 
siRNA                             small interference Ribonucleic Acid 
SV40T                             simian virus large T antigen 
V                                     volts 
WT                                  wild-type 
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Appendix-List of plasmids 
 
name tag gene insert species vector  
 RB    1 hww45 Full length hww45    human pCMV-Sport6  
 RB    2 hww45 Full length hww45 human pBS SK 
 RB    3 myc hww45 Full length hww45 human pcDNA3.1  
  RB    4 BD hww45  Full length hww45 human pGBD-C1   
  RB    5 His6 hww45 Full length hww45 human pQE-30  
 RB    6 GFP hww45 Full length hww45 human pEGFP-T7/C1  
 RB    7 His6 hww45 aa 1-174 human pQE-30  
 RB    8 AD hww45 Full length hww45 human pGAD-C1  
 RB    9 YFP  pEYFP-N1 human  
 RB  10 YFP α-tub human pEYFP-Tub  
 RB  11 CFP human pECFP-N1  
 RB  12 CFP H2B human pBOS    
  RB  13 Ect2                               Full length Ect2 human pBS KS 
 RB  14 myc Ect2 Full length Ect2 human pcDNA3.1 
 RB  15 GFP Ect2 Full length Ect2 human pEGFP-T7/C1  
 RB  16 His6 Ect2 Full length Ect2 human pQE-30  
 RB  17 GST Ect2 Full length Ect2 human pGEX-6P-3  
 RB  18 myc Ect2 Ect2 aa 1-387 human pcDNA3.1 
 RB  19 myc Ect2 Ect2 aa 1-288 human pcDNA3.1 
 RB  20 Ect2 Ect2 aa 1-214 human pBSKS 
 RB  21 myc Ect2 Ect2 aa 476-883 human pcDNA3.1 
 RB  22 myc Ect2 Ect2 aa 1-214 human pcDNA3.1 
 RB  23 His6 Ect2 Ect2 aa 1-387 human pQE-30  
 RB  24 His6 Ect2 Full length Ect2 human pVL1393  
 RB  25 RhoA Full length RhoA EST human pCMV Sport6 
 RB  26 GST RhoA Full length RhoA  human pGEX-6P-3  
 RB  27 His6 Ect2 Ect2 aa 476-884 human pQE-81L  
 RB  28 GFP Ect2 Ect2 aa 1-387 human pEGFP-T7/C1  
 RB  29 GFP Ect2 Ect2 aa 1-214 human pEGFP-T7/C1  
 RB  30 GFP Ect2 Ect2 aa 476-883 human pEGFP-C3  
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 RB  31 His6 Ect2 Ect2 aa 476-883 human pQE-31  
 RB  32 Ect2 Ect2 E428A human pBS KS 
  RB  33 GST Ect2 Full length Ect2 human pVL13GST93  
 RB  34 myc Ect2 Ect2 E428A human pCDNA3.1 
 RB  35 GST Ect2 Ect2 E428A human pVL13GST93  
 RB  36 His6 Ect2 Ect2 E428A human pVL1393  
 RB  37 BD Ect2 Ect2 human pGBD-C3  
 RB  38 myc Ect2  Full length Ect2  human pcDNA4/TO/myc 
  RB  39            myc Ect2                          Full length Ect2                                   human                     pcDNA4/TO/myc    
  RB  40                 Ect2                          Full length Ect2                                   human               pBSKS+ 
 RB  41 myc Ect2  Full length V566D human pcDNA 3.1 
 RB  42            GST Ect2  Full length V566D human pVL1393  
 RB  44 BD Ect2  Ect2 1-387 human pGBDΩ-C(1)  
 RB  45 BD Ect2  Ect2 476-883 human pGBDΩ-C(1)  
 RB  46 AD Ect2  Ect2 1-387 human pGAD-C(1)  
 RB  47 AD Ect2  Ect2 476-883 human pGAD-C(1)  
  RB  48 myc RhoA Full length RhoA human pcDNA 3.1 
  RB  49 myc Ect2  Ect2 S40A(undesired point mutation) human pcDNA 3.1 
 RB  50 myc Ect2  Ect2S40A human pcDNA 3.1 
 RB  51 myc Ect2  Ect2 S40D human pcDNA 3.1 
 RB  52 myc Ect2  Ect2 T815A human pcDNA 3.1   
 RB  53 myc Ect2  Ect2 T815D human pcDNA 3.1   
 RB  55 GST Myc1 Rac1 Full length Rac1 human pGEX-2T    
 RB  56 GST Myc1 Cdc42 Full length Cdc42 human pGEX-2T   
   RB  57 GST Rhotekin RBD Rhotekin RBD                       pGEX-2T  
  RB  58           GST  SopE                        SopE 78-240                                     bacteria                    pGEX-2T 
 RB  59 myc Ect2 Ect2 1-333 human pcDNA3.1  
 RB  60 myc Ect2 Ect2 T815A human pcDNA3.1  
 RB  61 myc Ect2 Ect2 T815D human pcDNA3.1  
 RB  62 GST Ect2 Ect2 BRCT domains (113-342) human pGEX-6P-3  
 RB  63 GST Ect2 Ect2 BRCT domains w211R (113-342) human pGEX-6P-3  
 RB  64 GFP Ect2 Ect2 BRCT domains (113-342) human pEGFP-T7/C1  
 RB  65 GFP Ect2 Ect2 BRCT domains w211R (113-342) human pEGFP-T7/C1  
 RB  66 myc Ect2 Ect2 BRCT domains (113-342) human pcDNA3.1  
  RB  67 myc Ect2 Ect2 BRCT domains w211R (113-342) human pcDNA3.1  
   RB 68             His  Ect2                          Ect2 BRCTdomains (113-342) human pQE-30 
 RB  69             His Ect2 Ect2 BRCT domains w211R (113-342) human pQE-30  
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 RB  70 GFP Ect2 Ect2 s40A human pcDNA3.1  
  RB  71 GFP Ect2 Ect2 S40D human pEGFP-T7/C1  
  RB  72 myc Ect2 Ect2 1-360 human pcDNA3.1  
 RB  73 myc MKlp1 Full length human pcDNA3.1  
 RB  74 GFP Ect2 Ect2 V566D human pEGFP-T7/C1  
 RB  75 GFP Ect2 Ect2 E428A human pEGFP-T7/C1  
 RB  76  Cdc42BPB (Kiaa1124) human pBSSK+ 
  RB  77  Trim56 (IMAGp958P2343) human poTB7 
  RB  78            GST Trim56                      Trim56                                             human              pGEX-6P-3  
 RB  79 myc Trim56 Trim56 human pcDNA3.1  
 RB  80 His Ect2 Ect2 349-639 human pQE-82L  
 RB  81 myc Ect2 Ect2 S20A human pcDNA3.1  
 RB  82 myc Ect2 Ect2 S366A (undesired point mutations) human pcDNA3.1  
 RB  83 myc Ect2 Ect2 S685A human pcDNA3.1  
 RB  84 myc Ect2 Ect2 S336A human pcDNA3.1  
 RB  85 myc Ect2 Ect2 S366A human pcDNA3.1  
 RB  86 myc Ect2 Ect2 S20A, S685A human pcDNA3.1  
 RB  87 myc Ect2  Ect2 S811A human pcDNA3.1  
 RB  88 myc Ect2 Ect2 S20A, S366A, S685A human pcDNA3.1  
 RB  89 myc Ect2 Ect2 S20D human pcDNA3.1  
 RB  90 myc Ect2 Ect2 S366D human pcDNA3.1 
 RB  91 myc Ect2 Ect2 S685D human pcDNA3.1  
 RB  92 myc Ect2  Ect2 S811D human pcDNA3.1  
 RB  93 Flag Ect2 WT Ect2 human pcDNA3.1/Flag-C  
 RB  94 HA Ect2 WT Ect2 human pcDNA3.1/HA-C  
 RB  95 GFP Ect2  Ect2 T815A human pEGFP-T7/C1  
 RB  96 GFP Ect2 Ect2 T815D human pEGFP-T7/C1  
 RB  97 GFP Ect2 Ect2 S20A human pEGFP-T7/C1  
 RB  98 GFP Ect2 Ect2 S336A human pEGFP-T7/C1  
 RB  99 GFP Ect2 Ect2 S366A human pEGFP-T7/C1  
 RB100 myc Ect2 Ect2 1-333 S20A human pcDNA 3.1 
 RB101 myc Ect2 Ect2 1-333 S40A human pcDNA 3.1 
 RB102 myc Ect2 Ect2 1-333 S20D human pcDNA 3.1 
 RB103 myc Ect2 Ect2 1-333 S40D human pcDNA 3.1 
 RB104 myc Ect2 Ect2 1-333 S20A S40A human pcDNA 3.1 
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 RB105            myc Ect2                          Ect2 1-333 S20D S40D human pcDNA 3.1 
   RB106 YFP                               3X-SV40NLS SV40virus pEYFP-Nuc  
 RB107 myc Ect2 3XSV40-NLS-Ect2 1-333 human pcDNA 3.1 
 RB108 myc 3XSV40-NLS SV40virus pcDNA 3.1 
 RB109 myc Ect2 Ect2 KRR→NQQ human pcDNA 3.1 
 RB110 myc Ect2 Ect2 RKR→QNQ human pcDNA 3.1 
 RB111 myc Ect2 Ect2 KRR→NQQ,RKR→QNQ human pcDNA 3.1 
 RB112 AD Ect2 Ect2 1-333 human pGAD-c(1)   
   RB113 BD Ect2 Ect2 1-333 human pGBDΩ-C(1)  
 RB114 HA-C Ect2 Ect2 1-333 human pcDNA3.1/HA-C  
 RB115 HA-C Ect2 Ect2 1-360 human pcDNA3.1/HA-C  
 RB116 Flag-C Ect2 Ect2 1-333 human pcDNA3.1/Flag-C  
 RB117 Flag-C Ect2 Ect2 1-360 human pcDNA3.1/Flag-C  
 RB118 myc Ect2 Ect2 1-333 human pcDNA4/TO   
 RB119 myc Ect2 Ect2 1-360 human pcDNA4/TO   
 RB120 myc Ect2 Ect2 336-883 human pcDNA 3.1 
 RB121 myc Ect2 Ect2 355-883 human pcDNA 3.1  
  RB122 Flag-C Ect2 Ect2 414-883 human pcDNA3.1/Flag-C  
 RB123 myc Ect2 Ect2 414-630 human pcDNA 3.1  
   RB124 myc Ect2 Ect2 753-883 human pcDNA 3.1 
 RB125 myc  Cyk4 Full length Human Cyk4 (MgcRacGap) human pcDNA3.1 
 RB126 GFP  Cyk4 Full length Human Cyk4 (MgcRacGap) human  
 RB127 myc Ect2 Ect2 S20A,S366A,S685A,S811A human pcDNA 3.1  
   RB128 myc Ect2 Ect2 S20A,S336A,S366A,S685A,S811A human pcDNA 3.1 
 RB129 myc Ect2 Ect2 S685D,S811D human pcDNA 3.1  
   RB130 myc Ect2 Ect2 S20D,S40D human pcDNA 3.1 
 RB131 myc Ect2 Ect2 S20D,S40D,S685D,S811D human pcDNA 3.1 
 RB132 myc Ect2 Ect2 S336D,S366D human pcDNA 3.1  
   RB133 myc Ect2 Ect2 S20D,S40D,S336D,S366D,S685D,S811D human pcDNA 3.1 
 RB134 myc Ect2 Ect21-388 KRR→NQQ,RKR→QNQ human pcDNA 3.1 
 RB135 myc Ect2 Ect21-477 KRR→NQQ,RKR→QNQ human pcDNA 3.1  
  RB136 myc Ect2 Ect21-569 KRR→NQQ,RKR→QNQ human pcDNA 3.1 
 RB137 myc Ect2 Ect2 414-883 human pcDNA 3.1  
   RB138 HA-C Ect2 Ect2 414-883 human pcDNA3.1/HA-C  
 RB139 Flag-C Ect2 Ect2 414-630 human pcDNA3.1/Flag-C  
 RB140 HA-C Ect2 Ect2 414-630 human pcDNA3.1/HA-C  
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 RB141          Flag-A Cyk4 Human Cyk4 human pcDNA3.1/Flag-A  
 RB142 myc-c Ect2 Ect2 1-370 human  pcDNA3.1   
  RB143 myc-c Ect2 Ect2 1-370 KRR→NQQ human pcDNA3.1    
  RB144 myc-c Ect2 Ect2 5S→5A,KRR→NQQ human pcDNA3.1 
 RB145 myc-c Ect2 Ect2 1-370 S366A human pcDNA3.1 
 RB146 myc-c Ect2 Ect2 1-370 S366D human pcDNA3.1 
 RB147 myc-c Ect2 Ect2 41-333 human pcDNA3.1 
 RB148 myc-c Ect2 Ect2 320-370 human pcDNA3.1 
 RB149 myc-c Ect2 Ect2 320-388 human pcDNA3.1 
 RB150 GFP Ect2 Ect2 1-333 human pEGFP-T7/C1  
 RB151 myc-c Ect2 Ect2 1-333 K195A human pcDNA3.1 
 RB152 His Ect2 Ect2 1-333 human pQE30  
 RB153 GST Ect2 Ect2 1-333 human pGEX-6P-3  
 RB154 GST Ect2 Ect2 1-333 K195A human pGEX-6P-3  
 RB155  Ect2 3x-myc-Ect2 1-333 K195A human pcDNA4/TO  
 RB156            GFP Ect2 Ect2 1-333 K195A                                human pEGFP-T7/C1  
 RB157 AD Ect2 Ect2 414-883 human pGAD-C1  
 RB158 AD Ect2 Ect2 414-630 human pGAD-C1  
 RB159 BD Human Cyk4 Human Cyk4 human pGBD omega C1  
 RB160 myc Ect2 Nterm 1-333+peptide human pcDNA3.1 
 RB161 myc Ect2 Full length human pcDNA3.1 
 RB162 myc Ect2 Nterm 1-333 T153A,K195A human pcDNA3.1 
 RB163 myc Ect2 Ect2 5S →5A human pcDNA3.1 
 RB164 myc Ect2 Ect2 6S →6D human pcDNA3.1 
 RB166 myc Ect2 Ect2 7S→7A human pcDNA3.1 
 RB167 myc Ect2 Ect2 8S→8D human pcDNA3.1  
   RB168 myc Ect2 Ect2 1-420 human pcDNA3.1 
 RB169 myc Ect2 Ect2 2S→2D human pcDNA3.1 
 RB170 BD Ect2 Ect2 414-883 human pGBDΩ-C1  
 RB171 myc Ect2 N-term 1-333 T153A,K195A,Q192A human pcDNA3.1 
 RB172 myc Ect2 Nterm 1-333 T153A,K195A,V281F human pcDNA3.1 
 RB173 Flag-c Ect2 Nterm 1-333 T153A,K195A human pcDNA3.1/Flag-c   
  RB174 Flag-c Ect2 Nterm 1-333 T153A,K195A,Q192A human pcDNA3.1/Flag-c  
 RB175 Flag-c Ect2 Nterm 1-333 T153A,K195A,V281F human pcDNA3.1/Flag-c  
 RB176 GST Ect2 Ect2 1-333 T153A,K195A human pGEX-6P-3  
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  RB 177                GST Ect2 Ect2 1-333 T153A,K195A,Q192A human pGEX-6P-3  
 RB178 GST Ect2 Ect2 1-333 T153A,K195A,V192F human pGEX-6P-3  
 RB179 GST Ect2 Ect2 414-630 human pGEX-6P-3  
 RB180 His Ect2 Ect2 1-333 T153A,K195A human pQE-30  
 RB181 GFP Ect2 Ect2 1-333 T153A,K195A human pEGFP-t7/C1  
 RB182 GFP Actin Actin human                     pAcGFP1  
 RB183 myc Ect2 Ect2 320-883 human pcDNA3.1 
 RB184 myc-HisA MKlp1 Full length human pcDNA4/TO/myc 
 RB185 myc Ect2 Ect2 all Alanine mutant+siRNA human pcDNA3.1/3x  
 RB186 myc Ect2 Ect2 1-333 T328A human pcDNA3.1 
 RB187 myc RhoA wildtype human pRK5myc  
 RB188 myc Rac1 wildtype human pRK5myc  
 RB189 myc Cdc42 wildtype human pRK5myc  
 RB190 myc N19RhoA Dominant negative human pRK5myc  
 RB191 myc N17Rac1 Dominant negative human pRK5myc  
 RB192 myc N17Cdc42 Dominant negative human pRK5myc  
 RB193 myc MKlp2 Dominant negative human pcDNA3.1/myc  
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Project assistant (Aug 2001-June 2002) 
I was pursuing as a project assistant for one year in Prof. Raghavan Varadarajan’s lab at the Indian 
Institute of Scineces, Bangalore, India. 
 
Masters degree (Aug1999-may2001):  
Completed Master of Science in Biotechnology at the Madurai Kamaraj University, India in April 
2001. I scored 76.4% in my master’s degree. 
 
Under graduation (1996-1999):  
Bachelor of Science in Biochemistry, Microbiology, Aquaculture from  
P. B. Siddhartha College of Arts and Science, Nagarjuna University, India. I scored 85% in my under graduation. 
 
 
Honours, Scholarships, Ranks and Prizes: 
1) In class X, I was ranked 2nd and received Rs. 300/- as prize money. 
 
2) For Intermediate course (1993-1995), I was selected for the Andhra Pradesh Residential Junior 
College, Nagarjuna Sagar, India through the entrance test conducted by the Andhra Pradesh 
State Government.   
 
3) I was selected to the MSc Biotechnology course by All India Entrance (Rank-36) conducted by 
the Jawaharlal Nehru University affiliated to 20 other universities all over India. Receiving a 
monthly studentship of Rs.400/-, this studentship is established and maintained by the 
Department of Biotechnology (DBT), Government of India. 
 
4) Apart from this, I was also selected for following universities for the Master’s degree program. 
The selection process is based on competitive written exams. 
     Jawaharlal Nehru University, New Delhi in Life Sciences, 
      Hyderabad Central University -3rd rank in Biochemistry, 
     Andhra University, Vizag - 1st in Biochemistry, 
     Nagarjuna University, Vijayawada - 3rd in Microbiology.  
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5)  In GATE 2001 exam (Graduate Aptitude Test in Engineering), I scored 94% percentile in 
biological sciences exam. This is an All India entrance exam conducted to assess the knowledge 
of students for further studies like PhD’s and M.Tech (Master of Technology) courses. 
 
6)   JRF-CSIR fellowship MAY-2001. 
       I was selected for the award, which would include a package of approximately 50,000 rupees (as 
of 2001) as a yearly grant for a period of 5 years for pursuing Ph.D. in India. The Universities 
Grant Commission, India (UGC) and the Council of Scientific and Industrial research (CSIR) are 
the key agencies to fund the Ph.D. students in India. The students for the award of fellowships are 
selected by a highly competitive National Eligibility Test (NET) examination. This examination is 
held twice during the year for selection for the award of Junior Research Fellowships (JRF). 
Nearly 50,000 applications are received annually for the two NET examinations of which nearly 
30,000 candidates take the examination and a total of 1,000 are normally selected for the grant of 
fellowship both from CSIR and UGC. I was among top 20% of the candidates qualified for Junior 
Research Fellow under CSIR in the year Dec 2000. 
         But, as I had the opportunity to pursue my PhD studies at Max Planck Institute for 
Biochemistry in the Department of Cell Biology, I came over here to be part of wonderful 
international scientific atmosphere in the department of Prof. Erich Nigg. 
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4. Chakshusmathi G, Mondal K, Lakshmi GS, Singh G, Roy A, Ch RB, Madhusudhanan S, 
Varadarajan R.  
Design of temperature-sensitive mutants solely from amino acid sequence. Proc Natl Acad Sci U S A. 
2004 May 25;101 (21):7925-30 
 
References: 
        1. Prof.Erich A.Nigg, 
Department of Cell Biology, 
Max Planck Institute for Biochemistry, 
Am klopferspitz 18a, 
Martinsried,  
Munich. 
 
        2. Dr.Herman Sillje, 
Department of Cell Biology, 
Max Planck Institute for Biochemistry, 
Am klopferspitz 18a, 
Martinsried,   
Munich. 
 
 
 
 
 
 
 
 
 
 
 
